false--12-31Q1202000016743352900000P1Yus-gaap:AccountingStandardsUpdate201613Member70000000.010.0190000000090000000012400000193941100668003105532580.02550.06000.03450.06250.02250.01680.01300.0463P30Y7980001569000633000169300000001150002270004300004300000.010.0190000000900000000000 0001674335 2020-01-01 2020-06-27 0001674335 2020-08-03 0001674335 2020-03-29 2020-06-27 0001674335 2019-03-31 2019-06-29 0001674335 2019-01-01 2019-06-29 0001674335 2019-12-31 0001674335 2020-06-27 0001674335 us-gaap:OtherAdditionalCapitalMember 2020-03-29 2020-06-27 0001674335 us-gaap:RetainedEarningsMember 2020-03-28 0001674335 us-gaap:OtherAdditionalCapitalMember 2019-03-30 0001674335 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2019-06-29 0001674335 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2019-03-31 2019-06-29 0001674335 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2020-03-28 0001674335 us-gaap:CommonStockMember 2019-03-31 2019-06-29 0001674335 2019-06-29 0001674335 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2020-06-27 0001674335 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-06-27 0001674335 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2019-03-30 0001674335 jeld:EmployeeStockNotesMember us-gaap:OtherAdditionalCapitalMember 2020-06-27 0001674335 us-gaap:AdditionalPaidInCapitalMember 2019-06-29 0001674335 us-gaap:RetainedEarningsMember 2020-03-29 2020-06-27 0001674335 jeld:EmployeeStockNotesMember us-gaap:OtherAdditionalCapitalMember 2020-03-28 0001674335 us-gaap:RetainedEarningsMember 2019-03-30 0001674335 us-gaap:PreferredStockMember 2020-06-27 0001674335 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2020-03-29 2020-06-27 0001674335 us-gaap:OtherAdditionalCapitalMember 2019-06-29 0001674335 us-gaap:PreferredStockMember 2019-06-29 0001674335 jeld:EmployeeStockNotesMember us-gaap:OtherAdditionalCapitalMember 2019-03-31 2019-06-29 0001674335 us-gaap:OtherAdditionalCapitalMember 2019-03-31 2019-06-29 0001674335 jeld:EmployeeStockNotesMember us-gaap:OtherAdditionalCapitalMember 2019-03-30 0001674335 jeld:EmployeeStockNotesMember us-gaap:OtherAdditionalCapitalMember 2020-03-29 2020-06-27 0001674335 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-28 0001674335 us-gaap:RetainedEarningsMember 2020-06-27 0001674335 us-gaap:RetainedEarningsMember 2019-03-31 2019-06-29 0001674335 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-03-30 0001674335 us-gaap:RetainedEarningsMember 2019-06-29 0001674335 us-gaap:AdditionalPaidInCapitalMember 2020-06-27 0001674335 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-06-29 0001674335 us-gaap:OtherAdditionalCapitalMember 2020-03-28 0001674335 jeld:EmployeeStockNotesMember us-gaap:OtherAdditionalCapitalMember 2019-06-29 0001674335 us-gaap:OtherAdditionalCapitalMember 2020-06-27 0001674335 jeld:EmployeeStockNotesMember us-gaap:OtherAdditionalCapitalMember 2019-12-31 0001674335 us-gaap:RetainedEarningsMember 2020-01-01 2020-06-27 0001674335 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2020-01-01 2020-06-27 0001674335 us-gaap:AccumulatedTranslationAdjustmentMember 2020-01-01 2020-06-27 0001674335 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2019-01-01 2019-06-29 0001674335 jeld:EmployeeStockNotesMember us-gaap:OtherAdditionalCapitalMember 2020-01-01 2020-06-27 0001674335 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-01-01 2019-06-29 0001674335 jeld:EmployeeStockNotesMember us-gaap:OtherAdditionalCapitalMember 2018-12-31 0001674335 us-gaap:PreferredStockMember 2018-12-31 0001674335 us-gaap:AccumulatedTranslationAdjustmentMember 2018-12-31 0001674335 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:AccountingStandardsUpdate201613Member us-gaap:RetainedEarningsMember 2019-12-31 0001674335 us-gaap:OtherAdditionalCapitalMember 2019-01-01 2019-06-29 0001674335 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-01-01 2019-06-29 0001674335 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-01-01 2020-06-27 0001674335 us-gaap:RetainedEarningsMember 2019-12-31 0001674335 us-gaap:AccumulatedTranslationAdjustmentMember 2019-12-31 0001674335 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2018-12-31 0001674335 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2019-12-31 0001674335 us-gaap:RetainedEarningsMember 2018-12-31 0001674335 us-gaap:PreferredStockMember 2019-12-31 0001674335 us-gaap:OtherAdditionalCapitalMember 2020-01-01 2020-06-27 0001674335 us-gaap:CommonStockMember 2019-01-01 2019-06-29 0001674335 us-gaap:AccumulatedTranslationAdjustmentMember 2019-01-01 2019-06-29 0001674335 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:AccountingStandardsUpdate201602Member us-gaap:RetainedEarningsMember 2018-12-31 0001674335 jeld:EmployeeStockNotesMember us-gaap:OtherAdditionalCapitalMember 2019-01-01 2019-06-29 0001674335 us-gaap:RetainedEarningsMember 2019-01-01 2019-06-29 0001674335 us-gaap:OtherAdditionalCapitalMember 2018-12-31 0001674335 us-gaap:CommonStockMember 2020-01-01 2020-06-27 0001674335 us-gaap:OtherAdditionalCapitalMember 2019-12-31 0001674335 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-01-01 2020-06-27 0001674335 2018-12-31 0001674335 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2019-12-31 0001674335 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:RetainedEarningsMember 2019-12-31 0001674335 2019-01-01 2019-12-31 0001674335 jeld:VPIQualityWindowsInc.Member 2019-01-01 2019-12-31 0001674335 jeld:VPIQualityWindowsInc.Member 2019-12-31 0001674335 jeld:VPIQualityWindowsInc.Member 2019-03-31 2019-12-31 0001674335 jeld:VPIQualityWindowsInc.Member 2019-03-30 0001674335 jeld:VPIQualityWindowsInc.Member 2019-03-01 2019-03-30 0001674335 us-gaap:CostOfSalesMember 2019-03-31 2019-06-29 0001674335 us-gaap:CostOfSalesMember 2020-01-01 2020-06-27 0001674335 us-gaap:CostOfSalesMember 2020-03-29 2020-06-27 0001674335 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-01-01 2019-06-29 0001674335 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-01-01 2020-06-27 0001674335 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-03-29 2020-06-27 0001674335 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-03-31 2019-06-29 0001674335 us-gaap:CostOfSalesMember 2019-01-01 2019-06-29 0001674335 us-gaap:PropertyPlantAndEquipmentMember 2020-01-01 2020-06-27 0001674335 us-gaap:PropertyPlantAndEquipmentMember 2020-03-29 2020-06-27 0001674335 us-gaap:PropertyPlantAndEquipmentMember 2019-01-01 2019-06-29 0001674335 us-gaap:PropertyPlantAndEquipmentMember 2019-03-31 2019-06-29 0001674335 jeld:EuropeSegmentMember 2020-06-27 0001674335 jeld:AustralasiaSegmentMember 2019-12-31 0001674335 jeld:EuropeSegmentMember 2019-12-31 0001674335 jeld:AustralasiaSegmentMember 2020-06-27 0001674335 jeld:NorthAmericaSegmentMember 2020-06-27 0001674335 jeld:AustralasiaSegmentMember 2020-01-01 2020-06-27 0001674335 jeld:NorthAmericaSegmentMember 2020-01-01 2020-06-27 0001674335 jeld:NorthAmericaSegmentMember 2019-12-31 0001674335 jeld:EuropeSegmentMember 2020-01-01 2020-06-27 0001674335 us-gaap:CustomerRelationshipsMember 2019-12-31 0001674335 us-gaap:TrademarksAndTradeNamesMember 2019-12-31 0001674335 us-gaap:IntellectualPropertyMember 2019-12-31 0001674335 us-gaap:ComputerSoftwareIntangibleAssetMember 2019-12-31 0001674335 us-gaap:IntellectualPropertyMember 2020-06-27 0001674335 us-gaap:CustomerRelationshipsMember 2020-06-27 0001674335 us-gaap:TrademarksAndTradeNamesMember 2020-06-27 0001674335 us-gaap:ComputerSoftwareIntangibleAssetMember 2020-06-27 0001674335 us-gaap:ComputerSoftwareIntangibleAssetMember 2020-01-01 2020-06-27 0001674335 us-gaap:ComputerSoftwareIntangibleAssetMember 2020-03-01 2020-03-31 0001674335 srt:MinimumMember 2020-01-01 2020-06-27 0001674335 srt:MaximumMember jeld:NorthAmericaSegmentMember 2020-06-27 0001674335 srt:MaximumMember 2020-01-01 2020-06-27 0001674335 srt:MinimumMember jeld:NorthAmericaSegmentMember 2020-06-27 0001674335 us-gaap:SecuredDebtMember jeld:AustralianFacilityMember 2019-06-29 0001674335 srt:MinimumMember us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LondonInterbankOfferedRateLIBORMember 2020-05-31 0001674335 srt:MaximumMember us-gaap:SecuredDebtMember jeld:AustralianFacilityMember us-gaap:NotesPayableToBanksMember jeld:BBSYMember 2019-06-01 2019-06-29 0001674335 us-gaap:SeniorNotesMember 2017-12-31 0001674335 us-gaap:SecuredDebtMember jeld:AmendedFloatingRateRevolvingLoanFacilityMember us-gaap:NotesPayableToBanksMember 2020-05-01 2020-05-31 0001674335 jeld:InterchangeableFacilityMember jeld:AustraliaSeniorSecuredCreditFacilityMember us-gaap:LineOfCreditMember 2019-06-01 2019-06-29 0001674335 jeld:InterchangeableFacilityMember jeld:AustraliaSeniorSecuredCreditFacilityMember us-gaap:LineOfCreditMember 2020-01-01 2020-06-27 0001674335 jeld:SeniorNoteMaturingDecember2025Member us-gaap:SeniorNotesMember 2017-12-31 0001674335 jeld:TermLoanMember us-gaap:NotesPayableToBanksMember 2019-09-28 0001674335 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-05-31 0001674335 jeld:TermLoanMember us-gaap:NotesPayableToBanksMember 2019-09-01 2019-09-28 0001674335 jeld:SeniorSecuredNotesMaturingMay2025Member us-gaap:SeniorNotesMember 2020-05-31 0001674335 jeld:SeniorNoteMaturingDecember2027Member us-gaap:SeniorNotesMember 2017-12-31 0001674335 jeld:TermLoanMember us-gaap:NotesPayableToBanksMember 2019-02-28 0001674335 srt:MinimumMember us-gaap:SecuredDebtMember jeld:AustralianFacilityMember us-gaap:NotesPayableToBanksMember jeld:BBSYMember 2019-06-01 2019-06-29 0001674335 jeld:InterchangeableFacilityMember jeld:AustraliaSeniorSecuredCreditFacilityMember us-gaap:LineOfCreditMember 2020-06-27 0001674335 us-gaap:SecuredDebtMember 2020-06-27 0001674335 us-gaap:SecuredDebtMember jeld:AustralianFacilityMember us-gaap:NotesPayableToBanksMember 2019-06-01 2019-06-29 0001674335 us-gaap:RevolvingCreditFacilityMember jeld:ABLFacilityMember us-gaap:LineOfCreditMember 2020-06-27 0001674335 us-gaap:RevolvingCreditFacilityMember jeld:ABLFacilityMember us-gaap:LineOfCreditMember 2020-03-01 2020-03-31 0001674335 us-gaap:SecuredDebtMember jeld:AmendedFloatingRateRevolvingLoanFacilityMember us-gaap:NotesPayableToBanksMember 2020-06-27 0001674335 us-gaap:SecuredDebtMember jeld:AmendedFloatingRateRevolvingLoanFacilityMember us-gaap:NotesPayableToBanksMember jeld:BBSYMember 2020-05-01 2020-05-31 0001674335 jeld:InstallmentLoanMember us-gaap:NotesPayableToBanksMember 2020-06-27 0001674335 jeld:InterchangeableFacilityMember jeld:AustraliaSeniorSecuredCreditFacilityMember us-gaap:LineOfCreditMember 2019-06-30 0001674335 us-gaap:SecuredDebtMember jeld:AustralianFacilityMember us-gaap:NotesPayableToBanksMember 2020-06-27 0001674335 jeld:TermLoanMember us-gaap:NotesPayableToBanksMember 2020-06-27 0001674335 us-gaap:RevolvingCreditFacilityMember 2020-06-27 0001674335 us-gaap:SeniorNotesMember 2019-12-31 0001674335 us-gaap:SecuredDebtMember 2019-12-31 0001674335 us-gaap:ConvertibleNotesPayableMember 2020-06-27 0001674335 jeld:InstallmentLoanMember us-gaap:NotesPayableToBanksMember 2019-12-31 0001674335 us-gaap:ConvertibleNotesPayableMember 2019-12-31 0001674335 us-gaap:SeniorNotesMember 2020-06-27 0001674335 jeld:TermLoanMember us-gaap:NotesPayableToBanksMember 2019-12-31 0001674335 us-gaap:SecuredDebtMember 2007-12-01 2007-12-31 0001674335 srt:MinimumMember jeld:InstallmentLoanMember us-gaap:NotesPayableToBanksMember 2020-06-27 0001674335 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2020-06-27 0001674335 srt:MaximumMember jeld:InstallmentLoanMember us-gaap:NotesPayableToBanksMember 2020-06-27 0001674335 srt:MaximumMember us-gaap:SeniorNotesMember 2020-06-27 0001674335 srt:MaximumMember jeld:TermLoanMember us-gaap:NotesPayableToBanksMember 2020-06-27 0001674335 srt:MinimumMember jeld:TermLoanMember us-gaap:NotesPayableToBanksMember 2020-06-27 0001674335 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2020-06-27 0001674335 srt:MinimumMember us-gaap:SeniorNotesMember 2020-06-27 0001674335 us-gaap:MajorityOwnedSubsidiaryUnconsolidatedMember 2019-01-01 2019-06-29 0001674335 us-gaap:ScenarioAdjustmentMember 2019-03-31 2019-06-29 0001674335 us-gaap:MajorityOwnedSubsidiaryUnconsolidatedMember 2019-03-31 2019-06-29 0001674335 us-gaap:ScenarioAdjustmentMember 2019-01-01 2019-06-29 0001674335 us-gaap:OperatingSegmentsMember jeld:AustralasiaSegmentMember 2020-03-29 2020-06-27 0001674335 jeld:AustralasiaSegmentMember 2020-03-29 2020-06-27 0001674335 jeld:AustralasiaSegmentMember 2019-03-31 2019-06-29 0001674335 us-gaap:OperatingSegmentsMember jeld:AustralasiaSegmentMember 2019-03-31 2019-06-29 0001674335 us-gaap:OperatingSegmentsMember 2019-03-31 2019-06-29 0001674335 us-gaap:IntersegmentEliminationMember jeld:EuropeSegmentMember 2020-03-29 2020-06-27 0001674335 jeld:NorthAmericaSegmentMember 2020-03-29 2020-06-27 0001674335 us-gaap:OperatingSegmentsMember 2020-03-29 2020-06-27 0001674335 us-gaap:IntersegmentEliminationMember 2019-03-31 2019-06-29 0001674335 us-gaap:OperatingSegmentsMember jeld:EuropeSegmentMember 2020-03-29 2020-06-27 0001674335 us-gaap:CorporateNonSegmentMember 2019-03-31 2019-06-29 0001674335 us-gaap:OperatingSegmentsMember jeld:NorthAmericaSegmentMember 2019-03-31 2019-06-29 0001674335 us-gaap:IntersegmentEliminationMember jeld:NorthAmericaSegmentMember 2020-03-29 2020-06-27 0001674335 us-gaap:IntersegmentEliminationMember 2020-03-29 2020-06-27 0001674335 jeld:NorthAmericaSegmentMember 2019-03-31 2019-06-29 0001674335 us-gaap:OperatingSegmentsMember jeld:NorthAmericaSegmentMember 2020-03-29 2020-06-27 0001674335 us-gaap:IntersegmentEliminationMember jeld:AustralasiaSegmentMember 2020-03-29 2020-06-27 0001674335 us-gaap:IntersegmentEliminationMember jeld:EuropeSegmentMember 2019-03-31 2019-06-29 0001674335 jeld:EuropeSegmentMember 2020-03-29 2020-06-27 0001674335 us-gaap:OperatingSegmentsMember jeld:EuropeSegmentMember 2019-03-31 2019-06-29 0001674335 jeld:EuropeSegmentMember 2019-03-31 2019-06-29 0001674335 us-gaap:IntersegmentEliminationMember jeld:AustralasiaSegmentMember 2019-03-31 2019-06-29 0001674335 us-gaap:CorporateNonSegmentMember 2020-03-29 2020-06-27 0001674335 us-gaap:IntersegmentEliminationMember jeld:NorthAmericaSegmentMember 2019-03-31 2019-06-29 0001674335 us-gaap:OperatingSegmentsMember 2020-01-01 2020-06-27 0001674335 us-gaap:OperatingSegmentsMember jeld:AustralasiaSegmentMember 2019-01-01 2019-06-29 0001674335 us-gaap:OperatingSegmentsMember 2019-01-01 2019-06-29 0001674335 us-gaap:CorporateNonSegmentMember 2020-01-01 2020-06-27 0001674335 us-gaap:IntersegmentEliminationMember jeld:NorthAmericaSegmentMember 2020-01-01 2020-06-27 0001674335 us-gaap:CorporateNonSegmentMember 2019-01-01 2019-06-29 0001674335 us-gaap:OperatingSegmentsMember jeld:NorthAmericaSegmentMember 2020-01-01 2020-06-27 0001674335 us-gaap:OperatingSegmentsMember jeld:AustralasiaSegmentMember 2020-01-01 2020-06-27 0001674335 us-gaap:IntersegmentEliminationMember jeld:NorthAmericaSegmentMember 2019-01-01 2019-06-29 0001674335 us-gaap:OperatingSegmentsMember jeld:EuropeSegmentMember 2020-01-01 2020-06-27 0001674335 us-gaap:IntersegmentEliminationMember 2020-01-01 2020-06-27 0001674335 jeld:AustralasiaSegmentMember 2019-01-01 2019-06-29 0001674335 us-gaap:OperatingSegmentsMember jeld:EuropeSegmentMember 2019-01-01 2019-06-29 0001674335 us-gaap:OperatingSegmentsMember jeld:NorthAmericaSegmentMember 2019-01-01 2019-06-29 0001674335 us-gaap:IntersegmentEliminationMember 2019-01-01 2019-06-29 0001674335 us-gaap:IntersegmentEliminationMember jeld:AustralasiaSegmentMember 2020-01-01 2020-06-27 0001674335 jeld:EuropeSegmentMember 2019-01-01 2019-06-29 0001674335 jeld:NorthAmericaSegmentMember 2019-01-01 2019-06-29 0001674335 us-gaap:IntersegmentEliminationMember jeld:EuropeSegmentMember 2019-01-01 2019-06-29 0001674335 us-gaap:IntersegmentEliminationMember jeld:EuropeSegmentMember 2020-01-01 2020-06-27 0001674335 us-gaap:IntersegmentEliminationMember jeld:AustralasiaSegmentMember 2019-01-01 2019-06-29 0001674335 2019-11-04 0001674335 us-gaap:CommonStockMember 2020-03-29 2020-06-27 0001674335 2018-04-30 0001674335 us-gaap:RestrictedStockUnitsRSUMember 2020-03-29 2020-06-27 0001674335 us-gaap:EmployeeStockOptionMember us-gaap:CommonStockMember 2020-03-29 2020-06-27 0001674335 us-gaap:RestrictedStockUnitsRSUMember 2020-01-01 2020-06-27 0001674335 us-gaap:PerformanceSharesMember 2019-01-01 2019-06-29 0001674335 us-gaap:PerformanceSharesMember 2020-03-29 2020-06-27 0001674335 us-gaap:RestrictedStockUnitsRSUMember 2019-01-01 2019-06-29 0001674335 us-gaap:EmployeeStockOptionMember us-gaap:CommonStockMember 2020-01-01 2020-06-27 0001674335 us-gaap:EmployeeStockOptionMember us-gaap:CommonStockMember 2019-03-31 2019-06-29 0001674335 us-gaap:RestrictedStockUnitsRSUMember 2019-03-31 2019-06-29 0001674335 us-gaap:EmployeeStockOptionMember us-gaap:CommonStockMember 2019-01-01 2019-06-29 0001674335 us-gaap:PerformanceSharesMember 2019-03-31 2019-06-29 0001674335 us-gaap:PerformanceSharesMember 2020-01-01 2020-06-27 0001674335 us-gaap:PerformanceSharesMember 2019-03-31 2019-06-29 0001674335 us-gaap:RestrictedStockUnitsRSUMember 2020-03-29 2020-06-27 0001674335 us-gaap:PerformanceSharesMember 2020-03-29 2020-06-27 0001674335 us-gaap:RestrictedStockUnitsRSUMember 2019-03-31 2019-06-29 0001674335 us-gaap:RestrictedStockUnitsRSUMember 2020-01-01 2020-06-27 0001674335 us-gaap:PerformanceSharesMember 2019-01-01 2019-06-29 0001674335 us-gaap:PerformanceSharesMember 2020-01-01 2020-06-27 0001674335 us-gaap:RestrictedStockUnitsRSUMember 2019-01-01 2019-06-29 0001674335 us-gaap:EmployeeSeveranceMember 2020-01-01 2020-06-27 0001674335 us-gaap:EmployeeSeveranceMember 2019-01-01 2019-06-29 0001674335 us-gaap:OtherRestructuringMember 2020-01-01 2020-06-27 0001674335 us-gaap:EmployeeSeveranceMember 2019-06-29 0001674335 us-gaap:OtherRestructuringMember 2019-01-01 2019-06-29 0001674335 us-gaap:OtherRestructuringMember 2019-06-29 0001674335 us-gaap:OtherRestructuringMember 2019-12-31 0001674335 us-gaap:EmployeeSeveranceMember 2020-06-27 0001674335 us-gaap:OtherRestructuringMember 2018-12-31 0001674335 us-gaap:EmployeeSeveranceMember 2019-12-31 0001674335 us-gaap:OtherRestructuringMember 2020-06-27 0001674335 us-gaap:EmployeeSeveranceMember 2018-12-31 0001674335 jeld:InterestRateSwapsEffectivePeriodFourMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2017-12-01 2017-12-31 0001674335 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-01-01 2019-06-29 0001674335 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-03-31 2019-06-29 0001674335 jeld:ForeignExchangeContractsConsolidatedEarningsMember us-gaap:NondesignatedMember 2020-06-27 0001674335 us-gaap:InterestRateCapMember 2019-06-29 0001674335 jeld:InterestRateSwapsEffectivePeriodFourMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2017-12-31 0001674335 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2019-03-31 2019-06-29 0001674335 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-01-01 2020-06-27 0001674335 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2020-01-01 2020-06-27 0001674335 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2020-03-29 2020-06-27 0001674335 jeld:ForeignExchangeContractsForecastedTransactionsMember us-gaap:NondesignatedMember 2020-06-27 0001674335 jeld:ForeignCurrencyExchangeContractsIntercompanyLoansandInterestMember us-gaap:NondesignatedMember 2020-06-27 0001674335 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2019-01-01 2019-06-29 0001674335 jeld:DeferredCreditsAndOtherLiabilitiesMember us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0001674335 us-gaap:AccruedLiabilitiesMember us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0001674335 jeld:DeferredCreditsAndOtherLiabilitiesMember us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-06-27 0001674335 us-gaap:AccruedLiabilitiesMember us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2020-06-27 0001674335 us-gaap:AccruedLiabilitiesMember us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-06-27 0001674335 us-gaap:AccruedLiabilitiesMember us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2019-12-31 0001674335 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2020-06-27 0001674335 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2019-12-31 0001674335 us-gaap:OtherAssetsMember us-gaap:InterestRateCapMember us-gaap:NondesignatedMember 2019-12-31 0001674335 us-gaap:OtherAssetsMember us-gaap:InterestRateCapMember us-gaap:NondesignatedMember 2020-06-27 0001674335 jeld:AccruedExpensesAndDeferredCreditsMember us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2020-06-27 0001674335 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2020-06-27 0001674335 us-gaap:OtherNoncurrentAssetsMember us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2020-06-27 0001674335 jeld:DeferredCreditsAndOtherLiabilitiesMember us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2020-06-27 0001674335 jeld:AccruedExpensesAndDeferredCreditsMember us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2020-06-27 0001674335 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2020-06-27 0001674335 us-gaap:OtherNoncurrentAssetsMember us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2020-06-27 0001674335 us-gaap:OtherCurrentAssetsMember us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2020-06-27 0001674335 us-gaap:OtherNoncurrentAssetsMember us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2020-06-27 0001674335 jeld:AccruedExpensesAndDeferredCreditsMember us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2020-06-27 0001674335 us-gaap:OtherCurrentAssetsMember us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2020-06-27 0001674335 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2020-06-27 0001674335 jeld:AccruedExpensesAndDeferredCreditsMember us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2020-06-27 0001674335 jeld:AccruedExpensesAndDeferredCreditsMember us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2020-06-27 0001674335 jeld:DeferredCreditsAndOtherLiabilitiesMember us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2020-06-27 0001674335 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2020-06-27 0001674335 us-gaap:OtherCurrentAssetsMember us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2020-06-27 0001674335 us-gaap:OtherCurrentAssetsMember us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2020-06-27 0001674335 jeld:DeferredCreditsAndOtherLiabilitiesMember us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2020-06-27 0001674335 us-gaap:OtherCurrentAssetsMember us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2020-06-27 0001674335 us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2020-06-27 0001674335 jeld:DeferredCreditsAndOtherLiabilitiesMember us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2020-06-27 0001674335 us-gaap:OtherNoncurrentAssetsMember us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2020-06-27 0001674335 us-gaap:OtherNoncurrentAssetsMember us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2020-06-27 0001674335 jeld:DeferredCreditsAndOtherLiabilitiesMember us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2020-06-27 0001674335 us-gaap:OtherCurrentAssetsMember us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001674335 jeld:AccruedExpensesAndDeferredCreditsMember us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001674335 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001674335 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001674335 us-gaap:OtherNoncurrentAssetsMember us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001674335 us-gaap:OtherNoncurrentAssetsMember us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001674335 us-gaap:OtherCurrentAssetsMember us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001674335 us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001674335 jeld:AccruedExpensesAndDeferredCreditsMember us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001674335 jeld:AccruedExpensesAndDeferredCreditsMember us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001674335 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001674335 us-gaap:OtherNoncurrentAssetsMember us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001674335 us-gaap:OtherCurrentAssetsMember us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001674335 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001674335 jeld:AccruedExpensesAndDeferredCreditsMember us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001674335 us-gaap:OtherCurrentAssetsMember us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001674335 jeld:AccruedExpensesAndDeferredCreditsMember us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001674335 us-gaap:OtherNoncurrentAssetsMember us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001674335 us-gaap:OtherNoncurrentAssetsMember us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001674335 us-gaap:OtherCurrentAssetsMember us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001674335 jeld:SettlementTwoMember jeld:SteveandSonsMember 2018-02-01 2018-02-28 0001674335 jeld:SteveandSonsMember 2019-03-13 2019-03-13 0001674335 jeld:SettlementOneMember jeld:SteveandSonsMember 2018-02-01 2018-02-28 0001674335 jeld:SteveandSonsMember jeld:AttorneyFeesMember 2019-04-12 2019-04-12 0001674335 jeld:SettlementOneMember jeld:SteveandSonsMember 2019-03-13 2019-03-13 0001674335 srt:MaximumMember jeld:AutoGeneralLiabilityPersonalInjuryandWorkersCompensationMember 2020-01-01 2020-06-27 0001674335 srt:MaximumMember jeld:DomesticProductLiabilityMember 2020-01-01 2020-06-27 0001674335 jeld:SteveandSonsMember 2018-05-11 2018-05-11 0001674335 jeld:SteveandSonsMember jeld:LegalCostMember 2019-04-12 2019-04-12 0001674335 jeld:SteveandSonsMember 2019-11-19 2019-11-19 0001674335 jeld:SteveandSonsMember 2019-12-31 0001674335 srt:MinimumMember jeld:AutoGeneralLiabilityPersonalInjuryandWorkersCompensationMember 2020-01-01 2020-06-27 0001674335 srt:MinimumMember jeld:DomesticProductLiabilityMember 2020-01-01 2020-06-27 0001674335 jeld:SettlementTwoMember jeld:SteveandSonsMember 2019-03-13 2019-03-13 0001674335 jeld:SteveandSonsMember 2020-06-27 0001674335 jeld:PennsylvaniaDepartmentofEnvironmentalProtectionMember 2020-06-27 0001674335 jeld:VPIQualityWindowsInc.Member jeld:AcquiredLeaseMember srt:AffiliatedEntityMember 2019-08-01 2019-08-31 0001674335 srt:AffiliatedEntityMember 2019-05-31 0001674335 srt:AffiliatedEntityMember 2020-06-27 0001674335 jeld:VPIQualityWindowsInc.Member jeld:AcquiredLeaseMember srt:AffiliatedEntityMember 2019-06-29 0001674335 jeld:VPIQualityWindowsInc.Member jeld:AcquiredLeaseMember srt:AffiliatedEntityMember 2020-06-27 0001674335 jeld:BoardOfDirectorsMemberMember jeld:SalesOfSubsidiaryMember srt:AffiliatedEntityMember 2019-03-31 2019-06-29 0001674335 jeld:BoardOfDirectorsMemberMember jeld:SalesOfSubsidiaryMember srt:AffiliatedEntityMember 2019-05-01 2019-05-31 xbrli:pure jeld:tranch iso4217:AUD iso4217:USD xbrli:shares iso4217:USD xbrli:shares iso4217:DKK jeld:instrument jeld:lease jeld:segment
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
____________________________
FORM 10-Q
____________________________

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 27, 2020
or
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _____ to _____
Commission File Number: 001-38000
____________________________
JELD-WEN Holding, Inc.
(Exact name of registrant as specified in its charter)
____________________________
Delaware
 
93-1273278
(State or other jurisdiction of
incorporation or organization)
 
(I.R.S. Employer
Identification No.)
2645 Silver Crescent Drive
Charlotte, North Carolina 28273
(Address of principal executive offices, zip code)
(704) 378-5700
(Registrant’s telephone number, including area code)
____________________________

Securities registered pursuant to Section 12(b) of the Act:
Title of each class
 
Trading Symbol(s)
 
Name of each exchange on which registered
Common Stock (par value $0.01 per share)
 
JELD
 
New York Stock Exchange

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
 
 
Accelerated filer
 
 
 
 
 
Non-accelerated filer
 
o
 
Smaller reporting company
 
 
 
 
 
 
 
 
 
 
 
 
Emerging growth company
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No
The registrant had 100,568,194 shares of Common Stock, par value $0.01 per share, outstanding as of August 3, 2020.





JELD-WEN HOLDING, Inc.
- Table of Contents –
 
 
Page No.
Part I - Financial Information
 
 
 
 
Item 1.
Unaudited Financial Statements
 
 
Consolidated Statements of Operations
5
 
Consolidated Statements of Comprehensive Income (Loss)
6
 
Consolidated Balance Sheets
7
 
Consolidated Statements of Equity
8
 
Consolidated Statements of Cash Flows
11
 
Notes to Unaudited Consolidated Financial Statements
12
Item 2.
Management’s Discussion and Analysis of Financial Condition and Results of Operations
35
Item 3.
Quantitative and Qualitative Disclosures about Market Risk
45
Item 4.
Controls and Procedures
45
 
 
 
Part II - Other Information
 
 
 
 
Item 1.
Legal Proceedings
48
Item 1A.
Risk Factors
50
Item 5.
Other Information
52
Item 6.
Exhibits
52
 
 
 
 
Signature
53



2


Back to top

Glossary of Terms

When the following terms and abbreviations appear in the text of this report, they have the meanings indicated below:
ABL Facility
Our $400 million asset-based loan revolving credit facility, dated as of October 15, 2014 and as amended from time to time, with JWI (as hereinafter defined) and JELD-WEN of Canada, Ltd., as borrowers, the guarantors party thereto, a syndicate of lenders, and Wells Fargo Bank, N.A., as administrative agent
ABS
American Building Supply, Inc.
Adjusted EBITDA
A supplemental non-GAAP financial measure of operating performance not based on any standardized methodology prescribed by GAAP that we define as net income (loss), adjusted for the following items: loss from discontinued operations, net of tax; equity earnings of non-consolidated entities; income tax (benefit) expense; depreciation and amortization; interest expense, net; impairment and restructuring charges; gain on previously held shares of equity investment; (gain) loss on sale of property and equipment; share-based compensation expense; non-cash foreign exchange transaction/translation (income) loss; other non-cash items; other items; and costs related to debt restructuring and debt refinancing
ASC
Accounting Standards Codification
ASU
Accounting Standards Update
AUD
Australian Dollar
Australia Senior Secured Credit Facility
Our senior secured credit facility, dated as of October 6, 2015 and as amended from time to time, with certain of our Australian subsidiaries, as borrowers, and Australia and New Zealand Banking Group Limited, as lender
BBSY
Bank Bill Swap Bid Rate
Bylaws
Amended and Restated Bylaws of JELD-WEN Holding, Inc.
CAP
Cleanup Action Plan
Charter
Restated Certificate of Incorporation of JELD-WEN Holding, Inc.
Class B-1 Common Stock
Shares of our Class B-1 common stock, par value $0.01 per share, all of which were converted into shares of our Common Stock on February 1, 2017
CMI
CraftMaster Manufacturing, Inc.
COA
Consent Order and Agreement
CODM
Chief Operating Decision Maker
Common Stock
The 900,000,000 shares of common stock, par value $0.01 per share, authorized under our Charter
Corporate Credit Facilities
Collectively, our ABL Facility and our Term Loan Facility
COVID-19
A novel strain of the 2019-nCov coronavirus
Credit Facilities
Collectively, our Corporate Credit Facilities and our Australia Senior Secured Credit Facility as well as other acquired term loans and revolving credit facilities
DKK
Danish Krone
ERP
Enterprise Resource Planning
ESOP
JELD-WEN, Inc. Employee Stock Ownership and Retirement Plan
Exchange Act
Securities Exchange Act of 1934, as amended
FASB
Financial Accounting Standards Board
10-K
Annual Report on Form 10-K for the fiscal year ended December 31, 2019
GAAP
Generally Accepted Accounting Principles in the United States
GHGs
Greenhouse Gases
GILTI
Global Intangible Low-Taxed Income
JELD-WEN
JELD-WEN Holding, Inc., together with its consolidated subsidiaries where the context requires
JEM
JELD-WEN Excellence Model
JWH
JELD-WEN Holding, Inc., a Delaware corporation
JWI
JELD-WEN, Inc., a Delaware corporation
LIBOR
London Interbank Offered Rate
MD&A
Management’s Discussion and Analysis of Financial Condition and Results of Operations

3


Back to top

Onex
Onex Partners III LP and certain affiliates
PaDEP
Pennsylvania Department of Environmental Protection
Preferred Stock
90,000,000 shares of Preferred Stock, par value $0.01 per share, authorized under our Charter
PSU
Performance stock unit
R&R
Repair and remodel
RSU
Restricted stock unit
SEC
Securities and Exchange Commission
Securities Act
Securities Act of 1933, as amended
Senior Notes
$800.0 million of unsecured notes issued in December 2017 in a private placement in two tranches: $400.0 million bearing interest at 4.625% and maturing in December 2025 and $400.0 million bearing interest at 4.875% and maturing in December 2027
Senior Secured Notes
$250.0 million of senior secured notes issued in May 2020 in a private placement bearing interest at 6.25% and maturing in May 2025
SG&A
Selling, general, and administrative expenses
Tax Act
Tax Cuts and Jobs Act
Term Loan Facility
Our term loan facility, dated as of October 15, 2014, and as amended from time to time with JWI, as borrower, the guarantors party thereto, a syndicate of lenders, and Bank of America, N.A., as administrative agent
U.S.
United States of America
VPI
VPI Quality Windows, Inc.
WADOE
Washington State Department of Ecology
CERTAIN TRADEMARKS, TRADE NAMES AND SERVICE MARKS
This 10-Q includes trademarks, trade names, and service marks owned by us. Our U.S. window and door trademarks include JELD-WEN®, AuraLast®, MiraTEC®, Extira®, LaCANTINATM, MMI DoorTM, KaronaTM, ImpactGard®, JW®, Aurora®, IWP®, True BLUTM, ABSTM, and VPITM . Our trademarks are either registered or have been used as common law trademarks by us. The trademarks we use outside the U.S. include the Stegbar®, Regency®, William Russell Doors®, Airlite®, Trend®, The Perfect FitTM, Aneeta®, Breezway®, KolderTM , Corinthian® and A&LTM marks in Australia, and Swedoor®, Dooria®, DANA®, MattioviTM, Alupan® and Domoferm® marks in Europe. ENERGY STAR® is a registered trademark of the U.S. Environmental Protection Agency. This 10-Q contains additional trademarks, trade names, and service marks of others, which are, to our knowledge, the property of their respective owners. Solely for convenience, trademarks, trade names, and service marks referred to in this 10-Q appear without the ®, ™ or SM symbols, but such references are not intended to indicate, in any way, that we will not assert, to the fullest extent under applicable law, our rights or the right of the applicable licensor to these trademarks, trade names, and service marks. We do not intend our use of other parties’ trademarks, trade names, or service marks to imply, and such use or display should not be construed to imply, a relationship with, or endorsement or sponsorship of us by, these other parties.

4



PART I - FINANCIAL INFORMATION
Item 1 - Unaudited Financial Statements

JELD-WEN HOLDING, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(unaudited)
 
Three Months Ended
 
Six Months Ended
(amounts in thousands, except share and per share data)
June 27,
2020
 
June 29,
2019
 
June 27,
2020
 
June 29,
2019
Net revenues
$
992,346

 
$
1,118,987

 
$
1,971,533

 
$
2,129,247

Cost of sales
773,675

 
878,768

 
1,558,493

 
1,680,899

Gross margin
218,671

 
240,219

 
413,040

 
448,348

Selling, general and administrative
166,327

 
176,585

 
338,911

 
340,685

Impairment and restructuring charges
2,266

 
5,734

 
8,811

 
9,453

Operating income
50,078

 
57,900

 
65,318

 
98,210

Interest expense, net
19,076

 
18,492

 
35,680

 
36,148

Other (income) expense
(2,498
)
 
4,871

 
(4,829
)
 
1,399

Income before taxes
33,500

 
34,537

 
34,467

 
60,663

Income tax expense
10,403

 
12,181

 
11,600

 
22,530

Net income
$
23,097

 
$
22,356

 
$
22,867

 
$
38,133

 
 
 
 
 
 
 
 
Weighted average common shares outstanding:
 
 
 
 
 
 
 
Basic
100,508,707
 
100,630,119
 
100,576,621

 
100,636,740

Diluted
100,934,273
 
101,473,530
 
101,303,975

 
101,465,071

Net income per share
 
 
 
 
 
 
 
Basic
$
0.23

 
$
0.22

 
$
0.23

 
$
0.38

Diluted
$
0.23

 
$
0.22

 
$
0.23

 
$
0.38



























The accompanying notes are an integral part of these unaudited Consolidated Financial Statements.

5



JELD-WEN HOLDING, INC.
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(unaudited)
 
Three Months Ended
 
Six Months Ended
(amounts in thousands)
June 27,
2020
 
June 29,
2019
 
June 27,
2020
 
June 29,
2019
Net income
$
23,097

 
$
22,356

 
$
22,867

 
$
38,133

Other comprehensive income (loss), net of tax:
 
 
 
 
 
 
 
Foreign currency translation adjustments, net tax of $0
49,896

 
10,079

 
(3,743
)
 
(1,967
)
Interest rate hedge adjustments, net of tax benefit of ($430), ($115), ($430), and ($227), respectively
(1,256
)
 
563

 
(1,256
)
 
1,113

Defined benefit pension plans, net of tax expense of $633, $798, $1,693, and $1,569, respectively
84

 
1,428

 
2,847

 
2,882

Total other comprehensive income (loss), net of tax
48,724

 
12,070

 
(2,152
)
 
2,028

Comprehensive income
$
71,821

 
$
34,426

 
$
20,715

 
$
40,161










































The accompanying notes are an integral part of these unaudited Consolidated Financial Statements.

6


JELD-WEN HOLDING, INC.
CONSOLIDATED BALANCE SHEETS
(unaudited)
(amounts in thousands, except share and per share data)
June 27,
2020
 
December 31,
2019
ASSETS
 
 
 
Current assets
 
 
 
Cash and cash equivalents
$
457,655

 
$
225,962

Restricted cash
782

 
3,914

Accounts receivable, net
549,446

 
469,762

Inventories
536,742

 
505,078

Other current assets
44,881

 
38,562

Total current assets
1,589,506

 
1,243,278

Property and equipment, net
841,436

 
864,375

Deferred tax assets
183,286

 
183,837

Goodwill
601,401

 
602,500

Intangible assets, net
243,322

 
250,327

Operating lease assets, net
208,316

 
202,053

Other assets
31,614

 
34,962

Total assets
$
3,698,881

 
$
3,381,332

LIABILITIES AND EQUITY
 
 
 
Current liabilities
 
 
 
Accounts payable
$
293,847

 
$
294,951

Accrued payroll and benefits
135,264

 
109,386

Accrued expenses and other current liabilities
319,132

 
298,603

Current maturities of long-term debt
69,194

 
65,846

Total current liabilities
817,437

 
768,786

Long-term debt
1,692,657

 
1,451,526

Unfunded pension liability
103,950

 
107,937

Operating lease liability
171,485

 
164,026

Deferred credits and other liabilities
73,323

 
67,682

Deferred tax liabilities
9,427

 
9,288

Total liabilities
2,868,279

 
2,569,245

Commitments and contingencies (Note 21)

 

Shareholders’ equity
 
 
 
Preferred Stock, par value $0.01 per share, 90,000,000 shares authorized; no shares issued and outstanding

 

Common Stock: 900,000,000 shares authorized, par value $0.01 per share, 100,553,258 shares outstanding as of June 27, 2020; 900,000,000 shares authorized, par value $0.01 per share, 100,668,003 shares outstanding as of December 31, 2019
1,005

 
1,007

Additional paid-in capital
680,281

 
671,772

Retained earnings
302,743

 
290,583

Accumulated other comprehensive loss
(153,427
)
 
(151,275
)
Total shareholders’ equity
830,602

 
812,087

Total liabilities and shareholders’ equity
$
3,698,881

 
$
3,381,332





The accompanying notes are an integral part of these unaudited Consolidated Financial Statements.

7


JELD-WEN HOLDING, INC.
CONSOLIDATED STATEMENTS OF EQUITY
(unaudited)
 
Three Months Ended
 
June 27, 2020
 
June 29, 2019
(amounts in thousands, except share and per share amounts)
Shares
 
Amount
 
Shares
 
Amount
Preferred stock, $0.01 par value per share

 
$

 

 
$

Common stock, $0.01 par value per share
 
 
 
 
 
 
 
Balance at beginning of period
100,487,485

 
$
1,005

 
100,664,822

 
$
1,007

Shares issued for exercise/vesting of share-based compensation awards
80,669

 
1

 
167,454

 
2

Shares repurchased

 

 
(252,621
)
 
(3
)
Shares surrendered for tax obligations for employee share-based transactions
(14,896
)
 
(1
)
 
(36,495
)
 
(1
)
Balance at period end
100,553,258

 
$
1,005

 
100,543,160

 
$
1,005

Additional paid-in capital
 
 
 
 
 
 
 
Balance at beginning of period
 
$
675,941

 
 
 
$
662,837

Shares issued for exercise/vesting of share-based compensation awards
 
77

 
 
 
190

Shares surrendered for tax obligations for employee share-based transactions
 
(227
)
 
 
 
(754
)
Amortization of share-based compensation
 
5,163

 
 
 
3,887

Balance at period end
 
680,954

 
 
 
666,160

Employee stock notes
 
 
 
 
 
 
 
Balance at beginning of period
 
(673
)
 
 
 
(654
)
Net issuances, payments and accrued interest on notes
 

 
 
 
(7
)
Balance at period end
 
(673
)
 
 
 
(661
)
Balance at period end
 
$
680,281

 
 
 
$
665,499

Retained earnings
 
 
 
 
 
 
 
Balance at beginning of period
 
$
279,646

 
 
 
$
248,381

Share repurchased
 

 
 
 
(4,992
)
Net income
 
23,097

 
 
 
22,356

Balance at period end
 
$
302,743

 
 
 
$
265,745

Accumulated other comprehensive income (loss)
 
 
 
 
 
 
 
Balance at beginning of period
 
$
(202,151
)
 
 
 
$
(154,847
)
Foreign currency adjustments
 
49,896

 
 
 
10,079

Unrealized gain on interest rate hedges
 
(1,256
)
 
 
 
563

Net actuarial pension gain
 
84

 
 
 
1,428

Balance at period end
 
$
(153,427
)
 
 
 
$
(142,777
)
 
 
 
 
 
 
 
 
Total shareholders’ equity at period end
 
$
830,602

 
 
 
$
789,472














The accompanying notes are an integral part of these unaudited Consolidated Financial Statements.

8


JELD-WEN HOLDING, INC.
CONSOLIDATED STATEMENTS OF EQUITY
(unaudited)
 
Six Months Ended
 
June 27, 2020
 
June 29, 2019
(amounts in thousands, except share and per share amounts)
Shares
 
Amount
 
Shares
 
Amount
Preferred stock, $0.01 par value per share

 
$

 

 
$

Common stock, $0.01 par value per share
 
 
 
 
 
 
 
Balance at beginning of period
100,668,003

 
$
1,007

 
101,310,862

 
$
1,013

Shares issued for exercise/vesting of share-based compensation awards
175,140

 
2

 
470,547

 
5

Shares repurchased
(265,589
)
 
(3
)
 
(1,192,419
)
 
(12
)
Shares surrendered for tax obligations for employee share-based transactions
(24,296
)
 
(1
)
 
(45,830
)
 
(1
)
Balance at period end
100,553,258

 
$
1,005

 
100,543,160

 
$
1,005

Additional paid-in capital
 
 
 
 
 
 
 
Balance at beginning of period
 
$
672,445

 
 
 
$
659,241

Shares issued for exercise/vesting of share-based compensation awards
 
77

 
 
 
1,477

Shares surrendered for tax obligations for employee share-based transactions
 
(464
)
 
 
 
(918
)
Amortization of share-based compensation
 
8,896

 
 
 
6,360

Balance at period end
 
680,954

 
 
 
666,160

Employee stock notes
 
 
 
 
 
 
 
Balance at beginning of period
 
(673
)
 
 
 
(648
)
Net issuances, payments and accrued interest on notes
 

 
 
 
(13
)
Balance at period end
 
(673
)
 
 
 
(661
)
Balance at period end
 
$
680,281

 
 
 
$
665,499

Retained earnings
 
 
 
 
 
 
 
Balance at beginning of period
 
$
290,583

 
 
 
$
246,833

Share repurchased
 
(4,997
)
 
 
 
(19,982
)
Adoption of new accounting standard ASU No. 2016-02
 

 
 
 
761

Adoption of new accounting standard ASU No. 2016-13
 
$
(5,710
)
 
 
 

Net income
 
22,867

 
 
 
38,133

Balance at period end
 
$
302,743

 
 
 
$
265,745

Accumulated other comprehensive income (loss)
 
 
 
 
 
 
 
Balance at beginning of period
 
$
(151,275
)
 
 
 
$
(144,805
)
Foreign currency adjustments
 
(3,743
)
 
 
 
(1,967
)
Unrealized gain on interest rate hedges
 
(1,256
)
 
 
 
1,113

Net actuarial pension gain
 
2,847

 
 
 
2,882

Balance at period end
 
$
(153,427
)
 
 
 
$
(142,777
)
 
 
 
 
 
 
 
 
Total shareholders’ equity at period end
 
$
830,602

 
 
 
$
789,472













9



The accompanying notes are an integral part of these unaudited Consolidated Financial Statements.

10


JELD-WEN HOLDING, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(unaudited)
 
 
Six Months Ended
(amounts in thousands)
 
June 27,
2020
 
June 29,
2019
OPERATING ACTIVITIES
 
 
 
 
Net income
 
$
22,867

 
$
38,133

Adjustments to reconcile net income to cash used in operating activities:
 
 
 
 
Depreciation and amortization
 
66,217

 
64,828

Deferred income taxes
 
674

 
213

Gain on sale of business units, property and equipment
 
(2,410
)
 
(1,695
)
Adjustment to carrying value of assets
 
5,075

 
2,584

Amortization of deferred financing costs
 
1,142

 
967

Stock-based compensation
 
8,895

 
6,477

Contributions to U.S. pension plan
 
(1,619
)
 
(3,021
)
Amortization of U.S. pension expense
 
3,450

 
4,450

Other items, net
 
12,353

 
1,690

Net change in operating assets and liabilities, net of effect of acquisitions:
 
 
 
 
Accounts receivable
 
(90,892
)
 
(97,942
)
Inventories
 
(34,885
)
 
(30,208
)
Other assets
 
(5,068
)
 
220

Accounts payable and accrued expenses
 
52,479

 
47,145

Change in short term and long-term tax liabilities
 
37

 
8,764

Net cash provided by operating activities
 
38,315

 
42,605

INVESTING ACTIVITIES
 
 
 
 
Purchases of property and equipment
 
(34,951
)
 
(41,108
)
Proceeds from sale of business units, property and equipment
 
8,497

 
6,489

Purchase of intangible assets
 
(11,586
)
 
(22,118
)
Purchases of businesses, net of cash acquired
 

 
(57,264
)
Cash received for notes receivable
 
27

 
244

Net cash used in investing activities
 
(38,013
)
 
(113,757
)
FINANCING ACTIVITIES
 
 
 
 
Change in long-term debt
 
234,296

 
95,400

Common stock issued for exercise of options
 
79

 
1,482

Common stock repurchased
 
(5,000
)
 
(19,994
)
Payments to tax authorities for employee share-based compensation
 
(932
)
 
(619
)
Net cash provided by financing activities
 
228,443

 
76,269

Effect of foreign currency exchange rates on cash
 
(184
)
 
733

Net increase in cash and cash equivalents
 
228,561

 
5,850

Cash, cash equivalents and restricted cash, beginning
 
229,876

 
117,623

Cash, cash equivalents and restricted cash, ending
 
$
458,437

 
$
123,473

For further information see Note 23 - Supplemental Cash Flow.
 
 
 
 





 




The accompanying notes are an integral part of these unaudited Consolidated Financial Statements.

11


JELD-WEN HOLDING, INC.
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

Note 1. Description of Company and Summary of Significant Accounting Policies
Nature of Business – JELD-WEN Holding, Inc., along with its subsidiaries, is a vertically integrated global manufacturer and distributor of windows and doors that derives substantially all of its revenues from the sale of its door and window products. Unless otherwise specified or the context otherwise requires, all references in these notes to “JELD-WEN,” “we,” “us,” “our,” or the “Company” are to JELD-WEN Holding, Inc. and its subsidiaries.
We have facilities located in the U.S., Canada, Europe, Australia, Asia, and Mexico. Our products are marketed primarily under the JELD-WEN brand name in the U.S. and Canada and under JELD-WEN and a variety of acquired brand names in Europe, Australia, and Asia.
Our revenues are affected by the level of new housing starts and remodeling activity in each of our markets. Our sales typically follow seasonal new construction and repair and remodeling industry patterns. The peak season for home construction and remodeling in many of our markets generally corresponds with the second and third calendar quarters, and therefore, sales volume is typically higher during those quarters. Our first and fourth quarter sales volumes are generally lower due to reduced repair and remodeling activity and reduced activity in the building and construction industry as a result of colder and more inclement weather in certain of our geographic end markets.
Basis of Presentation – The accompanying unaudited consolidated financial statements as of June 27, 2020 and for the three and six months ended June 27, 2020 and June 29, 2019, respectively, have been prepared in accordance with GAAP for interim financial information and pursuant to the rules and regulations of the SEC. In the opinion of management, the unaudited consolidated financial statements have been prepared on the same basis as the audited financial statements and include all adjustments, consisting only of normal recurring adjustments, necessary for the fair statement of the Company’s financial position for the periods presented. The results for the three and six months ended June 27, 2020 are not necessarily indicative of the results to be expected for the year ending December 31, 2020, or any other period. The accompanying consolidated balance sheet as of December 31, 2019 was derived from audited financial statements included in the Company’s Form 10-K. The accompanying consolidated financial statements do not include all of the information and footnotes required by GAAP for annual financial statements. Accordingly, they should be read in conjunction with the audited financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2019.
Certain prior year amounts have been reclassified to conform to current year presentation.
All U.S. dollar and other currency amounts, except per share amounts, are presented in thousands unless otherwise noted.
Fiscal Year – We operate on a fiscal calendar year, and each interim quarter is comprised of two 4-week periods and one 5-week period, with each week ending on a Saturday. Our fiscal year always begins on January 1 and ends on December 31. As a result, our first and fourth quarters may have more or fewer days included than a traditional 91-day fiscal quarter.
Use of Estimates – The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect amounts reported in the consolidated financial statements and related notes. Significant items that are subject to such estimates and assumptions include, but are not limited to, long-lived assets including goodwill and other intangible assets, employee benefit obligations, income tax uncertainties, contingent assets and liabilities, provisions for bad debt, inventory, warranty liabilities, legal claims, valuation of derivatives, environmental remediation and claims relating to self-insurance. Actual results could differ due to the uncertainty inherent in the nature of these estimates.
Factoring Arrangements – Our ABS subsidiary, acquired in March 2018, has entered into factoring agreements with a U.S.-based financial institution under which it can elect to sell certain of its accounts receivable under non-recourse agreements. These transactions are treated as a sale and are accounted for as a reduction in accounts receivable because the agreements transfer effective control over and risk of non-collection to the factor. Thus, cash proceeds from these arrangements are reflected as operating activities, including the change of accounts receivable on our statement of cash flows each period. We do not service any factored accounts after the factoring has occurred and do not have any servicing assets or liabilities. We utilize factoring arrangements as part of our financing to manage working capital. The aggregate gross amount factored under these arrangements was $21.5 million and $39.0 million for the six months ended June 27, 2020 and June 29, 2019, respectively. The cost of factoring is reflected in the accompanying unaudited consolidated statements of operations as interest expense with other financing costs and was $0.1 million and $0.1 million for the three

12


months ended June 27, 2020 and June 29, 2019, respectively, and $0.2 million and $0.3 million for the six months ended June 27, 2020 and June 29, 2019, respectively.
Recently Adopted Accounting Standards – In January 2017, the FASB issued ASU No. 2017-04, Intangibles—Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. To simplify the measurement of goodwill impairments, this ASU eliminates Step 2 from the goodwill impairment test, which required the calculation of the implied fair value of goodwill. Instead, under the amendments in this ASU, an entity should perform its annual, or interim, goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. We adopted this standard in the first quarter of 2020 and the adoption did not have an impact on our unaudited consolidated financial statements as of the date of adoption.
In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. The standard requires the measurement and recognition of expected credit losses for financial assets held at amortized cost and adds an impairment model that is based on expected losses rather than incurred losses. In April 2019, the FASB issued ASU No. 2019-04, Codification Improvements to (Topic 326), Financial Instruments-Credit Losses, (Topic 815), Derivatives and Hedging, and (Topic 825), Financial Instruments, to clarify and address certain items related to the amendments of ASU No. 2016-13. We adopted this standard in the first quarter of 2020 using the modified retrospective approach, which primarily impacted our allowance for doubtful accounts as a result of our analysis of customer historical credit and collections data. Additionally, we recognized a $5.7 million cumulative effect adjustment, net of tax, to retained earnings, which includes a $7.6 million increase to the allowance for doubtful accounts and a $1.9 million net impact to deferred tax assets.
Recent Accounting Standards Not Yet Adopted – In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which provides optional expedients and exceptions for applying U.S. GAAP to contracts, hedging relationships, and other transactions affected by the discontinuation of the London Interbank Offered Rate (“LIBOR”) or by another reference rate expected to be discontinued. The amendments are effective for all entities as of March 12, 2020 through December 31, 2022. In May 2020, we elected the expedient within ASC 848 which allows us to assume that our hedged interest payments are probable of occurring regardless of any expected modifications in their terms related to reference rate return. In addition, ASC 848 allows for the option to change the method of assessing effectiveness upon a chance in critical terms of the derivative or the hedged transactions and upon the end of relief under ASC 848. At this time, we have elected to continue the method of assessing effectiveness as documented in the original hedge documentation and apply the practical expedient so that the reference rate on the hypothetical derivative matches the reference rate on the hedging instrument. We plan to evaluate the remaining expedients for adoption, as applicable, when contracts are modified. Refer to Note 19 - Derivative Financial Instruments for additional disclosure information relating to our hedging activity.
In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which removes certain exceptions to the general principles of ASC 740, including, but not limited to, accounting relating to intraperiod tax allocations, deferred tax liabilities related to outside basis differences, and year to date losses in interim periods. This guidance is effective for fiscal years beginning after December 15, 2020. Early adoption is permitted. We are currently assessing the impact of this ASU on our consolidated financial statements and disclosures.
In August 2018, the FASB issued ASU No. 2018-14, Compensation - Retirement Benefits - Defined Benefit Plans - General (Subtopic 715-20): Disclosure Framework - Changes to the Disclosure Requirements for Defined Benefit Plans, which adds, modifies and clarifies several disclosure requirements for employers that sponsor defined benefit pension or other post retirement plans. This guidance is effective for fiscal years ending after December 15, 2020. Early adoption is permitted. We are currently assessing the effect that this ASU will have on our disclosures.
Note 2. Acquisitions
In March 2019, we acquired VPI Quality Windows, Inc (“VPI”). VPI is a leading manufacturer of vinyl windows, specializing in customized solutions for mid-rise multi-family, industrial, hospitality and commercial projects, primarily in the western U.S. VPI is located in Spokane, Washington and is a part of our North America segment.

13


The fair values of the assets and liabilities acquired of this acquisition are summarized below:
(amounts in thousands)
Preliminary Allocation
 
Measurement Period Adjustment
 
Final Allocation
Fair value of identifiable assets and liabilities:
 
 
 
 
 
Accounts receivable
$
11,417

 
$
(420
)
 
$
10,997

Inventories
2,555

 
(141
)
 
2,414

Other current assets
261

 
40

 
301

Property and equipment
3,166

 
176

 
3,342

Identifiable intangible assets
17,702

 
5,735

 
23,437

Operating lease assets
3,739

 

 
3,739

Goodwill
26,553

 
(3,053
)
 
23,500

Other assets
10

 

 
10

Total assets
$
65,403

 
$
2,337

 
$
67,740

Accounts payable
2,629

 

 
2,629

Other current liabilities
1,875

 
522

 
2,397

Operating lease liability
3,413

 

 
3,413

Other liabilities

 
1,502

 
1,502

Total liabilities
$
7,917

 
$
2,024

 
$
9,941

Purchase price:

 
 
 

Cash consideration, net of cash acquired
$
57,486

 
$
313

 
$
57,799


The final goodwill of $23.5 million, calculated as the excess of the purchase price over the fair value of net assets, represents operational efficiencies and sales synergies, and the full amount is expected to be tax-deductible. The intangible assets include customer relationships and tradenames and will be amortized over an estimated weighted average amortization period of 8 years.
Acquisition-related costs are expensed as incurred and are included in SG&A expense in our accompanying unaudited consolidated statements of operations. We incurred acquisition-related costs of $0.2 million and $0.4 million during the three and six months ended June 29, 2019, respectively. Prior to our purchase of VPI, certain employees held employment agreements including retention bonuses with service requirements extending into the post-acquisition period. As agreed with the former owners, the retention bonuses were prepaid at the acquisition date and any repayments of the retention bonuses under the terms of the employment agreements will accrue to the benefit of the former owners. The cash used to pay the retention bonuses was excluded from our determination of purchase price. In 2019, we expensed the post-acquisition value of these retention bonuses as acquisition-related cost totaling $7.1 million, which are included in SG&A expense in our consolidated statements of operations for the three and six months ended June 29, 2019.
The purchase price allocation was considered complete as of March 28, 2020.
We evaluated this acquisition quantitatively and qualitatively and determined it to be insignificant. Therefore, certain pro forma disclosures under ASC 805-10-50 have been omitted.
The results of this acquisition are included in our unaudited consolidated financial statements from the date of acquisition.
Note 3. Accounts Receivable
We sell our manufactured products to a large number of customers, primarily in the residential housing construction and remodel sectors, broadly dispersed across many domestic and foreign geographic regions. We assess the credit risk relating to our accounts receivable based on quantitative and qualitative factors, primarily historical credit collections within each region where we have operations. We perform ongoing credit evaluations of our customers to minimize credit risk. We do not usually require collateral for accounts receivable but will require advance payment, guarantees, a security interest in the products sold to a customer, and/or letters of credit in certain situations. Customer accounts receivable converted to notes receivable are primarily collateralized by inventory or other collateral.
As of January 1, 2020, we adopted ASC 326 - Measurement of Credit Losses on Financial Instruments on a modified retrospective basis, which increased the allowance for doubtful accounts by $7.6 million on the date of adoption.
At June 27, 2020 and December 31, 2019, we had an allowance for doubtful accounts of $14.3 million and $6.0 million, respectively.

14


Note 4. Inventories
Inventories are stated at the lower of cost or net realizable value. Finished goods and work-in-process inventories include material, labor and manufacturing overhead costs.
(amounts in thousands)
June 27,
2020
 
December 31,
2019
Raw materials
$
388,863

 
$
372,289

Work in process
37,223

 
38,432

Finished goods
110,656

 
94,357

Total inventories
$
536,742

 
$
505,078


Note 5. Property and Equipment, Net
(amounts in thousands)
June 27,
2020
 
December 31,
2019
Property and equipment
$
2,049,107

 
$
2,052,584

Accumulated depreciation
(1,207,671
)
 
(1,188,209
)
Total property and equipment, net
$
841,436

 
$
864,375


We monitor all property and equipment for any indicators of potential impairment. We recorded impairment charges of $0.6 million and $1.5 million during the three and six months ended June 27, 2020. We recorded impairment charges of $0.5 million and $1.4 million during the three and six months ended June 29, 2019, respectively.
Depreciation expense was recorded as follows:
 
Three Months Ended
 
Six Months Ended
(amounts in thousands)
June 27,
2020
 
June 29,
2019
 
June 27,
2020
 
June 29,
2019
Cost of sales
$
21,784

 
$
20,747

 
$
43,525

 
$
41,416

Selling, general and administrative
2,039

 
2,527

 
4,668

 
4,934

Total depreciation expense
$
23,823

 
$
23,274

 
$
48,193

 
$
46,350


Note 6. Goodwill
The following table summarizes the changes in goodwill by reportable segment:
(amounts in thousands)
North
America
 
Europe
 
Australasia
 
Total
Reportable
Segments
Balance as of January 1
$
247,502

 
$
273,912

 
$
81,086

 
$
602,500

Currency translation
(274
)
 
553

 
(1,378
)
 
(1,099
)
Balance at end of period
$
247,228

 
$
274,465

 
$
79,708

 
$
601,401



15


Note 7. Intangible Assets, Net
The cost and accumulated amortization values of our intangible assets were as follows:
 
June 27, 2020
(amounts in thousands)
Cost
 
Accumulated
Amortization
 
Net
Book Value
Customer relationships and agreements
$
146,522

 
$
(58,183
)
 
$
88,339

Software
99,378

 
(21,530
)
 
77,848

Trademarks and trade names
57,579

 
(8,718
)
 
48,861

Patents, licenses and rights
44,700

 
(16,426
)
 
28,274

Total amortizable intangibles
$
348,179

 
$
(104,857
)
 
$
243,322

 
December 31, 2019
(amounts in thousands)
Cost
 
Accumulated
Amortization
 
Net
Book Value
Customer relationships and agreements
$
151,540

 
$
(57,326
)
 
$
94,214

Software
92,821

 
(18,222
)
 
74,599

Trademarks and trade names
58,088

 
(7,512
)
 
50,576

Patents, licenses and rights
45,392

 
(14,454
)
 
30,938

Total amortizable intangibles
$
347,841

 
$
(97,514
)
 
$
250,327


At June 27, 2020, we have capitalized software costs of $66.9 million related to the application development stage of our global ERP system implementation, including $10.0 million during the six months ended June 27, 2020. As of June 27, 2020, we have placed $52.0 million in service and are amortizing the cost of our global ERP system over its estimated useful life of 15 years. In March 2020, we impaired $3.4 million of capitalized software due to delays in implementation of certain ERP modules and the uncertainty of its future.
Intangible assets are reviewed for impairment whenever events or changes in circumstances indicate the carrying amount of such assets may not be recoverable. Intangible assets that become fully amortized are removed from the accounts in the period that they become fully amortized. Amortization expense was recorded as follows:
 
Three Months Ended
 
Six Months Ended
(amounts in thousands)
June 27,
2020
 
June 29,
2019
 
June 27,
2020
 
June 29,
2019
Amortization expense
$
6,644

 
$
9,130

 
$
13,247

 
$
14,793


Note 8. Other Assets
(amounts in thousands)
June 27,
2020
 
December 31,
2019
Cloud computing arrangements
$
9,747

 
$
6,374

Customer displays
6,325

 
11,213

Deposits
5,975

 
6,440

Long-term notes receivable
4,547

 
4,614

Overfunded pension benefit obligation
2,063

 
2,015

Debt issuance costs on unused portion of revolver facility
1,227

 
1,472

Other prepaid expenses
766

 
1,896

Other long-term accounts receivable
553

 
563

Other long-term assets
411

 
375

Total other assets
$
31,614

 
$
34,962



16


Note 9. Accrued Expenses and Other Current Liabilities
(amounts in thousands)
June 27,
2020
 
December 31,
2019
Current portion of legal claims provision
$
81,022

 
$
79,332

Accrued sales and advertising rebates
69,244

 
67,250

Current portion of operating lease liability
43,824

 
45,254

Non-income related taxes
36,588

 
23,178

Accrued expenses
23,897

 
27,993

Current portion of warranty liability (Note 10)
20,310

 
21,054

Current portion of accrued claim costs relating to self-insurance programs
11,973

 
12,312

Current portion of deferred revenue
10,054

 
7,986

Accrued interest payable
8,568

 
2,126

Current portion of accrued income taxes payable
5,768

 
1,999

Current portion of restructuring accrual (Note 17)
4,516

 
6,051

Current portion of derivative liability (Note 19)
3,368

 
4,068

Total accrued expenses and other current liabilities
$
319,132

 
$
298,603


The legal claims provision relates primarily to contingencies associated with the ongoing legal matters disclosed in Note 21 - Commitments and Contingencies.
The accrued sales and advertising rebates, accrued interest payable, and non-income related taxes can fluctuate significantly period-over-period due to timing of payments.
Note 10. Warranty Liability
Warranty terms vary from one year to lifetime on certain window and door components. Warranties are normally limited to servicing or replacing defective components for the original customer. Product defects arising within six months of sale are classified as manufacturing defects and are not included in the current period expense below. Some warranties are transferable to subsequent owners and are either limited to 10 years from the date of manufacture or require pro-rata payments from the customer. A provision for estimated warranty costs is recorded at the time of sale based on historical experience and is periodically adjusted to reflect actual experience.
An analysis of our warranty liability is as follows:
(amounts in thousands)
June 27,
2020
 
June 29,
2019
Balance as of January 1
$
49,716

 
$
46,468

Current period expense
10,024

 
9,309

Liabilities assumed due to acquisition

 
79

Experience adjustments
2,293

 
1,549

Payments
(11,985
)
 
(11,109
)
Currency translation
(381
)
 
209

Balance at period end
49,667

 
46,505

Current portion
(20,310
)
 
(19,692
)
Long-term portion
$
29,357

 
$
26,813


The most significant component of our warranty liability is in the North America segment, which totaled $44.9 million at June 27, 2020, after discounting future estimated cash flows at rates between 0.76% and 4.75%. Without discounting, the liability would have been higher by approximately $2.7 million.

17


Note 11. Long-Term Debt
Our long-term debt, net of original issue discount and unamortized debt issuance costs, consisted of the following:
 
June 27, 2020
 
June 27,
2020
 
December 31,
2019
(amounts in thousands)
Interest Rate
 
 
Senior Secured Notes and Senior Notes
4.63% - 6.25%
 
$
1,050,000

 
$
800,000

Term loans
1.30% - 3.45%
 
589,075

 
591,153

Finance leases and other financing arrangements
1.68% - 6.00%
 
109,945

 
108,613

Mortgage notes
1.65%
 
27,483

 
28,175

Installment notes for stock
—%
 

 
205

Total Debt
 
 
1,776,503

 
1,528,146

Unamortized debt issuance costs and original issue discount
 
(14,652
)
 
(10,774
)
Current maturities of long-term debt
 
(69,194
)
 
(65,846
)
Long-term debt
 
$
1,692,657

 
$
1,451,526

Summaries of our significant changes to outstanding debt agreements as of June 27, 2020 are as follows:
Senior Secured Notes and Senior Notes

In May 2020, we issued $250.0 million of Senior Secured Notes bearing interest at 6.25% and maturing in May 2025 in a private placement for resale to qualified institutional buyers pursuant to Rule 144A under the Securities Act. The proceeds were net of fees and expenses associated with debt issuance, including an underwriting fee of 1.25%. Interest is payable semiannually, in arrears, each May and November through maturity, beginning November 2020.
In December 2017, we issued $800.0 million of unsecured Senior Notes in two tranches: $400.0 million bearing interest at 4.63% and maturing in December 2025, and $400.0 million bearing interest at 4.88% and maturing in December 2027 in a private placement for resale to qualified institutional buyers pursuant to Rule 144A under the Securities Act.
Term Loans
U.S. Facility - In February 2019, we purchased interest rate caps in order to effectively fix a 3.0% per annum ceiling on the LIBOR component of an aggregate $150 million of our term loans. The caps became effective March 29, 2019 and expire December 31, 2021.
In September 2019, we amended the Term Loan Facility to provide for an incremental aggregate principal amount of $125.0 million and used the proceeds primarily to repay $115.0 million of outstanding borrowings under the ABL Facility. The proceeds were net of the original issue discount of 0.5%, or $0.6 million, as well as $0.6 million in fees and expenses associated with the debt issuance. This amendment requires that approximately $1.4 million of the aggregate principal amount be repaid quarterly until the maturity date. There were no other changes to key terms and the facility maintains its original maturity date in December 2024. At June 27, 2020, the outstanding principal balance, net of original issue discount, was $553.6 million.
In May 2020, we entered into interest rate swap agreements with a weighted average fixed rate of 0.395% paid against one-month LIBOR floored at 0.00% with outstanding notional amounts aggregating to $370.0 million corresponding to that amount of the debt outstanding under our Term Loan Facility. The interest rate swap agreements are designated as cash flow hedges of a portion of the interest obligations on our Term Loan Facility borrowings and mature in December 2023. See Note 19-Derivative Financial Instruments for additional information on our derivative assets and liabilities.
Australia Facility - In June 2019, we reallocated AUD 5.0 million from the term loan commitment to the interchangeable commitment of the Australia Senior Secured Credit Facility. The amended AUD 50.0 million floating rate term loan facility bears interest at a base rate of BBSY plus a margin ranging from 1.00% to 1.10%, includes a line fee of 1.25% on the commitment amount, and matures in February 2023. This facility had an outstanding principal balance of AUD 50.0 million ($34.4 million) as of June 27, 2020.
Revolving Credit Facilities
ABL Facility - In December 2019, we amended our ABL facility to reflect current banking regulatory requirements, which do not have a financial impact. In March 2020, we drew $100.0 million under our ABL Facility as a precautionary measure

18


to ensure funding of our seasonal working capital cash requirements given the significant impact on global financial markets and economies as a result of the COVID-19 pandemic. In May 2020, we utilized a portion of the proceeds received from our issuance of the $250.0 million of Senior Secured Notes to repay the outstanding balance on our ABL Facility. As of June 27, 2020, we had no outstanding borrowings, $37.6 million in letters of credit and $315.7 million available under the ABL Facility.
Australia Senior Secured Credit Facility - In June 2019, we amended the Australia Senior Secured Credit Facility, reallocating availability from the Australia Term Loan Facility and collapsing the floating rate revolving loan facility into an AUD 35.0 million interchangeable facility to be used for guarantees, asset financing, and loans of 12 months or less. In May 2020, we amended this facility to relax certain financial covenants and provide for an AUD 30.0 million floating rate revolving loan facility to be used for loans bearing interest at BBSY plus a margin of 1.10%, and a line fee of 0.90%, and maturing on June 30, 2021. The facility may be used only when the AUD 35.0 million interchangeable facility is fully utilized. As of June 27, 2020, we had AUD 30.0 million ($20.6 million) available under this facility. In addition, the AUD 35.0 million interchangeable facility was renewed with relaxed financial maintenance covenants to at least June 30, 2021 and its line fee increased to 0.70%, compared to a line fee of 0.50% under the previous amendment. The non-term loan portion of the Australia Senior Secured Credit Facility no longer has a set maturity date but is instead subject to an annual review. As of June 27, 2020, we had AUD 21.2 million ($14.6 million) available under this facility.
At June 27, 2020, we had combined borrowing availability of $350.9 million under our revolving credit facilities.
Mortgage Notes – In December 2007, we entered into thirty-year mortgage notes secured by land and buildings with principal payments which began in 2018. At June 27, 2020, we had DKK 182.6 million (or $27.5 million) outstanding under these notes.
Finance leases and other financing arrangements In addition to finance leases, we include insurance premium financing arrangements and loans secured by equipment in this category. At June 27, 2020, we had $109.9 million outstanding in this category, with maturities ranging from 2020 to 2027.
As of June 27, 2020, we were in compliance with the terms of all of our credit facilities and the indentures governing the Senior Notes and Senior Secured Notes.
Note 12. Income Taxes

The Company has completed its accounting for the income tax effects of the Tax Act. Although the measurement period has effectively ended, additional guidance and regulations continue to be released or finalized. We have considered these ongoing developments and determined that they have no impact on our tax accounts for the six months ended June 27, 2020. Final guidance, once issued, may materially affect our conclusions regarding the net related effects of the Tax Act on our unaudited consolidated financial statements. Until then, management will continue to monitor and work with its tax advisors to interpret any guidance issued.

The effective income tax rate for continuing operations was 31.1% and 33.7% for the three and six months ended June 27, 2020, respectively compared to 35.3% and 37.2% for the three and six months ended June 29, 2019, respectively. In accordance with ASC 740-270, we recorded tax expense of $10.4 million and $11.6 million from continuing operations in the three and six months ended June 27, 2020, respectively, compared to a tax expense of $12.2 million and $22.5 million for the corresponding periods ended June 29, 2019, by applying an estimated annual effective tax rate to our year-to-date income for includable entities during the respective periods. Our estimated annual effective tax rate for both years includes the impact of the tax on GILTI. The application of the estimated annual effective tax rate in interim periods may result in a significant variation in the customary relationship between income tax expense and pretax accounting income due to the seasonality of our global business. Entities that are currently generating losses and for which there is a full valuation allowance are excluded from the worldwide effective tax rate calculation and are calculated separately. The estimated annual effective tax rate for the current year is materially impacted by changes in management’s judgment regarding the realizability of deferred tax assets. Due to the ongoing financial and operational impacts on our business arising from COVID-19 focused in the current year, our ability to realize certain tax benefits related primarily to US foreign tax credits has been impacted. As such, management believes that our existing valuation allowance against these credits as well as our net operating losses at the state level will likely increase through the year as events occur. In accordance with guidance, we have factored the predicted increases as of the balance sheet date into our estimated annual effective tax rate for the current year. To the extent that actual results and/or events differ from our predicted results, we may continue to see effects on our estimated annual effective tax rate.

The impact of significant discrete items is separately recognized in the quarter in which they occur. The tax benefit for discrete items included in the tax provision for continuing operations for the three months ended June 27, 2020 was $2.9

19


million compared to $1.6 million of tax expense for the three months ended June 29, 2019, respectively. The discrete amounts for the three months ended June 27, 2020 were comprised primarily of $3.9 million of tax benefit attributed to the expiration of the statute of limitations on certain tax years in Estonia, offset by tax expense of $0.4 million attributable to the shortfall recognized from exercises and forfeitures from share-based compensation awards, $0.3 million attributable to current period interest expense on uncertain tax positions, and $0.3 million attributed to the deferred tax impact of tax rate reductions. The discrete amounts for the three months ended June 29, 2019 were comprised primarily of $1.0 million related to the establishment of a valuation allowance for a Chilean subsidiary, $0.5 million related to return-to-provision adjustments for various entities for tax filings in the period, and $0.4 million attributable to current period interest expense on uncertain tax positions, partially offset by tax benefit of $0.3 million related to a release of prior year uncertain tax positions. The tax benefit related to discrete items included in the tax provision for continuing operations for the six months ended June 27, 2020 was $2.1 million compared to tax expense of $2.9 million for the six months ended June 29, 2019. The discrete amounts for the six months ended June 27, 2020 were comprised primarily of the $3.9 million of tax benefit attributed to the expiration of the statute of limitations on certain tax years in Estonia, partially offset by $1.1 million of current period interest expense on uncertain tax positions, $0.4 million for shortfalls arising from share-based compensation exercises and forfeitures, and $0.3 million for the deferred tax impact of tax rate decreases. The discrete amounts for the six months ended June 29, 2019 were comprised primarily of tax expense of $1.1 million related to shortfalls recognized from exercises and forfeitures from share-based compensation awards, $1.0 million related to the establishment of a valuation allowance for a Chilean subsidiary, $0.8 million attributable to current period interest expense on uncertain tax positions, and $0.5 million related to return-to-provision adjustments for various entities for tax filings in the period, partially offset by a tax benefit of $0.3 million related to a release of prior year uncertain tax positions, and $0.2 million for other matters.

Under ASC 740-10, we provide for uncertain tax positions and the related interest expense by adjusting unrecognized tax benefits and accrued interest accordingly. We recognize potential interest and penalties related to unrecognized tax benefits in income tax expense. We had unrecognized tax benefits without regard to accrued interest of $14.6 million and $16.2 million as of June 27, 2020 and December 31, 2019, respectively.
Note 13. Segment Information
We report our segment information in the same way management internally organizes the business in assessing performance and making decisions regarding allocation of resources in accordance with ASC 280-10- Segment Reporting. We determined that we have three reportable segments, organized and managed principally by geographic region. Our reportable segments are North America, Europe, and Australasia. We report all other business activities in Corporate and unallocated costs. Factors considered in determining the three reportable segments include the nature of business activities, the management structure accountable directly to the CODM, the discrete financial information available and the information regularly reviewed by the CODM. Management reviews net revenues and Adjusted EBITDA to evaluate segment performance and allocate resources. We define Adjusted EBITDA as net income (loss), adjusted for the following items: loss from discontinued operations, net of tax; equity earnings of non-consolidated entities; income tax (benefit) expense; depreciation and amortization; interest expense, net; impairment and restructuring charges; gain on previously held shares of equity investment; (gain) loss on sale of property and equipment; share-based compensation expense; non-cash foreign exchange transaction/translation (income) loss; other items; other non-cash items; and costs related to debt restructuring and debt refinancing.

20


The following tables set forth certain information relating to our segments’ operations:
(amounts in thousands)
North
America
 
Europe
 
Australasia
 
Total Operating
Segments
 
Corporate
and
Unallocated
Costs
 
Total
Consolidated
Three Months Ended June 27, 2020
 
 
 
 
 
 
 
 
 
 
Total net revenues
$
608,345

 
$
262,173

 
$
124,717

 
$
995,235

 
$

 
$
995,235

Intersegment net revenues
(232
)
 
(649
)
 
(2,008
)
 
(2,889
)
 

 
(2,889
)
Net revenues from external customers
$
608,113

 
$
261,524

 
$
122,709

 
$
992,346

 
$

 
$
992,346

Impairment and restructuring charges
$
1,266

 
$
153

 
$
833

 
$
2,252

 
$
14

 
$
2,266

Adjusted EBITDA
$
91,115

 
$
28,354

 
$
15,235

 
$
134,704

 
$
(8,985
)
 
$
125,719

Three Months Ended June 29, 2019
 
 
 
 
 
 
 
 
 

Total net revenues
$
668,866

 
$
300,479

 
$
152,203

 
$
1,121,548

 
$

 
$
1,121,548

Intersegment net revenues
(494
)
 
(93
)
 
(1,974
)
 
(2,561
)
 

 
(2,561
)
Net revenues from external customers
$
668,372

 
$
300,386

 
$
150,229

 
$
1,118,987

 
$

 
$
1,118,987

Impairment and restructuring charges
$
2,190

 
$
644

 
$
1,953

 
$
4,787

 
$
947

 
$
5,734

Adjusted EBITDA
$
87,519

 
$
28,988

 
$
21,258

 
$
137,765

 
$
(10,182
)
 
$
127,583

(amounts in thousands)
North
America
 
Europe
 
Australasia
 
Total Operating
Segments
 
Corporate
and
Unallocated
Costs
 
Total
Consolidated
Six Months Ended June 27, 2020
 
 
 
 
 
 
 
 
 
 
Total net revenues
$
1,195,393

 
$
543,980

 
$
237,689

 
$
1,977,062

 
$

 
$
1,977,062

Intersegment net revenues
(544
)
 
(963
)
 
(4,022
)
 
(5,529
)
 

 
(5,529
)
Net revenues from external customers
$
1,194,849

 
$
543,017

 
$
233,667

 
$
1,971,533

 
$

 
$
1,971,533

Impairment and restructuring charges
$
2,209

 
$
2,154

 
$
1,097

 
$
5,460

 
$
3,351

 
$
8,811

Adjusted EBITDA
$
140,105

 
$
51,680

 
$
23,960

 
$
215,745

 
$
(15,518
)
 
$
200,227

Six Months Ended June 29, 2019
 
 
 
 
 
 
 
 
 
 
Total net revenues
$
1,234,568

 
$
600,471

 
$
298,723

 
$
2,133,762

 
$

 
$
2,133,762

Intersegment net revenues
(1,090
)
 
(120
)
 
(3,305
)
 
(4,515
)
 

 
(4,515
)
Net revenues from external customers
$
1,233,478

 
$
600,351

 
$
295,418

 
$
2,129,247

 
$

 
$
2,129,247

Impairment and restructuring charges
$
4,147

 
$
1,953

 
$
2,419

 
$
8,519

 
$
934

 
$
9,453

Adjusted EBITDA
$
140,314

 
$
56,627

 
$
37,638

 
$
234,579

 
$
(17,718
)
 
$
216,861



21


Reconciliations of net income to Adjusted EBITDA are as follows:
 
Three Months Ended
 
Six Months Ended
(amounts in thousands)
June 27,
2020
 
June 29,
2019
 
June 27,
2020
 
June 29,
2019
Net income
$
23,097

 
$
22,356

 
$
22,867

 
$
38,133

Income tax expense
10,403

 
12,181

 
11,600

 
22,530

Depreciation and amortization
32,771

 
33,930

 
66,217

 
64,828

Interest expense, net
19,076

 
18,492

 
35,680

 
36,148

Impairment and restructuring charges(1)
2,343

 
6,214

 
9,038

 
10,317

(Gain) loss on sale of property and equipment
(337
)
 
568

 
(2,410
)
 
1,080

Share-based compensation expense
5,162

 
3,882

 
8,895

 
6,477

Non-cash foreign exchange transaction/translation (income) loss
8,784

 
7,484

 
7,595

 
3,797

Other items (2)
24,250

 
22,407

 
40,575

 
32,817

Other non-cash items (3) 

 
69

 

 
734

Costs relating to debt restructuring and debt refinancing
170

 

 
170

 

Adjusted EBITDA
$
125,719

 
$
127,583

 
$
200,227

 
$
216,861

(1)
Impairment and restructuring charges consist of (i) impairment and restructuring charges that are included in our consolidated unaudited statements of operations plus (ii) additional charges relating to inventory and/or manufacturing of our products that are included in cost of sales in the accompanying unaudited consolidated statements of operations in the amount of $77 and $480 for the three months ended June 27, 2020 and June 29, 2019, respectively, and $227 and $864 for the six months ended June 27, 2020 and June 29, 2019, respectively. For further explanation of impairment and restructuring charges that are included in our consolidated statements of operations, see Note 17 - Impairment and Restructuring Charges in our financial statements.
(2)
Other non-recurring items not core to ongoing business activity include: (i) in the three months ended June 27, 2020 (1) $22,994 in legal costs and professional expenses relating primarily to litigation and (2) $967 in facility closure and consolidation costs related to our facility footprint rationalization program; (ii) in the three months ended June 29, 2019 (1) $9,063 in acquisition and integration costs including $7,077 related to purchase price structured by the former owners as retention payments for key employees of a recent acquisition, (2) $8,324 in facility closure and consolidation costs related to our facility footprint rationalization program, (3) $4,640 in legal costs and professional expenses relating primarily to litigation, (4) $274 in miscellaneous costs, and (5) $100 in costs related to departure of former executives; (iii) in the six months ended June 27, 2020 (1) $34,700 in legal costs and professional expenses relating primarily to litigation, (2) $4,077 in facility closure and consolidation costs related to our facility footprint rationalization program, and (3) $1,235 in one-time lease termination charges; (iv) in the six months ended June 29, 2019 (1) $13,151 in facility closure and consolidation costs related to our facility footprint rationalization program, (2) $11,997 in acquisition and integration costs including $7,077 related to purchase price structured by the former owners as retention payments for key employees of a recent acquisition, (3) $6,288 in legal costs and professional expenses relating primarily to litigation, (4) $856 in miscellaneous costs, and (5) $525 in costs related to departure of former executives.
(3)
Other non-cash items include: (i) in the three months ended June 29, 2019, $69 for initial inventory adjustments related to the VPI acquisition; (ii) in the six months ended June 29, 2019, $734 for inventory adjustments.
The prior period information has been reclassified to conform with current period presentation.
Note 14. Capital Stock
Preferred Stock - Our Board of Directors is authorized to issue Preferred Stock from time to time in one or more series and with such rights, privileges, and preferences as the Board of Directors shall from time to time determine. We have not issued any shares of Preferred Stock.
Common Stock - Common Stock includes the basis of shares outstanding plus amounts recorded as additional paid-in capital. Shares outstanding exclude the shares issued to the Employee Benefit Trust that are considered similar to treasury shares and total 193,941 shares at both June 27, 2020 and December 31, 2019 with a total original issuance value of $12.4 million.

22


We record share repurchases on their trade date and reduce shareholders’ equity and increase accounts payable. Repurchased shares are retired, and the excess of the repurchase price over the par value of the shares is charged to retained earnings.
In April 2018, our Board of Directors authorized the repurchase of up to $250.0 million of our Common Stock through December 2019.
On November 4, 2019, the Board of Directors authorized an increase to the remaining authorization under the share repurchase program to a total of $175.0 million with no expiration date. As of June 27, 2020, $170.0 million was remaining under the repurchase authorization.
We did not repurchase shares during the three months ended June 27, 2020. During the six months ended June 27, 2020, we repurchased 265,589 shares of our Common Stock at an average price per share of $18.83. During the three and six months ended June 29, 2019, we repurchased 252,621 and 1,192,419 shares of our Common Stock at an average price per share of $19.77 and $16.77, respectively.
Note 15. Earnings Per Share
The basic and diluted income per share calculations were determined based on the following share data:
 
Three Months Ended
 
Six Months Ended
 
June 27,
2020
 
June 29,
2019
 
June 27,
2020
 
June 29,
2019
Weighted average outstanding shares of Common Stock basic
100,508,707

 
100,630,119

 
100,576,621

 
100,636,740

Restricted stock units, performance share units, and options to purchase Common Stock
425,566

 
843,411

 
727,354

 
828,331

Weighted average outstanding shares of Common Stock diluted
100,934,273

 
101,473,530

 
101,303,975

 
101,465,071


The following table provides the securities that could potentially dilute basic earnings per share in the future but were not included in the computation of diluted income per share as their inclusion would be anti-dilutive:
 
Three Months Ended
 
Six Months Ended
 
June 27,
2020
 
June 29,
2019
 
June 27,
2020
 
June 29,
2019
Common Stock options
2,274,069

 
1,696,599

 
2,050,159

 
1,715,363

Restricted stock units
730,782

 
77,724

 
387,476

 
595,436

Performance share units
465,473

 
378,898

 
242,400

 
266,586



23


Note 16. Stock Compensation

The activity under our incentive plans for the periods presented are reflected in the following tables:
 
Three Months Ended
 
June 27, 2020
 
June 29, 2019
 
Shares
 
Weighted Average Exercise Price Per Share
 
Shares
 
Weighted Average Exercise Price Per Share
Options granted
6,613

 
$
9.55

 

 
$

Options canceled
74,686

 
$
26.55

 
60,865

 
$
31.54

Options exercised
8,942

 
$
8.57

 
183,512

 
$
10.14

 
 
 
 
 
 
 
 
 
Shares
 
Weighted Average Grant Date Fair Value
 
Shares
 
Weighted Average Grant Date Fair Value
RSUs granted
105,123

 
$
11.93

 
80,173

 
$
19.70

PSUs granted
6,175

 
$
9.92

 

 
$


 
Six Months Ended
 
June 27, 2020
 
June 29, 2019
 
Shares
 
Weighted Average Exercise Price Per Share
 
Shares
 
Weighted Average Exercise Price Per Share
Options granted
407,607

 
$
24.30

 
424,944

 
$
20.94

Options canceled
116,175

 
$
26.05

 
169,202

 
$
26.59

Options exercised
104,380

 
$
11.61

 
387,057

 
$
8.91

 
 
 
 
 
 
 
 
 
Shares
 
Weighted Average Grant Date Fair Value
 
Shares
 
Weighted Average Grant Date Fair Value
RSUs granted
686,915

 
$
19.52

 
653,988

 
$
20.79

PSUs granted
311,275

 
$
25.19

 
387,568

 
$
22.21



Stock-based compensation expense was $5.2 million and $8.9 million for the three and six months ended June 27, 2020, respectively, and $3.9 million and $6.5 million for the three and six months ended June 29, 2019, respectively. As of June 27, 2020, we had $38.1 million of total unrecognized compensation expense related to non-vested share-based compensation arrangements. This cost is expected to be recognized over the remaining weighted-average vesting period of 2.12 years.
Note 17. Impairment and Restructuring Charges
During 2020 and 2019, we engaged in restructuring activities intended to improve productivity, operating margins, and working capital levels. Restructuring costs primarily relate to workforce reductions, repositioning of management structure and costs associated with plant consolidations and closures.
Asset impairment charges were recorded in addition to our restructuring costs. In the six months ended June 27, 2020, impairment charges primarily related to capitalized costs of certain ERP modules due to delays in implementation and uncertainty of their future use. In the three and six months ended June 29, 2019, impairment charges were primarily related to ROU assets and property and equipment held by operations impacted by restructuring.

24


The following table summarizes the restructuring charges for the periods indicated:
(amounts in thousands)
North
America
 
Europe
 
Australasia
 
Corporate
and
Unallocated
Costs
 
Total
Consolidated
Three Months Ended June 27, 2020
 
 
 
 
 
 
 
 
Severance costs
$
509

 
$
115

 
$
136

 
$

 
$
760

Other exit costs

 
38

 
633

 
14

 
685

Total restructuring costs
509

 
153

 
769

 
14

 
1,445

Impairments
757

 

 
64

 

 
821

Total impairment and restructuring charges
$
1,266

 
$
153

 
$
833

 
$
14

 
$
2,266

Three Months Ended June 29, 2019
 
 
 
 
 
 
 
 
Severance costs
$
1,629

 
$
523

 
$
1,337

 
$
961

 
$
4,450

Other exit costs
38

 
121

 
189

 
(14
)
 
334

Total restructuring costs
1,667

 
644

 
1,526

 
947

 
4,784

Impairments
523

 

 
427

 

 
950

Total impairment and restructuring charges
$
2,190

 
$
644

 
$
1,953

 
$
947

 
$
5,734


(amounts in thousands)
North
America
 
Europe
 
Australasia
 
Corporate
and
Unallocated
Costs
 
Total
Consolidated
Six Months Ended June 27, 2020
 
 
 
 
 
 
 
 
Severance costs
$
1,453

 
$
1,026

 
$
183

 
$
(10
)
 
$
2,652

Other exit costs
(1
)
 
233

 
850

 
2

 
1,084

Total restructuring costs
1,452

 
1,259

 
1,033

 
(8
)
 
3,736

Impairments
757

 
895

 
64

 
3,359

 
5,075

Total impairment and restructuring charges
$
2,209

 
$
2,154

 
$
1,097

 
$
3,351

 
$
8,811

Six Months Ended June 29, 2019
 

 

 

 

Severance costs
$
2,159

 
$
1,671

 
$
1,537

 
$
961

 
$
6,328

Other exit costs
34

 
121

 
413

 
(27
)
 
541

Total restructuring costs
2,193

 
1,792

 
1,950

 
934

 
6,869

Impairments
1,954

 
161

 
469

 

 
2,584

Total impairment and restructuring charges
$
4,147

 
$
1,953

 
$
2,419

 
$
934

 
$
9,453


Short-term restructuring accruals are recorded in accrued expenses and totaled $4.5 million and $6.1 million as of June 27, 2020 and December 31, 2019, respectively. Long-term restructuring accruals are recorded in deferred credits and other liabilities and totaled $0.8 million and $1.0 million as of June 27, 2020 and December 31, 2019, respectively.

25


The following is a summary of the restructuring accruals recorded and charges incurred:
(amounts in thousands)
Beginning
Accrual
Balance
 
Additions
Charged to
Expense
 
Payments
or
Utilization
 
Ending
Accrual
Balance
June 27, 2020
 
 
 
 
 
 
 
Severance costs
$
5,314

 
$
2,652

 
$
(4,770
)
 
$
3,196

Other exit costs
1,729

 
1,084

 
(752
)
 
2,061

Total
$
7,043

 
$
3,736

 
$
(5,522
)
 
$
5,257

June 29, 2019
 
 
 
 
 
 
 
Severance costs
$
5,353

 
$
6,328

 
$
(8,258
)
 
$
3,423

Other exit costs
3,287

 
541

 
(849
)
 
2,979

Total
$
8,640

 
$
6,869

 
$
(9,107
)
 
$
6,402



Note 18. Other (Income) Expense
The table below summarizes the amounts included in other (income) expense in the accompanying unaudited consolidated statements of operations:
 
Three Months Ended
 
Six Months Ended
(amounts in thousands)
June 27,
2020
 
June 29,
2019
 
June 27,
2020
 
June 29,
2019
Foreign currency losses
$
6,324

 
$
5,475

 
$
4,074

 
$
179

Governmental pandemic assistance reimbursement
(5,881
)
 

 
$
(5,881
)
 
$

Pension benefit expense
(2,156
)
 
2,652

 
$
631

 
$
5,400

Other items
(448
)
 
(882
)
 
(1,243
)
 
(1,141
)
Gain on sale of business units, property, and equipment
(337
)
 
(2,374
)
 
(2,410
)
 
(1,792
)
Legal settlement income

 

 

 
(1,247
)
Total other (income) expense
$
(2,498
)
 
$
4,871

 
$
(4,829
)
 
$
1,399


Governmental pandemic assistance reimbursement for the three and six months ended June 27, 2020 primarily consisted of cash received from governmental pandemic assistance programs within our North America and Europe segments as a result of the outbreak of COVID-19.
The prior period information has been reclassified to conform to current period presentation.

26


Note 19. Derivative Financial Instruments
All derivatives are recorded as assets or liabilities in the consolidated balance sheets at their respective fair values. For derivatives that qualify for hedge accounting, we assess, both at inception and on an ongoing basis, whether the derivative financial instrument is highly effective in offsetting cash flows of the hedged item and whether it is probable that the hedged forecasted transaction will occur. Changes in the fair value related to the derivatives considered highly effective are initially recorded in accumulated other comprehensive income and recognized in earnings at the same time as either the change in fair value of the underlying hedged item or the effect of the hedged item’s exposure to the variability of cash flows. Changes in the fair value of derivatives that do not qualify for hedge accounting, or fail to meet the criteria, thereafter, are also recognized in the consolidated statements of operations. See Note 20 - Fair Value of Financial Instruments for additional information on the fair value of our derivative assets and liabilities.
Foreign currency derivatives – We are exposed to the impact of foreign currency fluctuations in certain countries in which we operate. In most of these countries, the exposure to foreign currency movements is limited because the operating revenues and expenses of our business units are substantially denominated in the local currency. To the extent borrowings, sales, purchases, or other transactions are not executed in the local currency of the operating unit, we are exposed to foreign currency risk. To mitigate the exposure, we enter into a variety of foreign currency derivative contracts, such as forward contracts, option collars, and cross-currency hedges. We use foreign currency derivative contracts, with a total notional amount of $99.9 million, to manage the effect of exchange fluctuations on forecasted sales, purchases, acquisitions, inventory and capital expenditures, and certain intercompany transactions that are denominated in foreign currencies. We use foreign currency derivative contracts, with a total notional amount of $29.2 million, to hedge the effects of translation gains and losses on intercompany loans and interest. We also use foreign currency derivative contracts, with a total notional amount of $73.5 million, to mitigate the impact to the consolidated earnings of the Company from the effect of the translation of certain subsidiaries’ local currency results into U.S. dollars. We do not use derivative financial instruments for trading or speculative purposes. We have not elected hedge accounting for any foreign currency derivative contracts. We record mark-to-market changes in the values of these derivatives in other (income) expense. We recorded mark-to-market losses of $12.6 million and gains of $3.2 million in the three and six months ended June 27, 2020, respectively, and gains of $0.5 million and losses of $2.8 million in the three and six months ended June 29, 2019, respectively.
Interest rate derivatives – We are exposed to interest rate risk in connection with our variable rate long-term debt and partially mitigate this risk through interest rate derivatives such as swaps and caps. In May 2020, we entered into interest rate swap agreements to manage this risk. The interest rate swaps have outstanding notional amounts aggregating to $370.0 million and mature in December 2023 with a weighted average fixed rate of 0.395% paid against one-month LIBOR floored at 0.00%. The interest rate swap agreements are designated as cash flow hedges and will effectively change the base rate on a portion of the aggregate debt outstanding under our Term Loan Facility.
The cumulative pre-tax mark-to-market loss of $1.7 million relating to these interest rate contracts was recorded in other comprehensive income (loss) at June 27, 2020 as no portion was deemed ineffective. As of June 27, 2020, approximately $0.9 million is expected to be reclassified to interest expense over the next 12 months.
The derivative agreements with our swap counterparties contain a provision whereby we could be declared in default on our derivative obligations if we either default or, in certain cases, are capable of being declared in default of any of our indebtedness greater than specified thresholds. These agreements also contain a provision where we could be declared in default subsequent to a merger or restructuring type event if the creditworthiness of the resulting entity is materially weaker.
During the first quarter of 2019, we entered into two interest rate cap contracts against three-month U.S.-dollar LIBOR, each with a cap rate of 3.00%. These caps have a combined notional amount of $150.0 million, were effective as of March 2019, and terminate in December 2021. We have not elected hedge accounting and have recorded insignificant mark-to-market adjustments in the three months ended June 27, 2020 and June 29, 2019.
In conjunction with the December 2017 refinancing of the Term Loan Facility, we terminated all of the interest rate swaps which had outstanding notional amounts aggregating to $914.3 million and recorded a loss on termination of $3.6 million in consolidated other comprehensive income (loss), which was being amortized as interest expense over the pre-termination life of the interest rate swaps. As of December 31, 2019, the loss on termination has been fully amortized. We recorded interest expense deriving from the amortization of the loss on termination of interest rate swaps of $0.4 million and $0.9 million during the three and six months ended June 29, 2019.

27


The fair values of derivative instruments held are as follows:
 
Derivative assets
(amounts in thousands)
Balance Sheet Location
 
June 27,
2020
 
December 31,
2019
Derivatives not designated as hedging instruments:
 
 
 
 
Foreign currency forward contracts
Other current assets
 
$
3,067

 
$
1,372

Interest rate cap contracts
Other assets
 
$
23

 
$
6

 
Derivatives liabilities
(amounts in thousands)
Balance Sheet Location
 
June 27,
2020
 
December 31,
2019
Derivatives designated as hedging instruments:
 
 
 
 
Interest rate contracts
Accrued expenses and other current liabilities
 
$
757

 
$

Interest rate contracts
Deferred credits and other liabilities
 
$
929

 
$

Derivatives not designated as hedging instruments:
 
 
 
 
Foreign currency forward contracts
Accrued expenses and other current liabilities
 
$
2,611

 
$
4,068


Note 20. Fair Value of Financial Instruments
We record financial assets and liabilities at fair value based on FASB guidance related to fair value measurements. The guidance requires fair value to be determined based on the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. Three levels of inputs may be used to measure fair value:
Level 1 – Quoted prices in active markets for identical assets or liabilities.
Level 2 – Quoted market-based inputs or unobservable inputs that are corroborated by market data.
Level 3 – Unobservable inputs that are not corroborated by market data.
The recorded carrying amounts and fair values of these instruments were as follows:
 
June 27, 2020
(amounts in thousands)
Carrying Amount
 
Total
Fair Value
 
Level 1
 
Level 2
 
Level 3
Assets:
 
 
 
 
 
 
 
 
 
Cash equivalents
$
270,069

 
$
270,069

 
$

 
$
270,069

 
$

Derivative assets, recorded in other current assets
3,067

 
3,067

 

 
3,067

 

Derivative assets, recorded in other assets
23

 
23

 

 
23

 

Liabilities:
 
 
 
 
 
 
 
 
 
Debt, recorded in long-term debt and current maturities of long-term debt
$
1,776,503

 
$
1,741,628

 
$

 
$
1,741,628

 
$

Derivative liabilities, recorded in accrued expenses and other current liabilities
3,368

 
3,368

 

 
3,368

 

Derivative liabilities, recorded in deferred credits and other liabilities
929

 
929

 

 
929

 


28


 
December 31, 2019
(amounts in thousands)
Carrying Amount
 
Total
Fair Value
 
Level 1
 
Level 2
 
Level 3
Assets:
 
 
 
 
 
 
 
 
 
Derivative assets, recorded in other current assets
$
1,372

 
$
1,372

 
$

 
$
1,372

 
$

Derivative assets, recorded in other assets
6

 
6

 

 
6

 

Liabilities:
 
 
 
 
 
 
 
 
 
Debt, recorded in long-term debt and current maturities of long-term debt
$
1,528,146

 
$
1,554,425

 
$

 
$
1,554,425

 
$

Derivative liabilities, recorded in accrued expenses and other current assets
4,068

 
4,068

 

 
4,068

 


Derivative assets and liabilities reported in level 2 include foreign currency and interest rate contracts. See Note 19- Derivative Financial Instruments for additional information about our derivative assets and liabilities.
There are no material non-financial assets or liabilities as of June 27, 2020 or December 31, 2019.
Note 21. Commitments and Contingencies
Litigation – We are involved in various legal proceedings, claims, and government audits arising in the ordinary course of business. We record our best estimate of a loss when the loss is considered probable and the amount of such loss can be reasonably estimated. When a loss is probable and there is a range of estimated loss with no best estimate within the range, we record the minimum estimated liability related to the lawsuit or claim. As additional information becomes available, we reassess the potential liability and revise our accruals, if necessary. Because of uncertainties related to the resolution of lawsuits and claims, the ultimate outcome may differ materially from our estimates.
Other than the matters described below, as of June 27, 2020, there are no current proceedings or litigation matters involving the Company or its property that we believe would have a material adverse effect on our consolidated financial position or cash flows, although they could have a material adverse effect on our operating results for a particular reporting period.
Steves & Sons, Inc. vs JELD-WEN – We sell molded door skins to certain customers pursuant to long-term contracts, and these customers in turn use the molded door skins to manufacture interior doors and compete directly against us in the marketplace. We gave notice of termination of one of these contracts and, on June 29, 2016, the counterparty to the agreement, Steves and Sons, Inc. (“Steves”) filed a claim against JWI in the U.S. District Court for the Eastern District of Virginia, Richmond Division (“Eastern District of Virginia”). The complaint alleged that our acquisition of CMI, a competitor in the molded door skins market, together with subsequent price increases and other alleged acts and omissions, violated antitrust laws, and constituted a breach of contract and breach of warranty. Specifically, the complaint alleged that our acquisition of CMI substantially lessened competition in the molded door skins market. The complaint sought declaratory relief, ordinary and treble damages, and injunctive relief, including divestiture of certain assets acquired in the CMI acquisition.
In February 2018, a jury in the Eastern District of Virginia returned a verdict that was unfavorable to JWI with respect to Steves’ claims that our acquisition of CMI violated Section 7 of the Clayton Act and found that JWI breached the supply agreement between the parties (the “Original Action”). The verdict awarded Steves $12.2 million for past damages under both the Clayton Act and breach of contract claims and $46.5 million in future lost profits under the Clayton Act claim.
On March 13, 2019, the presiding judge entered an Amended Final Judgment Order awarding $36.5 million in past damages under the Clayton Act (representing a trebling of the jury’s verdict) and granting divestiture of CMI, subject to appeal. The judgment also conditionally awarded damages in the event the judgment is overturned on appeal. Specifically, the court awarded $139.4 million as future antitrust damages in the event the divestiture order is overturned on appeal and $9.9 million as past contract damages in the event both the divestiture and antitrust claims are overturned on appeal.
JELD-WEN filed a supersedeas bond and notice of appeal of the judgment, which was heard by the Fourth Circuit Court of Appeals on May 29, 2020.
On April 12, 2019, the plaintiffs filed a petition requesting an award of their fees and a bill of costs seeking $28.4 million in attorneys’ fees and $1.7 million in costs in connection with the Original Action. That petition remains pending and subject to further appeal. On November 19, 2019, the presiding judge entered an order for further relief awarding Steves an additional $7.1 million in damages for pricing differences from the date of the underlying jury verdict through May 31, 2019 (the “Pricing Action”). We also appealed that ruling. On April 14, 2020, Steves filed a motion for further

29


supplemental relief for pricing differences from the date of the prior order and going forward through the end of the parties’ current supply agreement. We opposed that request for further relief (the “Future Pricing Action”).
We continue to believe that Steves’ claims lack merit, Steves’ damages calculations are speculative and excessive, and Steves is not entitled in any event to the extraordinary remedy of divestiture of CMI. We believe that multiple pretrial and trial rulings were erroneous and improperly limited the Company’s defenses, and that the judgment in accordance with the verdict was improper for several reasons under applicable law. The judgment, if ultimately upheld after exhaustion of our appellate remedies, could have a material adverse effect on our financial position, operating results, or cash flows, particularly for the reporting period in which a loss is recorded or a payment is required. Because the operations acquired from CMI have been fully integrated into the Company’s operations, divestiture of those operations would be difficult if not impossible and, therefore, it is not possible to estimate the cost of any final divestiture order or the extent to which such an order would have a material adverse effect on our financial position, operating results, or cash flows.
During the course of the proceedings in the Eastern District of Virginia, we discovered certain facts that led us to conclude that Steves, its principals, and certain former employees of the Company had misappropriated Company trade secrets, violated the terms of various agreements between the Company and those parties, and violated other laws. On May 11, 2018, a jury in the Eastern District of Virginia returned a verdict on our trade secrets claims against Steves and awarded damages in the amount of $1.2 million. The presiding judge entered a judgment in our favor for those damages and the entire amount has been paid by Steves. On August 16, 2019, the presiding judge granted Steves’ request for an injunction, prohibiting us from pursuing certain claims against individual defendants pending in Bexar County, Texas (the “Steves Texas Trade Secret Theft Action”). These claims have been stayed pending appeal.
Separately, on February 14, 2020, Steves filed a complaint and motion for preliminary injunction in the U.S. District Court for the Eastern District of Virginia, Richmond Division, alleging that we breached the long-term supply agreement between the parties, among other claims, including by incorrectly calculating the allocation of door skins owed to Steves (the “Allocation Action”). Steves sought an additional allotment of door skins and damages for violation of antitrust laws, tortious interference, and breach of contract. On April 10, 2020, the presiding judge granted Steves’ motion for preliminary injunction and the parties settled the issues underlying the preliminary injunction on April 30, 2020 and reserved the right to appeal the ruling in the Fourth Circuit Court of Appeals. The Company believed all the claims lacked merit and moved to dismiss the antitrust and tortious interference claims.
On June 2, 2020, we entered into a settlement agreement with Steves to resolve the Pricing Action, the Future Pricing Action, and the Allocation Action. As a result of the settlement, Steves filed a notice of satisfaction of judgment in the Pricing Action, withdrew its Future Pricing Action with prejudice, and filed a stipulated dismissal with prejudice in the Allocation Action. The Company also withdrew its appeal of the Pricing Action. The parties agreed to bear their own respective attorneys’ fees and costs in these actions. In partial consideration of the settlement, JWI and Steves entered into an amended supply agreement satisfactory to both parties that ends on September 10, 2021. This settlement has no effect on the Original Action between the parties that is currently on appeal in the Fourth Circuit except to agree that certain specific terms of the Amended Final Judgment Order in the Original Action shall apply to the amended supply agreement during the pendency of the appeal of the Original Action, nor does this settlement have any effect on the Steves Texas Trade Secret Theft Action, which remains on appeal in the Fourth Circuit. We continue to believe the claims in the settled actions lacked merit and made no admission of liability in these matters.
Cambridge Retirement System v. JELD-WEN Holding, Inc., et al. – On February 19, 2020, Cambridge Retirement System filed a putative class action lawsuit in the U.S. District Court for the Eastern District of Virginia against the Company, current and former Company executives, and various Onex-related entities alleging violations of Section 10(b) and Rule 10b-5 of the Exchange Act, as well as violations of Section 20(a) of the Exchange Act against the individual defendants and Onex-related entities.  The lawsuit seeks compensatory damages, equitable relief and an award of attorneys’ fees and costs. The Company believes the claims lack merit and intends to vigorously defend against the action. On May 8, 2020, the Public Employees Retirement System of Mississippi and the Plumbers and Pipefitters National Pension Fund were named as co-lead plaintiffs and filed an amended complaint on June 22, 2020. We filed a motion to dismiss the amended complaint on July 29, 2020.
In Re: Interior Molded Doors Antitrust Litigation – On October 19, 2018, Grubb Lumber Company, on behalf of itself and others similarly situated, filed a putative class action lawsuit against us and one of our competitors in the doors market, Masonite Corporation (“Masonite”), in the Eastern District of Virginia. We subsequently received additional complaints from and on behalf of direct and indirect purchasers of interior molded doors. The suits have been consolidated into two separate actions, a Direct Purchaser Action and an Indirect Purchaser Action. The suits allege that Masonite and we violated Section 1 of the Sherman Act, and in the Indirect Purchaser Action, related state law antitrust and consumer protection laws, by engaging in a scheme to artificially raise, fix, maintain or stabilize the prices of interior molded doors in the United States. The complaints seek unquantified ordinary and treble damages, declaratory relief, interest, costs and

30


attorneys’ fees. The Company believes the claims lack merit and intends to vigorously defend against the actions. On September 18, 2019, the court denied the defendants’ motions to dismiss the lawsuits in their entirety and granted the defendants’ motions to dismiss various state law claims and to limit all claims to a four-year statute of limitations. As a result, the plaintiffs’ damages period is limited to the four-year period between 2014 and 2018. Together with Masonite, we filed motions to oppose class certification in both the Direct Purchaser and Indirect Purchaser Actions on May 19, 2020. Trial in the two matters has been set for February 8, 2021.
Development Emeraude Litigation – On May 15, 2020, Development Emeraude Inc., on behalf of itself and others similarly situated, filed a putative class action lawsuit against us and Masonite in the Superior Court of the Province of Quebec, Canada. The putative class is constituted of any person in Canada who, since October 2012, purchased one or more interior molded doors from us or Masonite. The suit alleges an illegal conspiracy between us and Masonite to agree on prices, the distribution of market shares and/or the production levels of interior molded doors and that the plaintiffs suffered damages in that they were charged and paid higher prices for interior molded doors than they would have had to pay but for the alleged anti-competitive conduct. The plaintiffs are seeking compensatory and punitive damages, attorneys’ fees, and costs. The Company believes the claims lack merit and intends to vigorously defend against the action.
We have evaluated the claims against us and recorded provisions based on management’s judgment about the probable outcome of the litigation and have included our estimates in accrued expenses in the accompanying balance sheets. See Note 9 - Accrued Expenses and Other Current Liabilities. While we expect a favorable resolution to these matters, the dispute resolution process could be lengthy, and if the plaintiffs were to prevail completely or substantially in the respective matters described above, such an outcome could have a material adverse effect on our operating results, consolidated financial position, or cash flows.
Self-Insured Risk – We self-insure substantially all of our domestic business liability risks including general liability, product liability, warranty, personal injury, auto liability, workers’ compensation and employee medical benefits. Excess insurance policies from independent insurance companies generally cover exposures between $3.0 million and $200.0 million for domestic product liability risk and exposures between $0.5 million and $200.0 million for auto, general liability, personal injury and workers’ compensation. We have no stop loss insurance covering our self-insured employee medical plan and are responsible for all claims thereunder. We estimate our provision for self-insured losses based upon an evaluation of current claim exposure and historical loss experience. Actual self-insurance losses may vary significantly from these estimates. At June 27, 2020 and December 31, 2019, our accrued liability for self-insured risks was $76.0 million and $76.6 million, respectively.
Indemnifications – At June 27, 2020, we had commitments related to certain representations made in contracts for the purchase or sale of businesses or property. These representations primarily relate to past actions such as responsibility for transfer taxes if they should be claimed, and the adequacy of recorded liabilities, warranty matters, employment benefit plans, income tax matters or environmental exposures. These guarantees or indemnification responsibilities typically expire within one to three years. We are not aware of any material amounts claimed or expected to be claimed under these indemnities. From time to time and in limited geographic areas, we have entered into agreements for the sale of our products to certain customers that provide additional indemnifications for liabilities arising from construction or product defects. We cannot estimate the potential magnitude of such exposures, but to the extent specific liabilities have been identified related to product sales, liabilities have been provided in the warranty accrual in the accompanying consolidated balance sheets.

31


Performance Bonds and Letters of Credit – At times, we are required to provide letters of credit, surety bonds or guarantees to customers, vendors and others. Stand-by letters of credit are provided to certain customers and counterparties in the ordinary course of business as credit support for contractual performance guarantees, advanced payments received from customers, and future funding commitments. During 2019, we filed bonds in the amount of $47.7 million related to the Steves’ legal proceeding which were subsequently reduced to $40.0 million. The outstanding performance bonds and stand-by letters of credit were as follows:
(amounts in thousands)
June 27,
2020
 
December 31,
2019
Self-insurance workers’ compensation
$
24,738

 
$
23,638

Legal
40,861

 
48,561

Liability and other insurance
17,708

 
16,678

Environmental
8,286

 
8,186

Other
6,545

 
5,864

Total outstanding performance bonds and stand-by letters of credit
$
98,138

 
$
102,927


Environmental Contingencies – We periodically incur environmental liabilities associated with remediating our current and former manufacturing sites as well as penalties for not complying with environmental rules and regulations. We record a liability for remediation costs when it is probable that we will be responsible for such costs and the costs can be reasonably estimated. These environmental liabilities are estimated based on current available facts and current laws and regulations. Accordingly, it is likely that adjustments to the estimated liabilities will be necessary as additional information becomes available. Short-term environmental liabilities and settlements are recorded in accrued expenses in the accompanying consolidated balance sheets and totaled $0.7 million at both June 27, 2020 and December 31, 2019. Long-term environmental liabilities are recorded in deferred credits and other liabilities in the accompanying consolidated balance sheets. No long-term environmental liabilities were recorded at either June 27, 2020 or December 31, 2019.
Everett, Washington WADOE Action In 2008, we entered into an Agreed Order with the WADOE to assess historic environmental contamination and remediation feasibility at our former manufacturing site in Everett, Washington. As part of this agreement, we also agreed to develop a Corrective Action Plan (“CAP”), arising from the feasibility assessment. We are currently working with WADOE to finalize our Remedial Investigation and Feasibility Study (“RI/FS”), and, on April 30, 2020, we provided the WADOE with our revised draft RI/FS. The WADOE will review our RI/FS and provide a public comment period, potentially in the third quarter of 2020, before we can develop the CAP. However, at this time, we cannot reasonably estimate the cost associated with any remedial actions we will be required to undertake under the CAP; therefore, we have not provided accruals for any remedial action in our accompanying consolidated financial statements.
Towanda, Pennsylvania Consent Order In 2015, we entered into a COA with the PaDEP to remove a pile of wood fiber waste from our site in Towanda, Pennsylvania, which we acquired in connection with our acquisition of CMI in 2013, by using it as fuel for a boiler at that site. The COA replaced a 1995 Consent Decree between CMI’s predecessor Masonite, Inc. and PaDEP. Under the COA, we are required to achieve certain periodic removal objectives and ultimately remove the entire pile by August 31, 2022. There are currently $2.3 million in bonds posted in connection with these obligations. If we are unable to remove this pile by August 31, 2022, then the bonds will be forfeited, and we may be subject to penalties by PaDEP. We currently anticipate meeting all applicable removal deadlines; however, if our operations at this site decrease and we burn less fuel than currently anticipated, we may not be able to meet such deadlines.

32


Note 22. Employee Retirement and Pension Benefits

U.S. Defined Benefit Pension Plan – Certain U.S. hourly employees participate in our defined benefit pension plan. The plan is not open to new employees. Pension expense, as recorded in the accompanying unaudited consolidated statements of operations, is determined by using spot rate assumptions made on January 1 of each year as summarized below:
 
Three Months Ended
 
Six Months Ended
(amounts in thousands)
June 27,
2020
 
June 29,
2019
 
June 27,
2020
 
June 29,
2019
Components of pension benefit expense - U.S. benefit plan:
 
 
 
 
 
 
 
Administrative cost
$
300

 
$
1,250

 
$
1,550

 
$
2,500

Interest cost
2,375

 
3,725

 
6,100

 
7,450

Expected return on plan assets
(6,300
)
 
(4,650
)
 
(10,950
)
 
(9,300
)
Amortization of net actuarial pension loss
1,225

 
2,225

 
3,450

 
4,450

Pension benefit expense
$
(2,400
)
 
$
2,550

 
$
150

 
$
5,100



During the six months ended June 27, 2020, we made required contributions to our U.S. defined benefit pension plan or “Plan”, of $1.6 million. During the three and six months ended June 29, 2019, we made required contributions to the Plan of $1.6 million and $3.0 million, respectively. We did not make any voluntary contributions during any of the periods described above. On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) was enacted. In conjunction with the CARES Act, companies were provided relief for defined benefit pension plans, which allows us to defer the remaining $2.8 million of minimum contributions until December 31, 2020.

During the three months ended June 27, 2020, we elected to utilize the alternative method when calculating the Pension Benefit Guarantee Corporation premiums for 2020 and the succeeding 4 years, rather than the standard method utilized during the previous 5 years, resulting in a reduction to pension benefit expenses in the period.

33


Note 23. Supplemental Cash Flow Information
 
Six Months Ended
(amounts in thousands)
June 27, 2020
 
June 29, 2019
Cash Operating Activities:
 
 
 
Operating leases
$
28,112

 
$
28,069

Finance leases
87

 
45

Cash paid for amounts included in the measurement of lease liabilities
$
28,199

 
$
28,114

 
 
 
 
Non-cash Investing Activities:
 
 
 
Property, equipment and intangibles purchased in accounts payable
$
4,517

 
$
9,503

Property, equipment and intangibles purchased for debt
7,913

 
18,252

Customer accounts receivable converted to notes receivable

 
400

 
 
 
 
Cash Financing Activities:
 
 
 
Proceeds from issuance of new debt
$
250,000

 
$

Borrowings on long-term debt
353

 
109,527

Payments of long-term debt
(11,921
)
 
(14,127
)
 Payments of debt issuance and extinguishment costs, including underwriting fees
(4,136
)
 

Change in long-term debt
$
234,296

 
$
95,400

 
 
 
 
Cash paid for amounts included in the measurement of finance lease liabilities
$
712

 
$
330

 
 
 
 
Non-cash Financing Activities:
 
 
 
Debt issuance costs deducted from long-term debt borrowings in accounts payable
$
697

 
$

Prepaid insurance funded through short-term debt borrowings
1,691

 
1,189

Prepaid ERP costs funded through short-term debt borrowings

 
1,430

Shares surrendered for tax obligations for employee share-based transactions in accrued liabilities
2

 
307

Accounts payable converted to installment notes
914

 
757

 
 
 
 
Other Supplemental Cash Flow Information:
 
 
 
Cash taxes paid, net of refunds
$
10,888

 
$
13,419

Cash interest paid
28,620

 
35,837

Leased assets obtained in exchange for new finance lease liabilities
394

 
247

Leased assets obtained in exchange for new operating lease liabilities
15,250

 
11,870


Note 24. Related Party Transactions
Sale of subsidiary – In May 2019, we sold Creative Media Development, Inc. “CMD”, a subsidiary, which was part of our North America segment, for $6.5 million, resulting in a gain of $2.8 million in the second quarter of 2019. A minority shareholder of the buying group also serves on our Board of Directors. Under the Stock Purchase Agreement for CMD, we agreed to use CMD for certain advertising services totaling $7.0 million between 2019 and 2023. As of June 27, 2020, the remaining balance is $2.7 million. At June 27, 2020, there is no amount due from the related party. This sale did not have a material impact on our results of operations.
Acquired lease – In conjunction with our acquisition of VPI, we assumed operating leases on two buildings are with a former shareholder of VPI and current employee. The leases are at market rates and resulted in an operating lease asset of $3.6 million as of the opening balance sheet. One of the leases was modified in August 2019, which increased the value by $0.6 million. At June 27, 2020, the operating lease asset is $3.7 million.


34


Item 2 - Management’s Discussion and Analysis of Financial Condition and Results of Operations
FORWARD-LOOKING STATEMENTS
In addition to historical information, this 10-Q contains “forward-looking statements” within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act, which are subject to the “safe harbor” created by those sections. All statements, other than statements of historical facts, included in this 10-Q are forward-looking statements. You can generally identify forward-looking statements by our use of forward-looking terminology such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “potential,” “predict,” “seek,” or “should,” or the negative thereof or other variations thereon or comparable terminology. In particular, statements about the markets in which we operate, including growth of our various markets, and our expectations, beliefs, plans, strategies, objectives, prospects, assumptions, including the impact of COVID-19, the outcome of legal proceeding, or future events or performance contained under the heading Item 2- Management’s Discussion and Analysis of Financial Condition and Results of Operations are forward-looking statements.
We have based these forward-looking statements on our current expectations, assumptions, estimates and projections. While we believe these expectations, assumptions, estimates, and projections are reasonable, such forward-looking statements are only predictions and involve known and unknown risks and uncertainties, many of which are beyond our control. These and other important factors, including those discussed under the headings Item 1A- Risk Factors in our annual report on Form 10-K and Item 1A- Risk Factors and Item 2- Management’s Discussion and Analysis of Financial Condition and Results of Operations in this 10-Q may cause our actual results, performance or achievements to differ materially from any future results, performance or achievements expressed or implied by these forward-looking statements. Some of the factors that could cause actual results to differ materially from those expressed or implied by the forward-looking statements include:
negative trends in overall business, financial market and economic conditions, and/or activity levels in our end markets;
our highly competitive business environment;
failure to timely identify or effectively respond to consumer needs, expectations or trends;
failure to maintain the performance, reliability, quality, and service standards required by our customers;
failure to implement our strategic initiatives, including JEM;
acquisitions or investments in other businesses that may not be successful;
adverse outcome of pending or future litigation;
declines in our relationships with and/or consolidation of our key customers;
increases in interest rates and reduced availability of financing for the purchase of new homes and home construction and improvements;
fluctuations in the prices of raw materials used to manufacture our products;
delays or interruptions in the delivery of raw materials or finished goods;
seasonal business and varying revenue and profit;
changes in weather patterns;
political, economic, and other risks, including pandemics, such as COVID-19, that arise from operating a multinational business;
exchange rate fluctuations;
disruptions in our operations;
manufacturing realignments and cost savings programs resulting in a decrease in short-term earnings;
our new Enterprise Resource Planning system that we are currently implementing proving ineffective;
security breaches and other cybersecurity incidents;
increases in labor costs, potential labor disputes, and work stoppages at our facilities;  
changes in building codes that could increase the cost of our products or lower the demand for our windows and doors;
compliance costs and liabilities under environmental, health, and safety laws and regulations;

35



compliance costs with respect to legislative and regulatory proposals to restrict emission of GHGs;
lack of transparency, threat of fraud, public sector corruption, and other forms of criminal activity involving government officials;
product liability claims, product recalls, or warranty claims;
inability to protect our intellectual property;
loss of key officers or employees;
pension plan obligations;
our current level of indebtedness;
risks associated with any material weaknesses in our internal controls;
the extent of Onex’s control of us; and
other risks and uncertainties, including those listed under Item 1A- Risk Factors in our 10-K and Item 1A- Risk Factors in this 10-Q.
Given these risks and uncertainties, you are cautioned not to place undue reliance on such forward-looking statements. The forward-looking statements contained in this 10-Q are not guarantees of future performance and our actual results of operations, financial condition, and liquidity, and the development of the industry in which we operate, may differ materially from the forward-looking statements contained herein. In addition, even if our results of operations, financial condition, and liquidity, and events in the industry in which we operate, are consistent with the forward-looking statements contained in this 10-Q, they may not be predictive of results or developments in future periods.
Any forward-looking statement in this 10-Q speaks only as of the date of this 10-Q or as of the date such statement was made. We do not undertake any obligation to update or revise, or to publicly announce any update or revision to, any of the forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
Unless the context requires otherwise, references in this 10-Q to “we,” “us,” “our,” “the Company,” or “JELD-WEN” mean JELD-WEN Holding, Inc., together with our consolidated subsidiaries where the context requires, including our wholly owned subsidiary JWI.
This discussion should be read in conjunction with our historical financial statements and related notes thereto and the other disclosures contained elsewhere in this 10-Q. The results of operations for the periods reflected herein are not necessarily indicative of results that may be expected for future periods, and our actual results may differ materially from those discussed in the forward-looking statements as a result of various factors, including but not limited to those listed under Item 1A- Risk Factors in our annual report on Form 10-K and Item 1A - Risk Factors in this 10-Q and included elsewhere in this 10-Q.
This MD&A is a supplement to our financial statements and notes thereto included elsewhere in this 10-Q and is provided to enhance your understanding of our results of operations and financial condition. Our discussion of results of operations is presented in millions throughout the MD&A and due to rounding may not sum or calculate precisely to the totals and percentages provided in the tables. Our MD&A is organized as follows:
Overview and Background. This section provides a general description of our Company and reportable segments, business and industry trends, our key business strategies and background information on other matters discussed in this MD&A.
Consolidated Results of Operations and Operating Results by Business Segment. This section provides our analysis and outlook for the significant line items on our consolidated statements of operations, as well as other information that we deem meaningful to an understanding of our results of operations on both a consolidated basis and a business segment basis.
Liquidity and Capital Resources. This section contains an overview of our financing arrangements and provides an analysis of trends and uncertainties affecting liquidity, cash requirements for our business and sources and uses of our cash.
Critical Accounting Policies and Estimates. This section discusses the accounting policies that we consider important to the evaluation and reporting of our financial condition and results of operations, and whose application requires significant judgments or a complex estimation process.

36



Overview and Background
We are one of the world’s largest door and window manufacturers, and we hold a leading position by net revenues in the majority of the countries and markets we serve. We design, produce and distribute an extensive range of interior and exterior doors, wood, vinyl and aluminum windows, and related products for use in the new construction, R&R of residential homes, and, to a lesser extent, non-residential buildings.
We operate manufacturing and distribution facilities in approximately 20 countries, located primarily in North America, Europe, and Australia. For many product lines, our manufacturing processes are vertically integrated, enhancing our range of capabilities, our ability to innovate, and our quality control as well as providing supply chain, transportation, and working capital savings.
Business Segments
Our business is organized in geographic regions to ensure integration across operations serving common end markets and customers. We have three reportable segments: North America, Europe, and Australasia. Financial information related to our business segments can be found in Note 13 - Segment Information of our financial statements included elsewhere in this 10-Q.
Acquisitions
In March 2019, we acquired VPI Quality Windows, Inc., a leading manufacturer of vinyl windows, specializing in customized solutions for mid-rise multi-family, industrial, hospitality and commercial projects, primarily in the western U.S. VPI is located in Spokane, Washington. VPI is part of our North America segment. We paid approximately $57.8 million in cash, net of cash acquired, for the acquisition of VPI.
For additional information on our acquisition activity, see Note 2 - Acquisitions of our financial statements included elsewhere in this 10-Q.
Significant Developments
In March 2020, the World Health Organization declared the outbreak of COVID-19 a global pandemic. In the following weeks, global restrictions, including stay at home and similar orders, were implemented in a significant number of regions in which we operate. During the second quarter of 2020, we experienced intermittent closures of certain manufacturing facilities due to local and governmental mandates, with disruptions occurring primarily in April and May and full resumption of operations by the end of the quarter. Customer demand and revenue were consistent with our expectations during April and May with high-teens percentage declines from the prior year, however, improved through the last half of the quarter to prior year levels as a result of plant reopenings. We have modified our manufacturing facilities and procedures, based on recommended public health guidelines, to ensure the health and well-being of our employees. During the second quarter, we received approximately $5.9 million relating to governmental pandemic assistance programs, which are primarily relate to reimbursements for additional costs incurred as a result of the outbreak of COVID-19.
We took measures during the second quarter of 2020 to enhance our liquidity and mitigate potential negative impacts to our financial results, including by issuing $250.0 million of Senior Secured Notes to provide additional capital. We have also taken measures to reduce discretionary spending. We have, for example, restricted travel, implemented hiring freezes for non-essential positions, delayed merit increases, and suspended all non-critical spending, such as marketing and discretionary projects. In addition, we have implemented actions to reduce salary costs globally, including our executive leadership team and Board of Directors elected to reduce their second quarter compensation by 25%, and implemented short-term employee furloughs throughout our company. Further, to maintain sufficient levels of cash and liquidity, we have suspended any non-critical capital expenditures, are deferring tax payments where permitted through COVID-19 related government subsidy programs, and are actively monitoring our accounts receivable for customers with elevated credit risk. We are monitoring the situation closely and, if necessary, will relax cost saving measures or implement additional measures as appropriate.
The scope and nature of impacts from COVID-19, most of which are beyond the Company’s control, continue to evolve, and the outcome is uncertain. The ultimate extent of the effects of the COVID-19 pandemic on the Company, and the end markets we service, is highly uncertain and will depend on future developments and such effects could exist for an extended period even after the pandemic ends.
Results of Operations
The tables in this section summarize key components of our results of operations for the periods indicated, both in U.S. dollars and as a percentage of our net revenues. Certain percentages presented in this section have been rounded to the nearest whole number. Accordingly, totals may not equal the sum of the line items in the tables below.

37



Comparison of the Three Months Ended June 27, 2020 to the Three Months Ended June 29, 2019
 
Three Months Ended
 
June 27, 2020
 
June 29, 2019
(amounts in thousands)
 
% of Net 
Revenues
 
% of Net 
Revenues
Net revenues
$
992,346

 
100.0
 %
 
$
1,118,987

 
100.0
%
Cost of sales
773,675

 
78.0
 %
 
878,768

 
78.5
%
Gross margin
218,671

 
22.0
 %
 
240,219

 
21.5
%
Selling, general and administrative
166,327

 
16.8
 %
 
176,585

 
15.8
%
Impairment and restructuring charges
2,266

 
0.2
 %
 
5,734

 
0.5
%
Operating income
50,078

 
5.0
 %
 
57,900

 
5.2
%
Interest expense, net
19,076

 
1.9
 %
 
18,492

 
1.7
%
Other (income) expense
(2,498
)
 
(0.3
)%
 
4,871

 
0.4
%
Income before taxes
33,500

 
3.4
 %
 
34,537

 
3.1
%
Income tax expense
10,403

 
1.0
 %
 
12,181

 
1.1
%
Net income
$
23,097

 
2.3
 %
 
$
22,356

 
2.0
%
Consolidated Results
Net Revenues – Net revenues decreased $126.6 million, or 11.3%, to $992.3 million in the three months ended June 27, 2020 from $1,119.0 million in the three months ended June 29, 2019. The decrease in net revenues was driven by a 10% decline in core revenues and a 1% adverse impact from foreign exchange. Core revenues, which exclude the impact of foreign exchange and acquisitions completed in the last twelve months, declined by 10% during the quarter, driven by a 13% impact from unfavorable volume/mix, partially offset by a 3% net pricing benefit.
Gross Margin – Gross margin decreased $21.5 million, or 9.0%, to $218.7 million in the three months ended June 27, 2020 from $240.2 million in the three months ended June 29, 2019. Gross margin as a percentage of net revenues was 22.0% in the three months ended June 27, 2020 and 21.5% in the three months ended June 29, 2019. The increase in gross margin percentage was due to improved pricing, favorable productivity, and cost saving measures implemented in response to COVID-19, partially offset by unfavorable volume/mix across all regions.
SG&A Expense – SG&A expense decreased $10.3 million, or 5.8%, to $166.3 million for the three months ended June 27, 2020 from $176.6 million in the three months ended June 29, 2019. SG&A expense as a percentage of net revenues increased to 16.8% for the three months ended June 27, 2020 from 15.8% for the three months ended June 29, 2019. The decrease in SG&A expense was primarily due to reductions in spending relating to sales, marketing, travel, and salary expenses as a result of cost saving measures implemented in response to COVID-19, partially offset by increased legal expenses, principally relating to litigation.
Impairment and Restructuring Charges – Impairment and restructuring charges decreased $3.5 million, or 60.5%, to $2.3 million in the three months ended June 27, 2020 from $5.7 million in the three months ended June 29, 2019. The decrease in impairment and restructuring charges was primarily due to reduced restructuring efforts across all segments during the current quarter as compared to the second quarter of 2019.
Interest Expense, Net – Interest expense, net increased $0.6 million, or 3.2%, to $19.1 million in the three months ended June 27, 2020 from $18.5 million in the three months ended June 29, 2019. The increase was primarily due to increased borrowings during the period.
Other (Income) Expense – Other (income) expense changed $7.4 million to income of $2.5 million in the three months ended June 27, 2020 from expense of $4.9 million in the three months ended June 29, 2019. Other income in the three months ended June 27, 2020 consisted primarily of $5.9 million for cash received as a result of governmental pandemic assistance reimbursements relating to COVID-19 and a reduction in pension expenses of $2.2 million, partially offset by foreign currency losses of $6.3 million. Other expense in the three months ended June 29, 2019 primarily consisted of foreign currency losses of $5.5 million and pension expense of $2.7 million, partially offset by a gain on the sale of business units, property, and equipment of $2.4 million.
Income Taxes – Income tax expense decreased $1.8 million, or 14.6%, to $10.4 million in the three months ended June 27, 2020 from $12.2 million in the three months ended June 29, 2019. The effective tax rate in the three months ended June 27, 2020 was an expense of 31.1% compared to 35.3% in the three months ended June 29, 2019. The effective tax rate for the three months ended

38



June 27, 2020 was heavily impacted by the GILTI provisions of the Tax Act. The decrease in 2020 tax expense of $1.8 million was primarily driven by the tax benefit attributed to the expiration of the statute of limitations on certain tax years in Estonia and the decline and mix of income between jurisdictions in which we do business, offset by the increase of the estimated annual effective tax rate. Our 2020 estimated annual effective tax rate was increased due to certain projected changes in valuation allowances recorded against certain tax attribute carryforwards due to anticipated operational impacts of the COVID-19 pandemic. The effective tax rate for the three months ended June 29, 2019 includes the impact of GILTI tax as well as an establishment of a valuation allowance for our Chilean subsidiary, interest accrued on uncertain tax positions, and the mix of income/loss between jurisdictions in which the Company does business.
Comparison of the Six Months Ended June 27, 2020 to the Six Months Ended June 29, 2019
 
Six Months Ended
 
June 27, 2020
 
June 29, 2019
(amounts in thousands)
 
 
% of Net 
Revenues
 
 
% of Net 
Revenues
Net revenues
$
1,971,533

 
100.0
 %
 
$
2,129,247

 
100.0
%
Cost of sales
1,558,493

 
79.0
 %
 
1,680,899

 
78.9
%
Gross margin
413,040

 
21.0
 %
 
448,348

 
21.1
%
Selling, general and administrative
338,911

 
17.2
 %
 
340,685

 
16.0
%
Impairment and restructuring charges
8,811

 
0.4
 %
 
9,453

 
0.4
%
Operating income
65,318

 
3.3
 %
 
98,210

 
4.6
%
Interest expense, net
35,680

 
1.8
 %
 
36,148

 
1.7
%
Other (income) expense
(4,829
)
 
(0.2
)%
 
1,399

 
0.1
%
Income before taxes
34,467

 
1.7
 %
 
60,663

 
2.8
%
Income tax expense
11,600

 
0.6
 %
 
22,530

 
1.1
%
Net income
$
22,867

 
1.2
 %
 
$
38,133

 
1.8
%
Consolidated Results
Net Revenues – Net revenues decreased $157.7 million, or 7.4%, to $1,971.5 million in the six months ended June 27, 2020 from $2,129.2 million in the six months ended June 29, 2019. The decrease was driven by a decline in core revenue of 6% and adverse foreign exchange impact of 2%, partially offset by a 1% contribution from the VPI acquisition. The decrease in core revenue consisted of a 9% decline in volume/mix, partially offset by a 3% pricing benefit.
Gross Margin – Gross margin decreased $35.3 million, or 7.9%, to $413.0 million in the six months ended June 27, 2020 from $448.3 million in the six months ended June 29, 2019. Gross margin as a percentage of net revenues was 21.0% in the six months ended June 27, 2020 and 21.1% in the six months ended June 29, 2019. Gross margins remained stable due to a reduction in salary expenses as a result of plant closures and cost saving measures implemented in response to COVID-19, and favorable pricing within North America, partially offset by unfavorable volume/mix across all regions.
SG&A Expense – SG&A expense decreased $1.8 million, or 0.5%, to $338.9 million in the six months ended June 27, 2020 from $340.7 million in the six months ended June 29, 2019. The decrease in SG&A expense was primarily due to a reduction in spending relating to sales and marketing and a reduction of salary expenses as a result of cost saving measures implemented in response to COVID-19, partially offset by increased legal expenses, principally relating to litigation.
Impairment and Restructuring Charges – Impairment and restructuring charges decreased $0.6 million, or 6.8%, to $8.8 million in the six months ended June 27, 2020 from $9.5 million in the six months ended June 29, 2019. Charges incurred in 2020 primarily related to severance charges for ongoing restructuring projects across all segments as well as impairment charges primarily related to capitalized costs of certain ERP modules due to delays in implementation and uncertainty of their future use. Charges incurred in 2019 primarily related to impairment charges for ROU assets and property and equipment held by operations impacted by restructuring as well as severance costs across all segments and corporate. For more information, refer to Note 17 - Impairment and Restructuring Charges to our unaudited consolidated financial statements included in this 10-Q.
Interest Expense, Net – Interest expense, net, decreased $0.5 million, or 1.3%, to $35.7 million in the six months ended June 27, 2020 from $36.1 million in the six months ended June 29, 2019. The decrease was primarily due to lower interest rates in 2020, partially offset by increased borrowings during the second quarter.

39



Other (Income) Expense – Other (income) expense changed $6.2 million to income of $4.8 million in the six months ended June 27, 2020 from expense of $1.4 million in the six months ended June 29, 2019. The other income in the six months ended June 27, 2020 primarily consisted of $5.9 million for cash received as a result of governmental pandemic assistance reimbursements relating to COVID-19 and a gain on sale of property and equipment of $2.4 million, partially offset by foreign currency losses of $4.1 million. Other expense in the six months ended June 29, 2019 was primarily due to pension expense of $5.4 million and foreign currency losses of $0.2 million, partially offset by a gain on the sale of business units, property and equipment of $1.8 million and legal settlement income of $1.2 million.
Income Taxes – Income tax expense decreased $10.9 million, or 48.5%, to $11.6 million in the six months ended June 27, 2020 from $22.5 million in the six months ended June 29, 2019. The effective tax rate in the six months ended June 27, 2020 was 33.7% compared to 37.2% in the six months ended June 29, 2019. The decrease in 2020 tax expense of $10.9 million was primarily driven by the tax benefit attributed to the expiration of the statute of limitations on certain tax years in Estonia and the decline and mix of income between jurisdictions in which we do business, offset by the increase of the estimated annual effective estimated tax rate. Our 2020 estimated annual effective tax rate increased due to certain projected changes in valuation allowances recorded against certain tax attribute carryforwards due to anticipated operational impacts of the COVID-19 pandemic. The 2019 tax expense of $22.5 million was greater than the comparable period in 2020 primarily due to the establishment of the valuation allowance for our Chilean subsidiary, and the increased shortfalls for share-based compensation, exercises, and forfeitures, as well as the mix of income/loss between taxing jurisdictions.

40



Segment Results
We report our segment information in the same way management internally organizes the business in assessing performance and making decisions regarding allocation of resources in accordance with ASC 280-10- Segment Reporting. We have determined that we have three reportable segments, organized and managed principally by geographic region. Our reportable segments are North America, Europe, and Australasia. We report all other business activities in Corporate and unallocated costs. We define Adjusted EBITDA as net income (loss), adjusted for the following items: loss from discontinued operations, net of tax; equity earnings of non-consolidated entities; income tax (benefit) expense; depreciation and amortization; interest expense, net; impairment and restructuring charges; gain on previously held shares of equity investment; (gain) loss on sale of property and equipment; share-based compensation expense; non-cash foreign exchange transaction/translation (income) loss; other non-cash items; other items; and costs related to debt restructuring and debt refinancing. For additional information on segment Adjusted EBITDA, see Note 13 - Segment Information to our unaudited interim consolidated financial statements included in this 10-Q.
Comparison of the Three Months Ended June 27, 2020 to the Three Months Ended June 29, 2019
 
 
Three Months Ended
 
 
(amounts in thousands)
 
June 27,
2020
 
June 29,
2019
 
 
Net revenues from external customers
 
 
 
 
 
% Variance
North America
 
$
608,113

 
$
668,372

 
(9.0
)%
Europe
 
261,524

 
300,386

 
(12.9
)%
Australasia
 
122,709

 
150,229

 
(18.3
)%
Total Consolidated
 
$
992,346

 
$
1,118,987

 
(11.3
)%
Percentage of total consolidated net revenues
 
 
 
 
 
 
North America
 
61.3
%
 
59.7
%
 
 
Europe
 
26.3
%
 
26.9
%
 
 
Australasia
 
12.4
%
 
13.4
%
 
 
Total Consolidated
 
100.0
%
 
100.0
%
 
 
Adjusted EBITDA(1)
 
 
 
 
 
 
North America
 
$
91,115

 
$
87,519

 
4.1
 %
Europe
 
28,354

 
28,988

 
(2.2
)%
Australasia
 
15,235

 
21,258

 
(28.3
)%
Corporate and unallocated costs
 
(8,985
)
 
(10,182
)
 
(11.8
)%
Total Consolidated
 
$
125,719

 
$
127,583

 
(1.5
)%
Adjusted EBITDA as a percentage of segment net revenues
 
 
 
 
 
 
North America
 
15.0
%
 
13.1
%
 
 
Europe
 
10.8
%
 
9.7
%
 
 
Australasia
 
12.4
%
 
14.2
%
 
 
Total Consolidated
 
12.7
%
 
11.4
%
 
 
(1)
Adjusted EBITDA is a financial measure that is not calculated in accordance with GAAP. For a discussion of our presentation of Adjusted EBITDA, see Note 13 - Segment Information in our unaudited interim consolidated financial statements.
North America
Net revenues in North America decreased $60.3 million, or 9.0%, to $608.1 million in the three months ended June 27, 2020 from $668.4 million in the three months ended June 29, 2019. The decrease was due to a reduction in core revenues of 9%, consisting of a volume/mix headwind of 14%, partially offset by a 5% benefit from pricing.
Adjusted EBITDA in North America increased $3.6 million, or 4.1%, to $91.1 million in the three months ended June 27, 2020 from $87.5 million in the three months ended June 29, 2019. The increase was primarily due to improved pricing and lower salary and benefit costs, partially offset by lower volumes and the impact of unfavorable mix.
Europe
Net revenues in Europe decreased $38.9 million, or 12.9%, to $261.5 million in the three months ended June 27, 2020 from $300.4 million in the three months ended June 29, 2019. The decrease was primarily due to a reduction in core revenues of 11% decline in core revenues due to a volume/mix headwind and a 2% adverse impact from foreign exchange.

41




Adjusted EBITDA in Europe decreased $0.6 million, or 2.2%, to $28.4 million in the three months ended June 27, 2020 from $29.0 million in the three months ended June 29, 2019. The decrease was primarily due to volume/mix headwinds, partially offset by favorable productivity and reduced material costs.
Australasia
Net revenues in Australasia decreased $27.5 million, or 18.3%, to $122.7 million in the three months ended June 27, 2020 from $150.2 million in the three months ended June 29, 2019. The decrease was due to a reduction in core revenues of 12.0%, consisting of a decrease in volumes/mix from market headwinds of 11% and reduced pricing of 1%, as well as adverse foreign exchange impacts of 6%.
Adjusted EBITDA in Australasia decreased $6.0 million, or 28.3%, to $15.2 million in the three months ended June 27, 2020 from $21.3 million in the three months ended June 29, 2019. The decrease was primarily due to lower volumes and unfavorable pricing, partially offset by favorable productivity and lower salary and benefit costs.
Comparison of the Six Months Ended June 27, 2020 to the Six Months Ended June 29, 2019
 
 
Six Months Ended
 
 
(amounts in thousands)
 
June 27,
2020
 
June 29,
2019
 
 
Net revenues from external customers
 
 
 
 
 
% Variance
North America
 
$
1,194,849

 
$
1,233,478

 
(3.1
)%
Europe
 
543,017

 
600,351

 
(9.6)
 %
Australasia
 
233,667

 
295,418

 
(20.9)
 %
Total Consolidated
 
$
1,971,533

 
$
2,129,247

 
(7.4)
 %
Percentage of total consolidated net revenues
 
 
 
 
 
 
North America
 
60.6
%
 
57.9
%
 
 
Europe
 
27.5
%
 
28.2
%
 
 
Australasia
 
11.9
%
 
13.9
%
 
 
Total Consolidated
 
100.0
%
 
100.0
%
 
 
Adjusted EBITDA(1)
 
 
 
 
 
 
North America
 
$
140,105

 
$
140,314

 
(0.1)
 %
Europe
 
51,680

 
56,627

 
(8.7)
 %
Australasia
 
23,960

 
37,638

 
(36.3)
 %
Corporate and unallocated costs
 
(15,518
)
 
(17,718
)
 
(12.4)
 %
Total Consolidated
 
$
200,227

 
$
216,861

 
(7.7)
 %
Adjusted EBITDA as a percentage of segment net revenues
 
 
 
 
 
 
North America
 
11.7
%
 
11.4
%
 
 
Europe
 
9.5
%
 
9.4
%
 
 
Australasia
 
10.3
%
 
12.7
%
 
 
Total Consolidated
 
10.2
%
 
10.2
%
 
 
(1)
Adjusted EBITDA is a financial measure that is not calculated in accordance with GAAP. For a discussion of our presentation of Adjusted EBITDA, see Note 13 - Segment Information in our unaudited interim consolidated financial statements.
North America
Net revenues in North America decreased $38.6 million, or 3.1%, to $1,194.8 million in the six months ended June 27, 2020 from $1,233.5 million in the six months ended June 29, 2019. The decrease was primarily due to a reduction in core revenues of 5%, consisting of a decrease in volume/mix of 9% offset by a pricing benefit of 4%, and a 2% increase attributable to the acquisition of VPI.
Adjusted EBITDA in North America decreased $0.2 million, or 0.1%, to $140.1 million in the six months ended June 27, 2020 from $140.3 million in the six months ended June 29, 2019. The decrease was due to unfavorable revenue mix and decreased productivity, partially offset by favorable pricing, reduced salary and benefit costs, and contributions from our VPI acquisition.

42



Europe
Net revenues in Europe decreased $57.3 million, or 9.6%, to $543.0 million in the six months ended June 27, 2020 from $600.4 million in the six months ended June 29, 2019. The decrease was primarily due to a decrease in core revenue of 7%, consisting of a decrease in volume/mix of 8%, offset by a pricing benefit of 1%, and an adverse foreign exchange impact of 3%.
Adjusted EBITDA in Europe decreased $4.9 million, or 8.7%, to $51.7 million in the six months ended June 27, 2020 from $56.6 million in the six months ended June 29, 2019. The decrease was primarily due to the impact of unfavorable foreign exchange and revenue mix, partially offset by improved productivity and favorable pricing.
Australasia
Net revenues in Australasia decreased $61.8 million, or 20.9%, to $233.7 million in the six months ended June 27, 2020 from $295.4 million in the six months ended June 29, 2019. The decrease was due to a reduction in core revenues of 15%, consisting of a decrease in volume/mix of 14% and reduced pricing of 1%, as well as adverse foreign exchange impacts of 6%.
Adjusted EBITDA in Australasia decreased $13.7 million, or 36.3%, to $24.0 million in the six months ended June 27, 2020 from $37.6 million in the six months ended June 29, 2019. The decrease was primarily due to lower volumes from market headwinds, unfavorable revenue mix, pricing, and adverse foreign exchange impacts, partially offset by improved productivity and reduced salary and benefit costs.
Liquidity and Capital Resources
Overview
We have historically funded our operations through a combination of cash from operations, draws on our revolving credit facilities, factoring agreements, and the issuance of non-revolving debt such as our Term Loan Facility and Senior Notes. Working capital, which we define as accounts receivable plus inventory less accounts payable, fluctuates throughout the year and is affected by the seasonality of sales of our products, customer payment patterns, and the translation of the balance sheets of our foreign operations into the U.S. dollar. Typically, working capital increases at the end of the first quarter and beginning of the second quarter in conjunction with, and in preparation for, the peak season for home construction and remodeling in our North America and Europe segments, which represent the substantial majority of our revenues, and decreases starting in the fourth quarter as inventory levels and accounts receivable decline. Inventories fluctuate for raw materials with long delivery lead times, such as steel, as we work through prior shipments and take delivery of new orders.
As of June 27, 2020, our cash balances, including $0.8 million of restricted cash, consisted of $281.9 million in the U.S. and $176.5 million in non-U.S. subsidiaries. In May 2020, we issued $250.0 million in Senior Secured Notes, the proceeds of which were used to repay the outstanding balance under our ABL Facility with the remainder to be used for general corporate purposes. In addition, we amended our Australia Senior Credit Facility to add AUD 30.0 million of additional revolving loan capacity. Although there is uncertainty surrounding the anticipated impact of the recent COVID-19 pandemic on our operating results and liquidity, based on our current level of operations, the seasonality of our business and anticipated growth, we believe that cash provided by operations and other sources of liquidity, including cash, cash equivalents and borrowings under our revolving credit facilities, will provide adequate liquidity for ongoing operations, planned capital expenditures and other investments, and debt service requirements for at least the next twelve months.
As of June 27, 2020, we had total liquidity (a non-GAAP measure) of $808.6 million, consisting of $457.7 million in unrestricted cash, $315.7 million available for borrowing under the ABL Facility, AUD 30.0 million ($20.6 million USD) available for borrowing under the Australia Term Loan Facility, and AUD 21.2 million ($14.6 million USD) available for borrowing under the Australia Senior Secured Credit Facility compared to total liquidity of $554.5 million as of December 31, 2019. The increase in total liquidity was primarily due to the May 2020 Senior Secured Notes issuance.
We may, from time to time, refinance, reprice, extend, retire or otherwise modify our outstanding debt to lower our interest payments, reduce our debt or otherwise improve our financial position. These actions may include repricing amendments, extensions, and/or opportunistic refinancing of debt. The amount of debt that may be refinanced, repriced, extended, retired or otherwise modified, if any, will depend on market conditions, trading levels of our debt, our cash position, compliance with debt covenants and other considerations. Our affiliates may also purchase our debt from time to time, through open market purchases or other transactions. In such cases, our debt may not be retired, in which case we would continue to pay interest in accordance with the terms of the debt, and we would continue to reflect the debt as outstanding in our consolidated balance sheets.
Based on hypothetical variable rate debt that would have resulted from drawing each revolving credit facility up to the full commitment amount, a 1.0% decrease in interest rates would have reduced our interest expense by $3.9 million for the six months ended June 27, 2020. A 1.0% increase in interest rates would have increased our interest expense by $5.5 million for the same period. The impact of these hypothetical changes would have been partially mitigated by interest rate caps and the floors that apply to certain of our debt agreements.

43



Borrowings and Refinancings
In May 2020, we issued $250.0 million of Senior Secured Notes, the proceeds of which were used to repay the outstanding balance under our ABL Facility with the remainder to be used for general corporate purposes. In addition, we amended our Australia Senior Credit Facility to add AUD 30.0 million of additional revolving loan capacity.
In December 2019, we amended our ABL facility to reflect current banking regulatory requirements, which do not have a financial impact.
In September 2019, we amended the Term Loan Facility to provide for an incremental aggregate principal amount of $125.0 million and used the proceeds to repay $115.0 million of outstanding borrowings under the ABL Facility.
In June 2019, we reallocated AUD 5.0 million from the term loan commitment to the interchangeable commitment of the Australia Senior Secured Credit Facility.
As of June 27, 2020, we were in compliance with the terms of all of our Credit Facilities and the indentures governing the Senior Notes and Senior Secured Notes.
Our results have been and will continue to be impacted by substantial changes in our net interest expense throughout the periods presented and into the future. See Note 11 - Long-Term Debt in our consolidated financial statements for additional details.
Factoring arrangements
Our ABS subsidiary, acquired in March 2018, has entered into factoring agreements with a U.S.-based financial institution under which it can elect to sell certain of its accounts receivable under non-recourse agreements. These transactions are treated as a sale and are accounted for as a reduction in accounts receivable because the agreements transfer effective control over and risk of non-collection to the factor. Thus, cash proceeds from these arrangements are reflected as operating activities, including the change of accounts receivable on our statement of cash flows each period. We do not service any factored accounts after the factoring has occurred and do not have any servicing assets or liabilities. We utilize factoring arrangements as part of our financing to manage working capital. The aggregate gross amount factored under these arrangements was $21.5 million and $39.0 million for the six months ended June 27, 2020 and June 29, 2019, respectively. The cost of factoring is reflected in the accompanying unaudited consolidated statements of operations as interest expense with other financing costs and was $0.1 million and $0.1 million for the three months ended June 27, 2020 and June 29, 2019, respectively, and $0.2 million and $0.3 million for the six months ended June 27, 2020 and June 29, 2019, respectively.
Cash Flows
The following table summarizes the changes to our cash flows for the periods presented:
 
 
Six Months Ended
(amounts in thousands)
 
June 27,
2020
 
June 29,
2019
Cash provided by (used in):
 
 
 
 
Operating activities
 
$
38,315

 
$
42,605

Investing activities
 
(38,013
)
 
(113,757
)
Financing activities
 
228,443

 
76,269

Effect of changes in exchange rates on cash and cash equivalents
 
(184
)
 
733

Net change in cash and cash equivalents
 
$
228,561

 
$
5,850

Cash Flow from Operations
Net cash provided by operating activities decreased $4.3 million to $38.3 million in the six months ended June 27, 2020 from $42.6 million in net cash provided by operating activities in the six months ended June 29, 2019. The decrease in cash provided by operating activities was due primarily to decreased earnings offset by impacts from foreign exchange.
Cash Flow from Investing Activities
Net cash used in investing activities decreased $75.7 million to $38.0 million in the six months ended June 27, 2020 from $113.8 million in the six months ended June 29, 2019 primarily due to a decrease in the cash used for acquisitions and a reduction in capital expenditures.

44



Cash Flow from Financing Activities
Net cash provided by financing activities was $228.4 million in the six months ended June 27, 2020 and consisted primarily of increased borrowings of $234.3 million, offset by repurchases of our Common Stock of $5.0 million.
Net cash provided by financing activities was $76.3 million in the six months ended June 29, 2019 and consisted primarily of increased borrowings of $95.4 million, offset by repurchases of our common stock of $20.0 million.
Critical Accounting Policies and Estimates
Management’s Discussion and Analysis of Results of Operations is based upon our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of financial statements in conformity with those accounting principles requires management to use judgments in making estimates and assumptions based on the relevant information available at the end of each period. These estimates and assumptions may have a significant effect on reported amounts of assets and liabilities, revenue and expenses, as well as the disclosure of contingent assets and liabilities because they result primarily from the need to make estimates and assumptions on matters that are inherently uncertain. Actual results may differ from estimates.
Except for certain policy changes due to the adoption of ASU No. 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, management believes there have been no significant policy changes during the six months ended June 27, 2020. For information about recently issued accounting standards, see Note 1 - Description of Company and Summary of Significant Accounting Policies in our unaudited consolidated financial statements.
Holding Company Status
We are a holding company that conducts all of our operations through subsidiaries. The majority of our operating income is derived from JWI, our main operating subsidiary. Consequently, we rely on dividends or advances from our subsidiaries. The ability of our subsidiaries to pay dividends to us is subject to applicable local law and may be limited due to the terms of other contractual arrangements, including our Credit Facilities and the Senior Notes.
The Australia Senior Secured Credit Facility also contains restrictions on dividends that limit the amount of cash that the obligors under these facilities can distribute to JWI. Obligors under the Australia Senior Secured Credit Facility may pay dividends only to the extent they do not exceed 80% of after tax net profits (with a one-year carryforward of unused amounts) and only while no default is continuing under such agreement. For further information regarding the Australia Senior Secured Credit Facility, see Note 11 - Long-Term Debt in our consolidated financial statements.
The amount of our consolidated net assets that were available to be distributed under our credit facilities as of June 27, 2020 was $608.3 million.
Off-Balance Sheet Arrangements
We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future material effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures, or capital resources.

Item 3 - Quantitative and Qualitative Disclosures About Market Risk
We are exposed to various types of market risks, including the effects of adverse fluctuations in foreign currency exchange rates, adverse changes in interest rates, and adverse movements in commodity prices for products we use in our manufacturing. To reduce our exposure to these risks, we maintain risk management controls and policies to monitor these risks and take appropriate actions to attempt to mitigate such forms of market risk. Our market risks have not changed significantly from those disclosed in the 10-K.
Item 4 - Controls and Procedures
Disclosure Controls and Procedures
The Company maintains disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), which are designed to ensure that information required to be disclosed by the Company in reports that it files or submits under the Exchange Act, including this Report, are recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. These disclosure controls and procedures include controls

45



and procedures designed to ensure that information required to be disclosed by the Company under the Exchange Act is accumulated and communicated to the Company’s management, including its principal executive officer (“CEO”) and principal financial officer (“CFO”), as appropriate to allow timely decisions regarding required disclosure. The Company’s management, including the Company’s CEO and CFO, conducted an evaluation of the effectiveness of the Company’s disclosure controls and procedures as of the end of the period covered by this Report and, based on that evaluation, the CEO and CFO concluded that due to material weaknesses in internal control over financial reporting as described in Item 9A - Controls and Procedures in our Form 10-K, the Company’s disclosure controls and procedures were not effective as of June 27, 2020.
Remediation Plan for Previously Identified Material Weaknesses
As described in Item 9A - Controls and Procedures in our Form 10-K, we identified material weaknesses in our internal control over financial reporting and the Company’s management implemented a remediation plan to address the control deficiencies that led to the material weaknesses identified therein. The remediation plan includes the following:
Enhance and supplement the finance team in Europe by increasing the number of roles, reassigning responsibilities, and adding additional resources with an appropriate level of knowledge and experience in internal control over financial reporting commensurate with the financial reporting complexities of the organization;
Enhance the tone, communication and overall awareness of the importance of internal control over financial reporting from executive management;
Evaluate corporate and segment monitoring controls to ensure they are designed and operating at the appropriate level of precision required to support risk mitigation;
Implement enhancements to the design of our customer pricing controls in Europe;
Implement enhancements to the design of our journal entry controls in Europe;
Strengthen procedures and set guidelines for documentation of controls throughout our domestic and international locations for consistency of application; and
Institute additional training programs that occur on a regular basis related to internal control over financial reporting for our world-wide finance and accounting personnel.
During the period ended June 27, 2020, we executed the remediation plan above by:
The onboarding of additional personnel, including an experienced finance executive, in Europe with knowledge and experience in internal control over financial reporting;
conducting targeted web-based training sessions on internal controls over financial reporting, monitoring controls, complex accounting topics, account reconciliations and journal entry controls in Europe; and
implementing enhancements to closing processes that included the continuing centralization of certain tasks, development of manuals and standardized templates to enhance the evidence supporting the local teams’ execution of internal control over financial reporting.
Based on the actions taken to date, while management believes that it now has the requisite personnel to consistently operate the controls as designed, additional controls may need to be designed and implemented as part of the remediation plan, especially with respect to pricing. Additionally, for controls that were newly designed and implemented in 2019, management determined that a sustained period of operating effectiveness is required to conclude that the controls are operating effectively. Accordingly, with the exception of the material weakness related to the reconciliation of subsidiary ledger financial information used in the consolidated financial statements discussed below, the material weaknesses described in Item 9A - Controls and Procedures in our Form 10-K have not been remediated as of June 27, 2020.
Remediation of Material Weakness
As of June 27, 2020, we concluded that the enhancements to the design of our control activities related to the reconciliation of subsidiary ledger financial information used in the consolidated financial statements have been satisfactorily implemented and have operated effectively for a sufficient time. Therefore, it was concluded the material weakness has been remediated as of June 27, 2020.

46



Changes in Internal Control over Financial Reporting
There were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the Company’s most recently completed quarter ended June 27, 2020 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.



47



PART II - OTHER INFORMATION

Item 1 - Legal Proceedings
We are involved in various legal proceedings, claims, and government audits arising in the ordinary course of business. We record our best estimate of a loss when the loss is considered probable and the amount of such loss can be reasonably estimated. When a loss is probable and there is a range of estimated loss with no best estimate within the range, we record the minimum estimated liability related to the lawsuit or claim. As additional information becomes available, we reassess the potential liability and revise our accruals, if necessary. Because of uncertainties related to the resolution of lawsuits and claims, the ultimate outcome may differ materially from our estimates.
Other than the matters described below, as of June 27, 2020, there are no current proceedings or litigation matters involving the Company or its property that we believe would have a material adverse effect on our consolidated financial position or cash flows, although they could have a material adverse effect on our operating results for a particular reporting period.
Steves & Sons Litigation
We sell molded door skins to certain customers pursuant to long-term contracts, and these customers in turn use the molded door skins to manufacture interior doors and compete directly against us in the marketplace. We gave notice of termination of one of these contracts and, on June 29, 2016, the counterparty to the agreement, Steves and Sons, Inc. (“Steves”) filed a claim against JWI in the U.S. District Court for the Eastern District of Virginia, Richmond Division (“Eastern District of Virginia”). The complaint alleged that our acquisition of CMI, a competitor in the molded door skins market, together with subsequent price increases and other alleged acts and omissions, violated antitrust laws, and constituted a breach of contract and breach of warranty. Specifically, the complaint alleged that our acquisition of CMI substantially lessened competition in the molded door skins market. The complaint sought declaratory relief, ordinary and treble damages, and injunctive relief, including divestiture of certain assets acquired in the CMI acquisition.
In February 2018, a jury in the Eastern District of Virginia returned a verdict that was unfavorable to JWI with respect to Steves’ claims that our acquisition of CMI violated Section 7 of the Clayton Act and found that JWI breached the supply agreement between the parties (the “Original Action”). The verdict awarded Steves $12.2 million for past damages under both the Clayton Act and breach of contract claims and $46.5 million in future lost profits under the Clayton Act claim.
On March 13, 2019, the presiding judge entered an Amended Final Judgment Order awarding $36.5 million in past damages under the Clayton Act (representing a trebling of the jury’s verdict) and granting divestiture of CMI, subject to appeal. The judgment also conditionally awarded damages in the event the judgment is overturned on appeal. Specifically, the court awarded $139.4 million as future antitrust damages in the event the divestiture order is overturned on appeal and $9.9 million as past contract damages in the event both the divestiture and antitrust claims are overturned on appeal.
JELD-WEN filed a supersedeas bond and notice of appeal of the judgment, which was heard by the Fourth Circuit Court of Appeals on May 29, 2020.
On April 12, 2019, the plaintiffs filed a petition requesting an award of their fees and a bill of costs, seeking $28.4 million in attorneys’ fees and $1.7 million in costs in connection with the Original Action. That petition remains pending and subject to further appeal. On November 19, 2019, the presiding judge entered an order for further relief, awarding Steves an additional $7.1 million in damages for pricing differences from the date of the underlying jury verdict through May 31, 2019 (the “Pricing Action”). We also appealed that ruling. On April 14, 2020, Steves filed a motion for further supplemental relief for pricing differences from the date of the prior order and going forward through the end of the parties’ current supply agreement. We opposed that request for further relief (the “Future Pricing Action”).
We continue to believe that Steves’ claims lack merit, Steves’ damages calculations are speculative and excessive, and Steves is not entitled in any event to the extraordinary remedy of divestiture of CMI. We believe that multiple pretrial and trial rulings were erroneous and improperly limited the Company’s defenses, and that the judgment in accordance with the verdict was improper for several reasons under applicable law. The judgment, if ultimately upheld after exhaustion of our appellate remedies, could have a material adverse effect on our financial position, operating results, or cash flows, particularly for the reporting period in which a loss is recorded or a payment is required. Because the operations acquired from CMI have been fully integrated into the Company’s operations, divestiture of those operations would be difficult if not impossible and, therefore, it is not possible to estimate the cost of any final divestiture order or the extent to which such an order would have a material adverse effect on our financial position, operating results or cash flows.
During the course of the proceedings in the Eastern District of Virginia, we discovered certain facts that led us to conclude that Steves, its principals and certain former employees of the Company had misappropriated Company trade secrets, violated the

48



terms of various agreements between the Company and those parties, and violated other laws. On May 11, 2018, a jury in the Eastern District of Virginia returned a verdict on our trade secrets claims against Steves and awarded damages in the amount of $1.2 million. The presiding judge entered a judgment in our favor for those damages and the entire amount has been paid by Steves. On August 16, 2019, the presiding judge granted Steves’ request for an injunction, prohibiting us from pursuing certain claims against individual defendants pending in Bexar County, Texas (the “Steves Texas Trade Secret Theft Action”). These claims have been stayed pending appeal.
Separately, on February 14, 2020, Steves filed a complaint and motion for preliminary injunction in the U.S. District Court for the Eastern District of Virginia, Richmond Division, alleging that we breached the long-term supply agreement between the parties, among other claims, including by incorrectly calculating the allocation of door skins owed to Steves (the “Allocation Action”). Steves sought an additional allotment of door skins and damages for violation of antitrust laws, tortious interference, and breach of contract. On April 10, 2020, the presiding judge granted Steves’ motion for preliminary injunction and the parties settled the issues underlying the preliminary injunction on April 30, 2020 and reserved the right to appeal the ruling in the Fourth Circuit Court of Appeals. The Company believed all the claims lacked merit and moved to dismiss the antitrust and tortious interference claims.
On June 2, 2020, we entered into a settlement agreement with Steves to resolve the Pricing Action, the Future Pricing Action, and the Allocation Action. As a result of the settlement, Steves filed a notice of satisfaction of judgment in the Pricing Action, withdrew its Future Pricing Action with prejudice, and filed a stipulated dismissal with prejudice in the Allocation Action. The Company also withdrew its appeal of the Pricing Action. The parties agreed to bear their own respective attorneys’ fees and costs in these actions. In partial consideration of the settlement, JWI and Steves entered into an amended supply agreement satisfactory to both parties that ends on September 10, 2021. This settlement has no effect on the Original Action between the parties that is currently on appeal in the Fourth Circuit except to agree that certain specific terms of the Amended Final Judgment Order in the Original Action shall apply to the amended supply agreement during the pendency of the appeal of the Original Action, nor does this settlement have any effect on the Steves Texas Trade Secret Theft Action, which remains on appeal in the Fourth Circuit. We continue to believe the claims in the settled actions lacked merit and made no admission of liability in these matters.
Cambridge Retirement System Litigation
On February 19, 2020, Cambridge Retirement System filed a putative class action lawsuit in the U.S. District Court for the Eastern District of Virginia against the Company, current and former Company executives, and various Onex-related entities alleging violations of Section 10(b) and Rule 10b-5 of the Exchange Act, as well as violations of Section 20(a) of the Exchange Act against the individual defendants and Onex-related entities.  The lawsuit seeks compensatory damages, equitable relief and an award of attorneys’ fees and costs. The Company believes the claims lack merit and intends to vigorously defend against the action. On May 8, 2020, the Public Employees Retirement System of Mississippi and the Plumbers and Pipefitters National Pension Fund were named as co-lead plaintiffs and filed an amended complaint on June 22, 2020. We filed a motion to dismiss the amended complaint on July 29, 2020.
In Re: Interior Molded Doors Antitrust Litigation
On October 19, 2018, Grubb Lumber Company, on behalf of itself and others similarly situated, filed a putative class action lawsuit against us and one of our competitors in the doors market, Masonite Corporation (“Masonite”), in the Eastern District of Virginia. We subsequently received additional complaints from and on behalf of direct and indirect purchasers of interior molded doors. The suits have been consolidated into two separate actions, a Direct Purchaser Action and an Indirect Purchaser Action. The suits allege that Masonite and we violated Section 1 of the Sherman Act, and in the Indirect Purchaser Action, related state law antitrust and consumer protection laws, by engaging in a scheme to artificially raise, fix, maintain or stabilize the prices of interior molded doors in the United States. The complaints seek unquantified ordinary and treble damages, declaratory relief, interest, costs and attorneys’ fees. The Company believes the claims lack merit and intends to vigorously defend against the actions. On September 18, 2019, the court denied the defendants’ motions to dismiss the lawsuits in their entirety and granted the defendants’ motions to dismiss various state law claims and to limit all claims to a four-year statute of limitations. As a result, the plaintiffs’ damages period is limited to the four-year period between 2014 and 2018. Together with Masonite, we filed motions to oppose class certification in both the Direct Purchaser and Indirect Purchaser Actions on May 19, 2020. Trial in the two matters has been set for February 8, 2021.
Development Emeraude Litigation
On May 15, 2020, Development Emeraude Inc., on behalf of itself and others similarly situated, filed a putative class action lawsuit against us and Masonite in the Superior Court of the Province of Quebec, Canada. The putative class is constituted of any person in Canada who, since October 2012, purchased one or more interior molded doors from us or Masonite. The suit alleges an illegal conspiracy between us and Masonite to agree on prices, the distribution of market shares and/or the production levels of interior molded doors and that the plaintiffs suffered damages in that they were charged and paid higher prices for interior molded doors than they would have had to pay but for the alleged anti-competitive conduct. The plaintiffs are seeking compensatory and punitive damages, attorneys’ fees, and costs. The Company believes the claims lack merit and intends to vigorously defend against the action.

49



We have evaluated the claims against us and recorded provisions based on management’s judgment about the probable outcome of the litigation and have included our estimates in accrued expenses in the accompanying balance sheets. See Note 9 - Accrued Expenses and Other Current Liabilities. While we expect a favorable resolution to these matters, the dispute resolution process could be lengthy, and if the plaintiffs were to prevail completely or substantially in the respective matters described above, such an outcome could have a material adverse effect on our operating results, consolidated financial position, or cash flows.

Item 1A - Risk Factors

Except for the updates to the risk factors set forth below, there have been no material changes in our risk factors from those disclosed in our Annual Report on Form 10-K included in Part I Item 1A - Risk Factors for the year ended December 31, 2019.
The outbreak of COVID-19 has had, and may continue to have, a negative impact on the global economy and on our business, operations, and results.
The COVID-19 pandemic, and the measures taken to contain or mitigate it, have had dramatic adverse consequences for the economy, including on demand for goods and services, operations, supply chains and financial markets. The nature and scope of the consequences to date are difficult to evaluate precisely, and their future course is impossible to predict with confidence.
The COVID-19 crisis has already had several significant effects on our employees, operations, supply chain, distribution system, customer demand, the housing market and general market and economic conditions. The effects to date have included the following:
decreased demand for our products as a result of a slowdown in the U.S. and global economies and resulting decreases in construction and R&R;
increased storage costs as a result of larger volume of inventory that remains unsold; and
uncertain expense management in light of continued efforts to protect our employees and operational issues resulting from absenteeism and closures experienced by our facilities globally.
These effects began in the latter weeks of March 2020 and continued to throughout the second quarter, with the impact of COVID-19 expected to continue throughout the remainder of the year. In response to the effects of COVID-19, our named executive officers elected to reduce their 2020 base salaries by 25% during the second quarter of 2020, or until such time as ratified by the Compensation Committee of our Board. Our non-employee directors also elected to reduce their annual cash fees and committee chair fees by 25% until such time as the Board determines.
We experienced intermittent plant closures during the second quarter of 2020 as mandated by local governments and may continue to see similar closures as the COVID-19 pandemic evolves. Initiatives, including travel restrictions and quarantines, have and may continue to impact a significant percentage of our workforce and the workforce of our suppliers or transportation providers as they are unable to work as a result of the disease outbreak. If additional factory closures are required, current closures are extended, or reductions in capacity utilization levels occur, we expect to incur additional direct costs due to reduced productivity and lost revenue. If our suppliers experience closures or reductions in their capacity utilization levels in the future, we may have difficulty sourcing materials necessary to fulfill production requirements or be required to pay a higher price to fulfill our requirements.
Finally, in May 2020, we issued $250.0 million Senior Secured Notes, the proceeds of which were used to repay the outstanding balance under our ABL Facility with the remainder to be used for general corporate purposes. We cannot assure you that the available proceeds, or any of our other actions, will be sufficient to avoid liquidity constraints in the future or to mitigate any material or adverse effect of COVID-19 on our business, financial condition or results of operations.
The effects of the COVID-19 crisis could be aggravated if the crisis continues, and we could also see additional impacts that might include the following:
complete or partial closures of, or other operational issues at one or more of our manufacturing or distribution facilities resulting from government action;
difficulty sourcing materials necessary to fulfill production requirements or higher prices to fulfill our requirements as a result of suppliers experiencing closures or reductions in their capacity utilization levels;
reduced economic activity severely impacting our customers’ financial condition and liquidity, reducing the likelihood they will be purchasing additional products from us and increasing the likelihood they may require additional time to pay us or will fail to pay us at all, which could significantly increase the amount of accounts receivable and require us to record additional allowances for doubtful accounts;
reduced economic activity resulting in a prolonged recession, which could negatively impact consumer discretionary spending;
a decrease in the principal that may be drawn under our ABL Facility as a result of a decrease in our accounts receivable and inventory;

50



difficulty accessing debt and equity capital on attractive terms, or at all, an impact on our credit ratings, and a severe disruption and instability in the global financial markets or deterioration in credit and financing conditions that affect our access to capital necessary to fund business operations or to address maturing liabilities on a timely basis;
negative impact on our future compliance with financial covenants under our Corporate Credit Facilities and other debt agreements, which could result in a default and potentially an acceleration of indebtedness; and
the potential negative impact on the health of our personnel, particularly if a significant number of them are impacted, decreasing our ability to ensure business continuity during this disruption.
If these effects are sustained, they could have accounting consequences such as impairments of fixed assets or goodwill. They could affect our ability to operate effective internal control over financial reporting. They could also affect our ability to execute our expansion plans or invest in research and development.
The adverse effect on our business, financial condition, or results of operations of any of the matters described above could be material. The future impact of the COVID-19 crisis on our business, financial condition, or results of operations is highly uncertain and will depend on numerous evolving factors that we cannot predict, including, but not limited to:
the duration, scope, and severity of the COVID-19 pandemic;
the disruption or delay of production and delivery of materials and products in our supply chain;
the impact of travel bans, work-from-home policies, or shelter-in-place orders;
the temporary or prolonged shutdown of manufacturing facilities and decreased retail traffic;
staffing shortages;
general economic, financial, and industry conditions, particularly conditions relating to liquidity, financial performance, and related credit issues in our industry, which may be amplified by the effects of COVID-19; and
the long-term effects of COVID-19 on the national and global economy, including on consumer confidence and spending, financial markets and the availability of credit for us, our suppliers and our customers.
To the extent the COVID-19 pandemic or any other global health crisis does adversely affect our business, financial condition, or results of operations, it may also have the effect of heightening many of the “Risk Factors” included herein, in our Annual Report on Form 10-K included in Part I Item 1A - Risk Factors for the year ended December 31, 2019, or as disclosed in any subsequent filings with the SEC.
Prices and availability of the raw materials we use to manufacture our products are subject to fluctuations, and we may be unable to pass along to our customers the effects of any price increases.
We use wood, glass, vinyl and other plastics, fiberglass and other composites, aluminum, steel and other metals, as well as hardware and other components to manufacture our products. Prices and availability of our materials fluctuate for a variety of reasons beyond our control, many of which cannot be anticipated with any degree of reliability. Our most significant raw materials include logs and lumber, vinyl extrusions, glass, steel, and aluminum, each of which has been subject to periods of rapid and significant fluctuations in price. The reasons for these fluctuations include, among other things, variable worldwide supply and demand across different industries, speculation in commodities futures, general economic or environmental conditions, labor costs, competition, import duties, tariffs, worldwide currency fluctuations, freight, regulatory costs, and product and process evolutions that impact demand for the same materials.
The U.S. has imposed tariffs on certain products imported into the U.S. from China, as well as tariffs on certain steel and aluminum products imported from certain countries, and could impose additional tariffs or trade restrictions. The imposition of tariffs may impact the prices of materials purchased outside of the U.S. and include goods in transit as well as increasing the price of domestically sourced materials, including, in particular, steel and aluminum. Impositions of tariffs by other countries could also impact pricing and availability of raw materials. As another example, as global demand for key chemicals increases, the limited number of suppliers and investment in greater supply capacity drives increased global pricing. Additionally, anti-dumping and countervailing duty trade cases, such as the January 8, 2020, Coalition of American Millwork Producers’ anti-dumping petitions on imports of wood moldings and millwork products from Brazil and China and a countervailing duty petition on imports of wood moldings and millwork products from China, could impact our business and results of operations. While we believe our exposure to the potential increased costs of these tariffs and duties is no greater than the industry as a whole, our business and results of operations may be adversely affected if our efforts to mitigate their effects are unsuccessful.
We have short-term supply contracts with certain of our largest suppliers that limit our exposure to short-term fluctuations in prices and availability of our materials, but we are susceptible to longer-term fluctuations in prices. We generally do not hedge against commodity price fluctuations. Significant increases in the prices of raw materials for finished goods, including as a result of significant or protracted material shortages due to pandemic or otherwise, may be difficult to pass through to customers and may

51



negatively impact our profitability and net revenues. We may attempt to modify products that use certain raw materials, but these changes may not be successful.

Item 5 - Other Information
None.
Item 6 - Exhibits

Exhibit No.
 
Exhibit Description
Form
File No.
Exhibit
 
Filing Date
3.1
 
8-K
001-3800
3.1
 
May 13, 2020
3.2
 
8-K
001-3800
3.2
 
May 13, 2020
4.1
 
8-K
001-3800
4.1
 
May 5, 2020
4.2
 
8-K
001-3800
4.2
 
May 5, 2020
10.1+*
 
 
 
 
 
 
31.1*
 
 
 
 
 
 
31.2*
 
 
 
 
 
 
32.1*
 
 
 
 
 
 
101.INS*
 
XBRL Instance Document-the instance document does not appear in this Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
 
 
 
 
 
101.SCH*
 
Inline XBRL Taxonomy Extension Schema Document.
 
 
 
 
 
101.CAL*
 
Inline XBRL Taxonomy Extension Calculation Linkbase Document.
 
 
 
 
 
101.DEF*
 
Inline XBRL Taxonomy Extension Definition Linkbase Document.
 
 
 
 
 
101.LAB*
 
Inline XBRL Taxonomy Extension Label Linkbase Document.
 
 
 
 
 
101.PRE*
 
Inline XBRL Taxonomy Extension Presentation Linkbase Document.
 
 
 
 
 
104*
 
Cover page Interactive Data file (formatted as Inline XBRL and contained in Exhibit 101)
 
 
 
 
 
*
Filed herewith
 
 
 
 
 
+
Indicates management contract or compensatory plan
 
 
 
 
 


52



SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
JELD-WEN HOLDING, INC.
(Registrant)
 
 
By:
/s/ John Linker
 
John Linker
 
Chief Financial Officer

Date: August 5, 2020

53

Exhibit 10.1 EMPLOYMENT AGREEMENT THIS AGREEMENT (the “Agreement”) is made and entered into on [DATE] (the “Effective Date”), by and between JELD-WEN Holding, Inc., a Delaware corporation (the “Company”) and [NAME] (the “Executive”). 1. Term of Employment; Duties. (a) As used herein, the phrase “Term of Employment” shall mean the period commencing on the Effective Date and ending on the date of termination of Executive’s employment in accordance with any one of Sections 5(a) through 5(e) below. (b) The Company hereby agrees to employ Executive as its [TITLE] for the Term of Employment, and Executive agrees to serve in these capacities with the duties and responsibilities customary to such positions in a company of the size and nature of the Company, protecting, encouraging and promoting the interests of the Company, and performing such other duties consistent with the offices held by Executive as may be reasonably assigned to him from time to time by the Chief Executive Officer (“CEO”) or Board of Directors of the Company (the “Board”). During the Term of Employment, Executive shall report solely and directly to the CEO. (c) Executive shall devote all of Executive’s business time and attention to Executive’s duties on the Company’s behalf except for sick leave, vacations and approved leaves of absence; provided, however, that nothing shall preclude Executive from (i) managing Executive’s personal investments and affairs and (ii) participating as a member of the board of directors or similar governing body of no more than one (1) for-profit company which is not a direct competitor of the Company and approved by the Board in writing prior to Executive commencing service therewith and such not-for-profit companies or institutions as do not interfere with the performance of Executive’s duties; provided that in each case, Executive shall not engage in activities inconsistent with the Company’s ethics codes and other conflicts of interest policies in effect from time to time or which materially interfere with or adversely affect the performance of Executive’s duties under this Agreement. 2. Compensation. (a) Base Salary. The Company agrees to pay to Executive as a salary during the Term of Employment the sum of [BASE SALARY AMOUNT] per year, payable in accordance with the normal payroll practices of the Company in the United States as in effect from time to time. The Board shall review, and may adjust in its sole discretion, such base salary no less often than annually. Executive’s annual base salary rate, as in effect from time to time, is hereinafter referred to as the “Base Salary.” (b) Annual Bonuses. During the Term of Employment, Executive shall participate in the Company’s annual Management Incentive Plan or any successor plan (the “MIP”), on terms and conditions that are appropriate to Executive’s positions and responsibilities at the Company and are no less favorable than those applying to other senior executive officers of the Company. Executive’s target annual bonus under the MIP in respect of each Fiscal Year shall be [TARGET PERCENTAGE] of Base Salary and Executive’s maximum annual bonus shall be [MAXIMUM PERCENTAGE] of Base Salary. The Board shall review, and may adjust in its sole discretion, such bonus targets each year when it sets target bonuses for the MIP. Any annual bonus


 
paid to Executive shall be in addition to the Base Salary and to any and all other benefits to which Executive is entitled as provided in this Agreement. Except as in accordance with any deferral election made by Executive pursuant to any deferred compensation plan maintained by the Company, payment of annual bonuses shall be made at the same time that other senior executive officers of the Company receive their annual bonuses. (c) Long-Term Incentive Programs. Executive shall participate in the Company’s 2017 Omnibus Equity Plan or any successor plan and other long-term incentive compensation plans generally available to other senior executive officers of the Company from time to time on terms and conditions that are appropriate to Executive’s positions and responsibilities at the Company and are no less favorable than those generally applicable to such other senior executive officers. 3. Employee Benefit Programs. During the Term of Employment, Executive shall be entitled to participate in all employee retirement, savings and welfare benefit plans and programs made available to the Company’s executive officers, as such plans may be in effect from time to time and on terms and conditions that are no less favorable than those generally applicable to other senior executive officers to the extent not duplicative of benefits provided by this Agreement. 4. Perquisites, Vacations, and Reimbursement of Expenses. During the Term of Employment: (a) The Company shall furnish Executive with, and Executive shall be allowed full use of, office facilities, secretarial and clerical assistance and other Company property and services commensurate with Executive’s position and of at least comparable quality, nature and extent to those made available to other senior executive officers of the Company from time to time; (b) Executive shall be allowed a minimum of [NUMBER] weeks annual vacation and leaves of absence (“PTO”) with pay on a basis no less favorable than that applicable to other senior executive officers of the Company. PTO shall not be accrued, and any unused PTO shall be forfeited; and (c) The Company shall reimburse Executive for reasonable business expenses incurred by Executive in the performance of Executive’s duties hereunder, such reimbursements to be effected in accordance with normal Company reimbursement procedures in effect from time to time. 5. Termination of Employment. (a) Termination Due to Death. In the event that Executive’s employment is terminated due to Executive’s death, the Company’s payment obligations under this Agreement shall terminate, except that Executive’s estate or Executive’s beneficiaries, as the case may be, shall be entitled to the following: (1) (i) the Base Salary through the date of termination, (ii) any earned but unpaid portion of Executive’s annual bonus provided for in Section 2(b) for the Fiscal Year preceding the year of termination, (iii) reimbursement for any unreimbursed business expenses properly incurred by Executive pursuant to this Agreement or in accordance with Company policy 2


 
prior to the date of Executive’s termination, and (iv) such employee benefits, if any, to which Executive may be entitled under the employee benefit plans of the Company according to their terms (the amounts described in clauses (i) through (iv) of this Section 5(a)(1), reduced (but not below zero) by any amounts owed by Executive to the Company, being referred to as the “Accrued Rights”); (2) a pro rata annual bonus provided for in Section 2(b) for the Fiscal Year in which Executive’s death occurs, based on the Company’s actual performance for the entire Fiscal Year, prorated for the number of calendar months during the Fiscal Year that Executive was employed prior to such termination (rounded up to the next whole month), payable at the time annual bonuses are paid for such Fiscal Year to executives of the Company generally (a “Pro Rata Bonus”); and (3) except as otherwise provided in Section 2, Executive’s outstanding stock options, restricted stock, performance share units, and restricted stock units (“Stock Awards”) shall be administered in accordance with the terms of the written agreements setting forth the terms of each such Stock Award. A reduction to any amounts required to be provided or paid pursuant to Section 5(a)(1) that are subject to Section 409A shall not be effective until the amounts payable or provided to Executive under this Agreement sought to be reduced would otherwise have been paid to Executive pursuant to the terms of this Agreement. (b) Termination due to Disability. (1) If, as a result of Executive’s incapacity due to physical or mental illness, accident or other incapacity (as determined by the Board in good faith, after consideration of such medical opinion and advice as may be available to the Board from medical doctors selected by Executive or by the Board or both separately or jointly), Executive shall have been absent from Executive’s duties with the Company on a full-time basis for six consecutive months and, within 30 days after written notice of termination thereafter given by the Company, Executive shall not have returned to the full-time performance of Executive’s duties, the Company or Executive may terminate Executive’s employment for “Disability”. (2) In the event that Executive’s employment is terminated due to Disability, Executive shall be entitled to the following benefits: (i) the Accrued Rights; (ii) a Pro Rata Bonus for the Fiscal Year in which Executive’s termination occurs; and (iii) except as otherwise provided in Section 2, Executive’s outstanding Stock Awards shall be administered in accordance with the terms of the written agreements setting forth the terms of each such Stock Award. 3


 
(c) Termination by the Company for Cause. (1) The Company shall have the right to terminate Executive’s employment at any time for Cause in accordance with this Section 5(c). (2) For purposes of this Agreement, “Cause” shall mean: (i) the conviction or entry of a plea of guilty or nolo contendere to (A) any felony or (B) any crime (whether or not a felony) involving moral turpitude, fraud, theft, breach of trust or other similar acts, whether under the laws of the United States or any state thereof or any similar foreign law to which the person may be subject; (ii) being engaged or having engaged in conduct constituting breach of fiduciary duty, dishonesty, willful misconduct or material neglect relating to the Company or any of its subsidiaries or the performance of a person’s duties; (iii) appropriation (or an overt act attempting appropriation) of a material business opportunity of the Company or any of its subsidiaries; (iv) misappropriation (or an overt act attempting misappropriation) of any funds of the Company or any of its subsidiaries; (v) the willful failure to (A) follow a reasonable and lawful directive of the Company or any of its subsidiaries at which a person is employed or provides services, or the Board of Directors or (B) comply with any written rules, regulations, policies or procedures of the Company or a subsidiary at which a person is employed or to which he or she provides services which, if not complied with, would reasonably be expected to have more than a de minimis adverse effect on the business or financial condition of the Company; (vi) willful and knowing material violation of any (I) material rules or regulations of any governmental or regulatory body that are material to the business of the Company or (II) U.S. securities laws; provided that for the avoidance of doubt, a violation shall not be considered as willful or knowing where Executive has acted in a manner consistent with specific advice of outside counsel to the Company; (vii) failure to cooperate, if requested by the Board, with any investigation or inquiry by the Company, the Securities Exchange Commission or another governmental body into Executive’s or the Company’s business practices, whether internal or external, including, but not limited to, Executive’s refusal to be deposed or to provide testimony at any trial or inquiry; (viii) violation of a person’s employment, consulting, separation or similar agreement with the Company or any non-disclosure, non-solicitation or non-competition covenant in any other agreement to which the person is subject; (ix) deliberate and continued failure to perform material duties to the Company or any of its subsidiaries; or (x) violation of the Company’s Code of Business Conduct and Ethics, as it may be amended from time to time. (3) No termination of Executive’s employment by the Company for Cause pursuant to this Section 5(c) shall be effective unless the provisions of this Section 5(c)(3) shall have been complied with and unless a majority of the members of the Board have duly voted to approve such termination. Executive shall be given written notice by the Board of its intention to terminate him for Cause, which notice (A) shall state in detail the particular circumstances that constitute the grounds on which the proposed termination for Cause is based and (B) shall be given no later than ninety (90) days (or sixty (60) days on or after a Change in Control) after the first meeting of the Board at which the Board became aware of the occurrence of the event giving rise to such grounds. For purposes of this agreement, “Change in Control” shall have the meaning ascribed to it in the 2017 Omnibus Equity Plan. Executive shall have 30 days after receiving such notice in which to cure such grounds, to the extent curable, as determined by the Board in good faith. If Executive fails to cure such grounds within such 30-day period, Executive’s employment with the Company shall thereupon be terminated for Cause. If the Board determines in good faith 4


 
that the grounds are not curable, Executive’s employment with the Company shall be terminated for Cause upon Executive’s receipt of written notice from the Board. (4) In the event the Company terminates Executive’s employment for Cause pursuant to this Section 5(c), Executive shall be entitled to the Accrued Rights. Executive’s outstanding Stock Awards shall be administered in accordance with the terms of the written agreements setting forth the terms of each such Stock Award. (d) Termination Without Cause or for Good Reason. (1) In the event of a Termination without Cause or Resignation for Good Reason (a “Qualifying Termination”), Executive shall be entitled to 30 days’ notice, following which Executive shall receive the Accrued Rights and, subject to (X) Executive’s continued compliance with the provisions of Sections 10, 11, 12 and 13 hereof, and (Y) in the case of a Qualifying Termination which occurs prior to a Change in Control (a “Non-CIC Qualifying Termination”), Executive’s execution and non-revocation of a release of claims substantially in the form attached hereto as Annex A, with such changes as may be required by changes in applicable law (a “Release”) pursuant to Section 5(d)(4), the following: (i) (A) in the event of a Non-CIC Qualifying Termination, a Pro Rata Bonus for the Fiscal Year in which such termination occurs, at the time annual bonuses are paid for such Fiscal Year to executives of the Company generally; or (B) in the event of a Qualifying Termination which occurs on or after a Change in Control (a “CIC Qualifying Termination”), a pro rata annual bonus for the Fiscal Year in which such termination occurs, based on Executive’s target annual bonus for such Fiscal Year, prorated for the number of calendar months during the Fiscal Year that Executive was employed prior to such termination (rounded up to the next whole month), payable (I) in the event of a CIC Qualifying Termination which occurs two (2) years or less following a Change in Control, as soon as practicable following Executive’s termination of employment, and (II) in the event of a CIC Qualifying Termination which occurs more than two (2) years following a Change in Control, at the time annual bonuses are paid for such Fiscal Year to executives of the Company generally; (ii) a severance payment in an amount equal to the sum of (A) and (B) (or, in the event of a CIC Qualifying Termination, an amount equal to two times the sum of (A) and (B)), where (A) is the Base Salary, as in effect immediately prior to the delivery of notice of termination or, for a termination for Good Reason, as in effect immediately prior to the event giving rise to Good Reason, and (B)(1) in the event of a Non-CIC Qualifying Termination, is Executive’s target annual bonus provided for in Section 2(b) of this Agreement for the Fiscal Year in which such termination occurs or, for a termination for Good Reason, Executive’s target annual bonus as in effect immediately prior to the event giving rise to Good Reason, or (2) in the event of a CIC Qualifying Termination, is the average annual short-term incentive compensation bonus (including any bonus or portion thereof that has been earned but deferred, annualized for any fiscal year during which the Participant was employed for less than twelve (12) full months), the Participant received from the Company or any of its affiliates during (i) the three (3) full fiscal years of the Company immediately preceding the Change in Control (or such fewer number of fiscal years during which Executive was employed), or (ii) the three (3) full fiscal years of the Company immediately preceding the Date of Termination (or such fewer number of fiscal years 5


 
during which Executive was employed), if greater, payable (I) in the event of a Non-CIC Qualifying Termination or in the event of a CIC Qualifying Termination which occurs more than two (2) years following a Change in Control, in Twelve (12) equal monthly installments following Executive’s termination or (II) in the event of a CIC Qualifying Termination which occurs on or within two (2) years following a Change in Control, in a single lump sum not later than ten (10) days following Executive’s termination of employment; (iii) in the event of a CIC Qualifying Termination, all Stock Options, RSUs or similar equity incentives shall fully and immediately vest upon termination and all PSUs or similar equity incentives shall vest at target levels prorated for the number of years of service in the applicable performance period prior to termination (rounded up to the next full year) upon termination. In the event of a Non-CIC Qualifying Termination, all equity awards shall be treated in accordance with the applicable agreements; (iv) if Executive elects to continue coverage under the Company’s medical, dental, and/or vision insurance plans pursuant to COBRA following termination of employment, the Company shall pay Executive’s COBRA premiums or otherwise provide continuing coverage for a period of twelve (12) months following termination in the event of a Non-CIC Qualifying Termination and twenty-four (24) months following termination in the event of a CIC Qualifying Termination and timely report the COBRA premiums as taxable income to Executive in a manner necessary for Executive to not incur penalty taxes on such benefits pursuant to Section 409A; and (v) Company will provide Executive with outplacement services not to exceed $10,000 in total value. (2) For purposes of this Agreement, “Change in Control” shall mean the occurrence of any of the following: (i) An acquisition (other than directly from the Company) of any voting securities of the Company (the “Voting Securities”) by any Person, immediately after which such Person first acquires “Beneficial Ownership” (within the meaning of Rule 13d-3 promulgated under the Exchange Act) of fifty percent (50%) or more of the combined voting power of the Company’s then-outstanding Voting Securities; provided, however, that in determining whether a Change in Control has occurred pursuant to this section, the acquisition of Voting Securities in a Non-Control Acquisition (as hereinafter defined) shall not constitute a Change in Control. A “Non-Control Acquisition” shall mean an acquisition by (i) an employee benefit plan (or a trust forming a part thereof) maintained by (A) the Company or (B) any corporation or other Person the majority of the voting power, voting equity securities or equity interest of which is owned, directly or indirectly, by the Company (for purposes of this definition, a “Related Entity”), (ii) the Company or any Related Entity or (iii) any Person in connection with a Non-Control Transaction (as hereinafter defined); (ii) The individuals who, as of the Effective Date of this Plan, are members of the Board (the “Incumbent Board”) cease for any reason to constitute at least a majority of the members of the Board; provided, however, that if the election, or nomination for election by the Company’s common stockholders, of any new director was approved by a vote of 6


 
at least two-thirds of the Incumbent Board, such new director shall, for purposes of this Plan, be considered as a member of the Incumbent Board; provided further, however, that no individual shall be considered a member of the Incumbent Board if such individual initially assumed office as a result of either an actual or threatened solicitation of proxies or consents by or on behalf of a Person other than the Board (a “Proxy Contest”) including by reason of any agreement intended to avoid or settle any Proxy Contest; (iii) The consummation of: (a) A merger, consolidation or reorganization (x) with or into the Company or (y) in which securities of the Company are issued (a “Merger”), unless such Merger is a Non-Control Transaction. A “Non- Control Transaction” shall mean a Merger in which: (i) the stockholders of the Company immediately before such Merger own directly or indirectly immediately following such Merger at least a majority of the combined voting power of the outstanding voting securities of (1) the corporation resulting from such Merger (the “Surviving Corporation”), if fifty percent (50%) or more of the combined voting power of the then outstanding voting securities of the Surviving Corporation is not Beneficially Owned, directly or indirectly, by another Person (a “Parent Corporation”), or (2) if there is one or more than one Parent Corporation, the ultimate Parent Corporation; (ii) the individuals who were members of the Board immediately prior to the execution of the agreement providing for such Merger constitute at least a majority of the members of the board of directors of (1) the Surviving Corporation, if there is no Parent Corporation, or (2) if there is one or more than one Parent Corporation, the ultimate Parent Corporation; and (iii) no Person other than (1) the Company or another corporation that is a party to the agreement of Merger, (2) any Related Entity, (3) any employee benefit plan (or any trust forming a part thereof) that, immediately prior to the Merger, was maintained by the Company or any Related Entity or (4) any Person who, immediately prior to the Merger, had Beneficial Ownership of Voting Securities representing more than fifty percent (50%) of the combined voting power of the Company’s then-outstanding Voting Securities, has Beneficial Ownership, directly or indirectly, of fifty percent (50%) or more of the combined voting power of the outstanding voting securities of (x) the Surviving Corporation, if there is no Parent Corporation, or (y) if there is one or more than one Parent Corporation, the ultimate Parent Corporation; 7


 
(iv) The sale or other disposition of all or substantially all of the assets of the Company and its Subsidiaries taken as a whole to any Person (other than (x) a transfer to a Related Entity or (y) the distribution to the Company’s stockholders of the stock of a Related Entity or any other assets). Notwithstanding the foregoing, a Change in Control shall not be deemed to occur solely because any Person (the “Subject Person”) acquired Beneficial Ownership of more than the permitted amount of the then outstanding Voting Securities as a result of the acquisition of Voting Securities by the Company which, by reducing the number of Voting Securities then outstanding, increases the proportional number of shares Beneficially Owned by the Subject Person; provided that if a Change in Control would occur (but for the operation of this sentence) as a result of the acquisition of Voting Securities by the Company and, after such acquisition by the Company, the Subject Person becomes the Beneficial Owner of any additional Voting Securities and such Beneficial Ownership increases the percentage of the then outstanding Voting Securities Beneficially Owned by the Subject Person, then a Change in Control shall occur. (3) For purpose of this Agreement, “Good Reason” shall mean the occurrence of any of the following subsequent to the Effective Date of this Agreement without Executive’s consent: (i) Prior to a Change in Control, (A) the removal of Executive from the position of [TITLE]; (B) the assignment to Executive of duties that are materially inconsistent with, or that materially impair Executive’s ability to perform, the duties customarily assigned to an [TITLE] of a corporation of the size and nature of the Company; or a change in the reporting structure so that Executive reports to someone other than the CEO or is subject to the direct or indirect authority or control of a person or entity other than the CEO or the Board; (C) any material breach by the Company of this Agreement; (D) conduct by the Company that would cause Executive to commit fraudulent acts or would expose Executive to criminal liability; (E) the Company failing to obtain the assumption in writing of its obligation to perform this Agreement by any successor to all or substantially all of the Company’s business or assets; (F) a relocation of Executive’s principal place of employment to any place which is more than 50 miles from the Company’s corporate headquarters as of the Effective Date; (G) a decrease in Executive’s Base Salary below the Base Salary in effect on the Effective Date, other than an across the board reduction in base salary applicable in like proportions to all senior executive officers; or (H) a decrease in Executive’s target annual bonus percentage or maximum annual bonus percentage under the MIP below those in effect on the Effective Date, other than an across the board reduction of percentages or elimination of the MIP in like proportions to all senior executive officers. (ii) On or after a Change in Control, in addition to anything described in Section 5(d)(3)(i), (A) a substantial change in the nature, or diminution in the status of Executive’s duties or position from those in effect immediately prior to the Change in Control (which will be presumed to have occurred if, immediately following such Change in Control, the Company or its successor is not publicly traded and, if the ultimate parent of the Company is publicly traded, Executive is not [TITLE] of such ultimate parent); (B) a material reduction by the Company of Executive’s Base Salary as in effect on the date of a Change in Control or as in effect thereafter if such Base Salary has been increased and such increase was approved prior to the Change in Control; (C) a reduction by the Company in the overall value of benefits provided to 8


 
Executive (including profit sharing, retirement, health, medical, dental, disability, insurance, and similar benefits, to the extent provided by the Company prior to any such reduction), as in effect on the date of Change in Control or as in effect thereafter if such benefits have been increased and such increase was approved prior to the Change in Control; (D) a failure to continue in effect any MIP, stock option or other equity-based or non-equity based incentive compensation plan in effect immediately prior to the Change in Control, or a reduction in Executive’s participation in any such plan, unless Executive is afforded the opportunity to participate in an alternative incentive compensation plan of reasonably equivalent value; (E) a failure to provide Executive the same number of PTO days per year available to him prior to the Change in Control; (F) relocation of Executive’s principal place of employment to any place more than fifty (50) miles from Executive’s previous principal place of employment; (G) any material breach by the Company of any provision of this Agreement or any equity award agreement; (H) conduct by the Company, against Executive’s volition, that would cause Executive to commit fraudulent acts or would expose Executive to criminal liability or (I) any failure by the Company to obtain the assumption of this Agreement by any successor or assign of the Company; provided, that for purposes of clauses (B) through (E) above, “Good Reason” shall not exist (1) if the aggregate value of all salary, benefits, incentive compensation arrangements, perquisites and other compensation is reasonably equivalent to the aggregate value of salary, benefits, incentive compensation arrangements, perquisites and other compensation as in effect immediately prior to the Change in Control, or as in effect thereafter if the aggregate value of such items has been increased and such increase was approved prior to the Change in Control, or (2) if the reduction in aggregate value is due to the application of Company or Executive performance against the applicable performance targets, in each case applying standards reasonably equivalent to those utilized by the Company prior to the Change in Control. (4) No termination of Executive’s employment by Executive for Good Reason pursuant to Section (5)(d)(3)(i) shall be effective unless the provisions of this Section 5(d)(4) shall have been complied with. Executive shall give written notice to the Company of Executive’s intention to terminate Executive’s employment for Good Reason, which notice shall (i) state in detail the particular circumstances that constitute the grounds on which the proposed termination for Good Reason is based and (ii) be given no later than ninety (90) days after the first occurrence of such circumstances. The Company shall have thirty (30) days after receiving such notice in which to cure such grounds. If the Company fails to cure such grounds within such thirty (30)-day period, Executive’s employment with the Company shall thereupon terminate for Good Reason. (5) This Section 5(d)(5) shall apply only in the event of a Non-CIC Qualifying Termination. The Company shall furnish to Executive within five (5) business days following such termination a Release and Executive must return the Release and it must have become irrevocable before the sixtieth (60th) day after Executive’s termination before any payments or benefits may be provided. If the Release is timely provided and is irrevocable on or before the sixtieth (60th) day following Executive’s termination of employment, the benefits and amounts described in Section 5(d)(1) shall commence to be provided (and provided retroactively to the extent that the payment or benefit would otherwise have been provided but for the requirement of the Release) two (2) business days after the Release is irrevocable but in any event not later than the sixtieth (60th) day after termination of Executive’s employment; provided that if the sixty (60) day period following the termination of Executive’s employment expires in the 9


 
calendar year following the calendar year of Executive’s termination of employment, payments and benefits shall not commence earlier than the calendar year following termination of Executive’s employment. If the Company fails to furnish the form of Release timely to Executive, no Release shall be required and Executive shall be treated as if Executive had timely executed and submitted the Release and such Release had become irrevocable on the tenth (10th) day after termination of Executive’s employment. If Executive fails to submit the Release timely enough so that it is irrevocable on or before the sixtieth (60th) day following termination of employment and the Company has complied with its obligation to furnish the form of Release to Executive within five (5) business days following Executive’s termination of employment, then Executive shall not be entitled to receive any benefits under Section 5(d)(1) other than the Accrued Rights. (e) Voluntary Termination. Executive shall have the right to terminate Executive’s employment with the Company in a voluntary termination at any time upon thirty days’ notice. A voluntary termination shall mean a termination of employment by Executive on Executive’s own initiative, other than a termination due to Disability or for Good Reason. Executive’s voluntary termination shall have the same consequences as provided in Section 5(c) for a termination for Cause. (f) Reduction of Certain Payments. (1) Anything in this Agreement to the contrary notwithstanding, in the event that the receipt of all payments or distributions by the Company in the nature of compensation to or for Executive’s benefit, whether paid or payable pursuant to this Agreement or otherwise (a “Payment”), would subject Executive to the excise tax under Section 4999 of the Code, the accounting firm which audited the Company prior to the corporate transaction which results in the application of such excise tax (the “Accounting Firm”) shall determine whether to reduce any of the Payments paid or payable pursuant to this Agreement (the “Agreement Payments”) to the Reduced Amount (as defined below). The Agreement Payments shall be reduced to the Reduced Amount only if the Accounting Firm determines that Executive would have a greater Net After-Tax Receipt (as defined below) of aggregate Payments if Executive’s Agreement Payments were reduced to the Reduced Amount. If such a determination is not made by the Accounting Firm, Executive shall receive all Agreement Payments to which Executive is entitled under this Agreement. (2) If the Accounting Firm determines that aggregate Agreement Payments should be reduced to the Reduced Amount, the Company shall promptly give Executive notice to that effect and a copy of the detailed calculation thereof. All determinations made by the Accounting Firm under this Section 5(f) shall be made as soon as reasonably practicable and in no event later than sixty (60) days following the date of termination or such earlier date as requested by the Company and the Executive. For purposes of reducing the Agreement Payments to the Reduced Amount, only amounts payable under this Agreement (and no other Payments) shall be reduced. All fees and expenses of the Accounting Firm shall be borne solely by the Company. (3) As a result of the uncertainty in the application of Section 4999 of the Code at the time of the initial determination by the Accounting Firm hereunder, it is possible that amounts will have been paid or distributed by the Company to or for the benefit of Executive pursuant to this Agreement which should not have been so paid or distributed (the “Overpayment”) 10


 
or that additional amounts which will have not been paid or distributed by the Company to or for the benefit of Executive pursuant to this Agreement could have been so paid or distributed (the “Underpayment”), in each case, consistent with the calculation of the Reduced Amount hereunder. In the event that the Accounting Firm, based upon the assertion of a deficiency by the Internal Revenue Service against either the Company or Executive which the Accounting Firm believes has a high probability of success, determines that an Overpayment has been made, Executive shall pay any such Overpayment to the Company together with interest at the applicable federal rate provided for in Section 7872(f)(2) of the Code; provided, however, that no amount shall be payable by Executive to the Company if and to the extent such payment would not either reduce the amount on which Executive is subject to tax under Section 1 and Section 4999 of the Code or generate a refund of such taxes. In the event that the Accounting Firm, based upon controlling precedent or substantial authority, determines that an Underpayment has occurred, any such Underpayment shall be paid promptly (and in no event later than sixty (60) days following the date on which the Underpayment is determined) by the Company to or for the benefit of Executive together with interest at the applicable federal rate provided for in Section 7872(f)(2) of the Code. (4) For purposes hereof, the following terms have the meanings set forth below: (i) “Reduced Amount” shall mean the greatest amount of Payments that can be paid that would not result in the imposition of the excise tax under Section 4999 of the Code if the Accounting Firm determines to reduce Payments pursuant to this Section 5(g) and (ii) “Net After- Tax Receipt” shall mean the present value (as determined in accordance with Sections 280G(b)(2)(A)(ii) and 280G(d)(4) of the Code) of a Payment net of all taxes imposed on Executive with respect thereto under Sections 1 and 4999 of the Code and under applicable state and local laws, determined by applying the highest marginal rate under Section 1 of the Code and under state and local laws which applied to Executive’s taxable income for the immediately preceding taxable year, or such other rate(s) as Executive certifies, in Executive’s sole discretion, as likely to apply to him in the relevant tax year(s). 6. Indemnification and Insurance. (a) The Company and Executive acknowledge that they shall, as soon as reasonably practicable after the Effective Date, enter into an Indemnification Agreement, substantially in the form attached hereto as Annex B, which agreement shall not be affected by this Agreement. (b) The Company agrees that Executive shall be covered as a named insured under the Company’s Directors’ and Officers’ liability insurance as applicable from time to time to the Company’s senior executive officers on terms and conditions that are no less favorable than those applying to such other senior executive officers. 7. No Mitigation; No Offset. In the event of a termination of Executive’s employment for any reason, Executive shall not be required to seek other employment or to mitigate any of the Company’s obligations under this Agreement, and except as otherwise provided in this Agreement, no amount payable under Section 5 shall be reduced by (a) any claim the Company may assert against Executive or (b) any compensation or benefits earned by Executive as a result of employment by another employer, self-employment or from any other source after such termination of employment with the Company. 11


 
8. Designated Beneficiary. In the event of the death of Executive while in the employ of the Company, or at any time thereafter during which amounts remain payable to Executive under Section 5 above, such payments shall thereafter be made to such person or persons as Executive may specifically designate (successively or contingently) to receive payments under this Agreement following Executive’s death by filing a written beneficiary designation with the Company during Executive’s lifetime. Any change in the beneficiary designation shall be in such form as may be reasonably prescribed by the Company and may be amended from time to time or may be revoked by Executive pursuant to written instruments filed with the Company during Executive’s lifetime. Beneficiaries designated by Executive may be any natural or legal person or persons, including a fiduciary, such as a trustee of a trust, or the legal representative of an estate. Unless otherwise provided by the beneficiary designation filed by Executive, if all of the persons so designated die before Executive on the occurrence of a contingency not contemplated in such beneficiary designation, or if Executive shall have failed to provide such beneficiary designation, then the amount payable under this Agreement shall be paid to Executive’s estate. 9. Ethics. During the Term of Employment, Executive shall be subject to the Company’s Code of Business Conduct and Ethics and related policies (the “Policies”), as the Policies may be updated from time to time, which Policies are set forth on the Corporate Governance page of the Company’s website. If for any reason an arbitrator, subject to judicial review as provided by law, or a court should determine that any provision of the Policies is unreasonable in scope or otherwise unenforceable, such provision shall be deemed modified and fully enforceable as so modified to the extent the arbitrator and any reviewing court determines what would be reasonable and enforceable under the circumstances. 10. Confidential Information, Return of Property, Developments. (a) Executive covenants and agrees that, except to the extent the use or disclosure of any Confidential Information is required to carry out Executive’s assigned duties with the Company, during the Term and thereafter: (i) Executive shall keep strictly confidential and not disclose to any person not employed by the Company any Confidential Information; and (ii) Executive shall not use or refer to any Confidential Information. However, this provision shall not preclude Executive from: (x) the use or disclosure of information known generally to the public (other than information known generally to the public as a result of Executive’s violation of this Section), (y) any disclosure required by law or court order so long as Executive provides the Company prompt written notice of any such potential disclosure and reasonably cooperates with the Company to prevent or limit such disclosure to the extent lawful, or (z) communicating with a government office, official or agency. “Confidential Information” means confidential, proprietary or business information related to the Company’s business that is or was furnished to, obtained by, or created by Executive during Executive’s employment with the Company. Confidential Information includes by way of illustration, but is not limited to, such information relating to the Company’s: (A) customers and suppliers, including customer lists, supplier lists, contact information, contractual terms, prices, and billing histories; (B) finances, financial statements, balance sheets, forecasts, profit margins and cost analyses; (C) plans and projections for new and developing business opportunities and for maintaining existing business; and (D) operating methods, business processes and techniques, services, products, prices, costs, service performance, and operating results. For the avoidance of doubt, this provision in no way limits Executive’s obligations or the Company’s rights under applicable trade secrets statutes. 12


 
(b) All property, documents, data, and Confidential Information prepared or collected by Executive as part of Executive’s employment with the Company, in whatever form, are and shall remain the property of the Company. Executive agrees that Executive shall return upon the Company’s request at any time (and, in any event, before Executive’s employment with the Company ends) all documents, data, Confidential Information, and other property belonging to the Company in Executive’s possession or control, regardless of how stored or maintained and including all originals, copies and compilations. (c) Executive hereby assigns and agrees in the future to assign to the Company Executive’s full right, title and interest in all Developments (as defined below). In addition, all copyrightable works that Executive has created or creates in the course of or related to Executive’s employment with the Company shall be considered “work made for hire” and shall be owned exclusively by the Company. “Developments” means any invention, formula, process, development, design, innovation or improvement made, conceived or first reduced to practice by Executive, solely or jointly with others, during Executive’s employment with the Company and that was developed using the equipment, supplies, facilities or trade secret information of the Company or that relates at the time of conception or reduction to practice to: (i) the business of the Company, or (ii) any work performed by Executive for the Company. 11. Noncompete. (a) During the Restricted Period (as defined below), Executive shall not: (i) engage in Competitive Activity (as defined below) within or with respect to the Prohibited Territory (as defined below); or (ii) assist any entity or person to engage in Competitive Activity within or with respect to the Prohibited Territory, whether as an owner, financing source, consultant, employee or otherwise. In interpreting the foregoing, Executive agrees, for example, that Executive communicating about a project located within the Prohibited Territory (whether such communication is by telephone, e-mail, or otherwise) would constitute Executive engaging in activity “within or with respect to the Prohibited Territory” regardless of where Executive may be physically located at the time of that communication. (b) The “Restricted Period” means: (i) the Term; and (ii) the 24-month period following the last day of the Term (the “Separation Date”). (c) “Competitive Activity” means competing against the Company by: (i) engaging in work for a competitor of the Company that is the same as or substantially similar to the work Executive performed on behalf of the Company; and/or (ii) engaging in an aspect of the Restricted Business (as defined below) that Executive was involved with on behalf of the Company. Notwithstanding the preceding, passively owning less than 3% of a public company shall not constitute by itself Competitive Activity or assisting others to engage in Competitive Activity. (d) The “Restricted Business” means: (i) the business engaged in by the Company as of the Separation Date; and (ii) the business of the manufacture, sale and/or distribution of doors and/or windows. (e) “Prohibited Territory” means: (i) Executive’s geographic areas of responsibility for the Company at any point during the 6 months prior to the Separation Date; (ii) the area within 100 miles from Executive’s primary office location(s) for the Company at any point 13


 
during the 6 months prior to the Separation Date; and (iii) the continental United States. As a senior executive with the Company, Executive agrees that Executive’s duties and responsibilities for the Company extend to the entire area of the Company’s operations and that the Company does business throughout the United States. 12. Non-Interference Agreement. (a) During the Restricted Period, Executive shall not: (i) solicit, encourage, or cause any Restricted Client (as defined below) not to do business with or to reduce any part of its business with the Company; (ii) market, sell or provide to any Restricted Client any services or products that are competitive with or a substitute for the Company’s services or products; (iii) solicit, encourage, or cause any supplier of capital, goods or services to the Company not to do business with or to reduce any part of its business with the Company; (iv) make any disparaging comments about the Company or its business, services, officers, managers, directors or employees, whether in writing, verbally, or on any online forum; (v) assist or encourage anyone else to engage in any of the conduct prohibited by this Section; or (vi) allow any of Executive’s family members or any entity controlled by Executive to engage in any of the conduct prohibited by this Section. (b) “Restricted Client” means: (i) any Company customer or client with whom Executive had business contact or communications at any time during the 12 months prior to the Separation Date; (ii) any Company customer or client for whom Executive supervised or assisted with the Company’s dealings at any time during the 12 months prior to the Separation Date; (iii) any Company customer or client about whom Executive received Confidential Information at any time during the 12 months prior to the Separation Date; and (iv) any prospective Company customer or client with whom Executive had business contact or communications at any time during the 6 months prior to the Separation Date. As a senior executive with the Company, Executive agrees that Executive will receive confidential and trade secret information from the Company that would allow Executive to unfairly compete for business from any Company client such that the restrictions in this Section are necessary and reasonable. 13. Non-Raiding. During the Restricted Period, Executive shall not, directly or indirectly: (a) hire or engage or attempt to hire or engage for employment or as an independent contractor any Restricted Employee; or (b) solicit or encourage any Restricted Employee to leave the Company. “Restricted Employee” means: (i) each Company employee; and (ii) any person who was employed by the Company at any time during the then previous 12 months. 14. Reasonableness. Executive has carefully read and considered the provisions of this Agreement and, having done so, agrees that the restrictions set forth herein are fair, reasonable, and necessary to protect the Company’s legitimate business interests, its goodwill with its clients, suppliers and employees, and its confidential and trade secret information. In addition, Executive acknowledges and agrees that the foregoing restrictions do not unreasonably restrict Executive with respect to earning a living should Executive’s employment with the Company end. As such, Executive agrees not to contest the general validity or enforceability of this Agreement in any forum. The post-Term covenants in this Agreement shall survive the last day of the Term and shall be in addition to any restrictions imposed upon Executive by statute, at common law, or other written agreements. Executive agrees that the Company may share the terms of this Agreement with any business with which Executive becomes associated while any of the post-Term restrictions in this Agreement remain in effect. 14


 
15. Remedies. Executive acknowledges and agrees that Executive’s breach of this Agreement would result in irreparable damage and continuing injury to the Company. Therefore, in the event of any breach or threatened breach of this Agreement, the Company shall be entitled to an injunction enjoining Executive from committing any violation or threatened violation of this Agreement, without limiting the Company’s other remedies. The Company shall not be required to post a bond to obtain such an injunction. If the Company is successful in any litigation to enforce this Agreement, then Executive agrees that the Company shall be entitled to the reasonable attorneys’ fees it incurred in connection with such enforcement. In addition, if Executive breaches this Agreement, then (a) Executive will stop earning severance pay under this Agreement and such payments will stop; and (b) Employee agrees to repay any severance pay already paid under this Agreement beyond $2,000. Any such forfeiture and/or repayment of Severance Pay shall in no way impair Employee’s obligations to comply with this Agreement, the effectiveness of the Release, or the Company’s right to injunctive relief and damages for the breach. 16. Certain Affiliates. The “Company” as used in Section 11 (Non-Compete), Section 12 (Non-Interference) and Section 13 (Non-Raiding) shall mean: (a) the Company as defined above and (b) any Company affiliate with or for whom Executive performed services or had responsibilities any time during the last 12 months of the Term. The “Company” as used in Section 10 (Confidential Information, Return of Property, Developments) shall mean the Company and its affiliates. 17. Notices. For purposes of this Agreement, notices and all other communications provided for in the Agreement shall be in writing and shall be deemed to have been duly given when delivered or mailed by United States registered mail, return receipt requested, postage prepaid, or delivered by private courier, as follows: if to the Company — JELD-WEN Holding, Inc., 440 S. Church Street, Suite 400, Charlotte, NC 28202 (or such other address indicated from time to time as the worldwide corporate headquarters of JELD-WEN Holding, Inc. on its website or in its annual proxy statement) Attention: General Counsel; and if to Executive to the address of Executive as it appears in the records of the Company. Notice may also be given at such other address as either party may have furnished to the other in writing in accordance herewith, except that notices of change of address shall be effective only upon receipt. 18. Miscellaneous. This Agreement shall also be subject to the following miscellaneous provisions: (a) The Company represents and warrants to Executive that it has the authorization, power and right to deliver, execute and fully perform its obligations under this Agreement in accordance with its terms. (b) This Agreement contains a complete statement of all the agreements between the parties with respect to Executive’s employment by the Company, supersedes all prior and existing negotiations and agreements between them concerning the subject matter thereof and can only be changed or modified pursuant to a written instrument duly executed by each of the parties hereto and stating an intention to change or modify this Agreement. For the avoidance of doubt, the payments due under this Agreement upon termination apply in lieu of, and not in addition to, any severance policy or practice of the Company. No waiver by either party of any breach by the other party of any condition or provision contained in this Agreement to be 15


 
performed by such other party shall be deemed a waiver of a similar or dissimilar condition or provision at the same or any prior or subsequent time. Any waiver must be in writing and signed by Executive or an authorized officer of the Company, as the case may be. (c) The provisions of this Agreement are severable and in the event that a court of competent jurisdiction determines that any provision of this Agreement is in violation of any law or public policy, in whole or in part, only the portions of this Agreement that violate such law or public policy shall be stricken. All portions of this Agreement that do not violate any statute or public policy shall not be affected thereby and shall continue in full force and effect. Moreover, if any of the provisions contained in this Agreement are determined by a court of competent jurisdiction to be excessively broad as to duration, activity, geographic application or subject, it shall be construed, by limiting or reducing it to the extent legally permitted, so as to be enforceable to the extent compatible with then applicable law. (d) This Agreement shall be governed by and construed in accordance with North Carolina law, without regard to the choice of law principles of any jurisdiction. Each party further agrees that any litigation under this Agreement shall occur exclusively in a state or federal court in Mecklenburg County, North Carolina and in no other venue. As such, each party irrevocably consents to the jurisdiction of and venue in the courts in Mecklenburg County, North Carolina for all disputes with respect to this Agreement. Executive agrees to service of process in any such dispute via FedEx to Executive’s home address, without limiting other service methods allowed by applicable law. The parties agree that the terms in this Section are material to this Agreement, and that they will not challenge the enforceability of this Section in any forum. (e) All compensation payable hereunder shall be subject to such withholding taxes as may be required by law. (f) This Agreement shall be binding upon and inure to the benefit of the successors and assigns of the Company. No rights or obligations of the Company under this Agreement may be assigned or transferred by the Company except that such rights or obligations may be assigned or transferred pursuant to a merger or consolidation in which the Company is not the continuing entity, or the sale or liquidation of all or substantially all of the assets of the Company, provided that the assignee or transferee is the successor to all or substantially all of the assets of the Company and such assignee or transferee assumes the liabilities, obligations and duties of the Company, as contained in this Agreement, either contractually or as a matter of law. The Company further agrees that, in the event of a sale of assets or liquidation as described in the preceding sentence, it shall take commercially reasonable action in order to cause such assignee or transferee to expressly assume the liabilities, obligations and duties of the Company hereunder. Except as expressly provided herein, Executive may not sell, transfer, assign, or pledge any of Executive’s rights or obligations pursuant to this Agreement. (g) The rights of Executive hereunder shall be in addition to any rights Executive may otherwise have under any Company sponsored stock incentive plans or any grants or award agreements issued thereunder. The provisions of this Agreement shall not in any way abrogate Executive’s rights under such stock incentive plans and underlying grants or award agreements. 16


 
(h) The respective rights and obligations of the parties hereunder shall survive any termination of Executive’s employment to the extent necessary to the intended preservation of such rights and obligations. (i) The headings of the sections contained in this Agreement are for convenience only and shall not be deemed to control or affect the meaning or construction of any provision of this Agreement. (j) Each of the parties agrees to execute, acknowledge, deliver and perform, and cause to be executed, acknowledged, delivered and performed, at any time and from time to time, as the case may be, all such further acts, deeds, assignments, transfers, conveyances, powers of attorney and assurances as may be reasonably necessary to carry out the provisions or intent of this Agreement. (k) This Agreement may be executed in two or more counterparts each of which shall be legally binding and enforceable. (l) Without limiting any rights which the Company otherwise has or obligations to which Executive is otherwise subject pursuant to any compensation clawback policy adopted by the Company from time to time, Executive hereby acknowledges and agrees that, notwithstanding any provision of this Agreement to the contrary, Executive will be subject to any legally mandatory policy relating to the recovery of compensation, to the extent that the Company is required to adopt and/or implement such policy pursuant to applicable law, whether pursuant to the Sarbanes-Oxley Act of 2002, the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 or otherwise. 19. Section 409A. (a) Each payment under this Agreement is intended to be a separate payment which is compliant with or excepted from Section 409A, including, but not limited to, by compliance with the short-term deferral exception as specified in Treasury Regulation § 1.409A- 1(b)(4) and the involuntary separation pay exception within the meaning of Treasury Regulation § 1.409A-1(b)(9)(iii), and the provisions of this Agreement will be administered, interpreted and construed accordingly (or disregarded to the extent such provision cannot be so administered, interpreted or construed). (b) In the event that Executive is a “specified employee” (within the meaning of Section 409A and with such classification to be determined in accordance with the methodology established by the Company), amounts and benefits payable or to be provided under this Agreement that are deferred compensation (within the meaning of Section 409A) that would otherwise be paid or provided on account of Executive’s “separation from service” (as defined in Section 409A) during the six-month period immediately following such separation from service (the “Delayed Severance”) shall instead be paid, with interest (other than in respect of any payments for the vesting of Stock Awards) accrued at a per annum rate equal to the prime rate for large banks, as published in the Wall Street Journal on Executive’s separation from service for the period beginning on (but excluding) the date such payment would have been made but for Section 409A of the Code through (and including) the date of payment, on the earlier of (i) Executive’s death or (ii) the first business day after the date that is six months following such separation from service; provided, however, in the event of a CIC Qualifying Termination, the Delayed Severance 17


 
shall, on or as soon as practicable following Executive’s separation from service, be contributed into a rabbi trust established by the Company or the successor thereto. (c) All reimbursements or provisions of in-kind benefits pursuant to this Agreement shall be made in accordance with Treasury Regulation § 1.409A-3(i)(1)(iv) such that the reimbursement or provision will be deemed payable at a specified time or on a fixed schedule relative to a permissible payment event. Specifically, (i) the amount reimbursed or in-kind benefits provided under this Agreement during Executive’s taxable year may not affect the amounts reimbursed or provided in any other taxable year (except that total reimbursements may be limited by a lifetime maximum under a group health plan), (ii) the reimbursement of an eligible expense shall be made on or before the last day of Executive’s taxable year following the taxable year in which the expense was incurred, (iii) in the event that the provision of in-kind benefits requires the Company to impute income to Executive, the Company shall timely impute such income to Executive under applicable tax rules for the appropriate taxable year, and (iv) the right to reimbursements or provisions of in-kind benefits is not subject to liquidation or exchange for other benefit. IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of [DATE]. EXECUTIVE JELD-WEN HOLDING, INC. [NAME] [OFFICER NAME AND TITLE] 18


 
ANNEX A RELEASE OF CLAIMS Executive hereby irrevocably, fully and finally releases JELD-WEN Holding, Inc., a Delaware corporation (the “Company”), its parent, subsidiaries, affiliates, directors, officers, agents and employees (“Releasees”) from all causes of action, claims, suits, demands or other obligations or liabilities, whether known or unknown, suspected or unsuspected, that Executive ever had or now has as of the time that Executive signs this release which relate to Executive’s hiring, Executive’s employment with the Company, the termination of Executive’s employment with the Company and claims asserted in shareholder derivative actions or shareholder class actions against the Company and its officers and Board, to the extent those derivative or class actions relate to the period during which Executive was employed by the Company. The claims released include, but are not limited to, any claims arising from or related to Executive’s employment with the Company, such as claims arising under (as amended) Title VII of the Civil Rights Act of 1964, the Civil Rights Act of 1991, the Age Discrimination in Employment Act of 1974, the Americans with Disabilities Act, the Equal Pay Act, the Fair Labor Standards Act, the California Fair Employment and Housing Act, the California Labor Code, the Employee Retirement Income and Security Act of 1974 (“ERISA”) (except for any vested right Executive has to benefits under an ERISA plan), the state and federal Worker Adjustment and Retraining Notification Act, and the California Business and Professions Code; any other local, state, federal, or foreign law governing employment; and the common law of contract and tort. In no event, however, shall any claims, causes of action, suits, demands or other obligations or liabilities be released pursuant to the foregoing if and to the extent they relate to: (i) claims for workers’ compensation benefits under any of the Company’s workers’ compensation insurance policies or funds; (ii) claims related to Executive’s COBRA rights; (iii) claims for indemnification from the Company to which Executive is or may become entitled, including but not limited to claims submitted to an insurance company providing the Company with directors and officers liability insurance; and (iv) any claims for benefits under any employee benefit plans of the Company that become due or owing at any time following Executive’s termination of employment, including, but not limited to, any ERISA plans, deferred compensation plans or equity plans. Executive represents and warrants that Executive has not filed any claim, charge or complaint against any of the Releasees. Executive intends that this release of claims cover all claims, whether or not known to Executive. Executive further recognizes the risk that, subsequent to the execution of this release, Executive may incur loss, damage or injury which Executive attributes to the claims encompassed by this release. Executive expressly assumes this risk by signing this release and voluntarily and Annex A-1


 
specifically waives any rights conferred by California Civil Code section 1542 which provides as follows: A general release does not extend to claims which the creditor does not know or suspect to exist in Executive’s or her favor which if known by him or her must have materially affected his or her settlement with the debtor. Executive also hereby waives any rights under the laws of the Commonwealth of Virginia, the State of New York, or any other jurisdiction which Executive may otherwise possess that are comparable to those set forth under California Civil Code section 1542. Executive represents and warrants that there has been no assignment or other transfer of any interest in any claim by Executive that is covered by this release. Executive acknowledges that Executive has been given at least 21 days in which to review and consider this release, although Executive is free to execute this release at any time within that 21-day period. Executive acknowledges that Executive has been advised to consult with an attorney about this release. Executive also acknowledges Executive’s understanding that if Executive signs this release, Executive will have an additional 7 days from the date that Executive signs this release to revoke that acceptance, which Executive may effect by means of a written notice sent to the General Counsel of the Company at the Company’s corporate headquarters. If this 7-day period expires without a timely revocation, Executive acknowledges and agrees that this release will become final and effective on the eighth day following the date of Executive’s signature, which eighth day will be the effective date of this release. Executive acknowledges and agrees that Executive’s execution of this release is supported by independent and adequate consideration in the form of payments and/or benefits from the Company to which Executive would not have become entitled if Executive had not signed this release. IN WITNESS WHEREOF, Executive has duly executed this release as of the day and year set forth below. EXECUTIVE [NAME] Date: Annex A-2


 
ANNEX B FORM INDEMNIFICATION AGREEMENT INDEMNIFICATION AGREEMENT [Standard Form] Annex B-1


 
SCHEDULE OF MATERIAL DIFFERENCES TO FORM OF EMPLOYMENT AGREEMENT FOR CERTAIN CURRENT AND FORMER EXECUTIVE OFFICERS Executive John R. Linker Timothy R. Laura W. Doerre Craven Executive’s Title Executive Vice Executive Vice Former Executive Sections 1(b) and President and President, Human Vice President, 5(d)(3)(i) Chief Financial Resources General Counsel Officer and Chief Compliance Officer Executive’s Base Salary $450,000 $315,000 $500,000 Section 2(a) Executive’s MIP Target / 75% and 150% 60% and 120% 75% and 150% Maximum Section 2(b) Vacation and PTO Five (5) Five (5) Five (5) Section 4(b)


 
Exhibit 31.1

CERTIFICATION OF PERIODIC REPORT UNDER SECTION 302 OF
THE SARBANES-OXLEY ACT OF 2002

I, Gary S. Michel, certify that:
1.
I have reviewed this Quarterly Report on Form 10-Q for the fiscal period ended June 27, 2020 of JELD-WEN Holding, Inc.;
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 5, 2020

/s/ Gary S. Michel
Gary S. Michel
President and Chief Executive Officer
(Principal Executive Officer)

Exhibit 31.2

CERTIFICATION OF PERIODIC REPORT UNDER SECTION 302 OF
THE SARBANES-OXLEY ACT OF 2002

I, John Linker, certify that:
1.
I have reviewed this Quarterly Report on Form 10-Q for the fiscal period ended June 27, 2020 of JELD-WEN Holding, Inc.;
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; and
(c)
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 5, 2020


/s/ John Linker
John Linker
Executive Vice President and Chief Financial Officer (Principal Financial Officer)

Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to 18 U.S.C. §1350, we, the undersigned officers of JELD-WEN Holding, Inc. (the “Company”), do hereby certify that the Company's Quarterly Report on Form 10-Q for the fiscal period ended June 27, 2020 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


Date: August 5, 2020

      /s/ Gary S. Michel
Gary S. Michel
President and Chief Executive Officer
(Principal Executive Officer)


      /s/ John Linker         
John Linker
Executive Vice President and Chief Financial Officer (Principal Financial Officer)


The foregoing certification is being furnished solely pursuant to 18 U.S.C. §1350 and is not being filed as part of the Report or as a separate disclosure document.